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The stepped-wedge cluster randomised trial (SW-RT) is an increasingly used alternative to 
the standard parallel cluster randomised trial (P-CRT). This thesis extends the existing 
knowledge to enhance the methodological quality of future SW-CRTs. 
A methodological review of sample size calculations found a poor standard of reporting and 
substandard methodological rigor. Two key points emanating from the review were the lack 
of consideration of the decay of correlation over time, and little evidence of varying cluster 
size being included in the sample size calculation. 
Since SW-CRTs are longitudinal in design, they can be split into numerous time-periods – 
which may impact the correlation structure of the observations within a cluster. The intra-
cluster correlation coefficient is usually used in sample size calculations, but may not be 
sufficient in longitudinal CRTs. Instead the decay of correlation over time may need to be 
described using the inter-period correlation and the within-period correlation. However, 
there is currently a dearth in the literature on likely values of these – for which a set of 
estimates are reported for outcomes associated with type-2 diabetes. 
Though CRTs are likely to contain varying cluster size, there is a paucity of research into the 
effect of varying cluster size in a SW-CRT and a lack of appropriate methodology to adjust 
power calculations when clusters vary in size. A simulation study provides evidence that the 
SW-CRT is affected less, on average, than a P-CRT by varying cluster size, but there is a much 
larger degree of variability in the power of a SW-CRT. A practical method for estimating 
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CHAPTER 1:      INTRODUCTION 
 
1.1 Cluster randomised trials 
Clustered randomised trials (CRTs) are often a more feasible trial type than a conventional 
individually randomised controlled trial (RCT) (1). Situations may arise in which the 
intervention can be more naturally implemented at the cluster level, such as an obesity 
prevention programme targeting primary schools (2). In these situations, the randomisation 
of clusters, rather than the individuals within them, may reduce the risk of contamination 
(1). Another reason that a CRT may be more appropriate than an individually randomised 
trial is financial limitations - whereby the cost of implementing an intervention at the cluster 
level may be significantly less than implementation at the individual level (3). Additionally, 
the randomisation of clusters may alleviate concerns with ethics, or logistics, which may 
otherwise be present with an individually randomised design.  
 
1.2 Different forms of a cluster randomised trial 
When considering CRTs, there are a variety of ways in which they may be setup, some of 
which are highlighted below. 
1.2.1 Parallel cluster randomised trials 
The most common design type is the parallel cluster randomised trial (P-CRT). A P-CRT 
involves randomising half of the clusters to the intervention, and the remaining half to the 
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control. Figure 1.1 shows that all participants in the cluster either receive the intervention 
(shaded region) or the control (non-shaded region), and the intervention is not removed 
once implemented. 




1.2.2 Cluster randomised crossover trials 
A cluster randomised crossover (CRXO) design implements the intervention in all clusters in 
the study, but removes the intervention from some of the clusters during the study. A CRXO 
trial typically incorporates two time-periods, with half of the clusters randomised to receive 
the intervention during time-period one, before switching to the control during time-period 
two, whilst the other half receive the control during time-period one before switching to the 
intervention during time-period two (Figure 1.2).  
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Some CRXO trials require a washout period to remove the effects of the treatment from the 
participants (or clusters) (4). This washout period may extend the study duration by a 
significant amount and require knowledge of the dynamics of the treatment which may be 
unknown during the planning stage of a trial. In trials in which the intervention is an 
educational package, it may be impossible to withdraw the intervention, since it would be 
impossible to unlearn a skill – see for example, the trial by Bashour et al. (5).  
 
1.3 Stepped-wedge cluster randomised trials 
A stepped-wedge cluster randomised trial (SW-CRT) involves the sequential, but random, 
rollout of the intervention to clusters over multiple time-periods (6-8) and so can be viewed 
as a unidirectional crossover trial. In a SW-CRT, rather than randomising clusters to an 
intervention or control at the study beginning, the clusters are randomised to a time-period 
in which they will receive the intervention. A SW-CRT typically involves collecting 
observations at a baseline period in which no clusters are exposed to the intervention, and 
then at regular intervals (time-periods) in which the intervention is rolled out to a cluster (or 
group of clusters) – who then cross from the control condition to the intervention condition. 
This process continues at each time-period (step) until all clusters have crossed over to 
receive the intervention. A SW-CRT usually has one time-period in which observations are 
made whilst all clusters are exposed to the intervention.  
Observations are typically made in every cluster during each time-period in which a new 
cluster is exposed to the intervention (9). However, there is some thoughts as to whether a 
SW-CRT can contain designs in which observations are not collected at each time-period or 
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do not contribute to the analysis (9-12). By collecting data during each time-period, each 
cluster contributes observations to the control and intervention conditions. A key aspect of 
the SW-CRT is that the intervention is not removed once implemented. Nevertheless, whilst 
here we are concerned with clusters crossing from unexposed to exposed, there have been 
instances of individual randomised stepped-wedge trials (13-17) and studies that cross from 
exposed to unexposed (18).  
Figure 1.3 illustrates a SW-CRT, alongside a CRXO trial and a P-CRT for a trial with 4 clusters 
(or four groups of clusters).  





In a P-CRT, clusters are randomised to receive the control or intervention only; whilst in a 
CRXO trial, clusters are randomised as to whether they will receive the control or 
intervention first. In a SW-CRT the time-period in which the cluster will crossover to the 
intervention is randomised. 
Unlike a P-CRT and CRXO trial, in a SW-CRT, as time increases, the number of clusters 
exposed to the intervention increases. This means that more clusters are exposed to the 
intervention at later time-periods than earlier ones. As such, an underlying temporal trend 
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may confound the intervention effect, and so the effect of time must be accounted for in 
pre-trial power calculations and post-trial analysis. 
1.3.1 A typical stepped-wedge cluster randomised trial 
In a traditional SW-CRT, one cluster crosses from unexposed to exposed at each step. As 
such, in a traditional SW-CRT with 5 clusters, the study would contain 5 crossover points. 
There would be one additional time-period in which data is collected whilst all clusters are 
unexposed, resulting in 6 time-periods. However, the SW-CRT could also contain a group of 
clusters crossing over at each step.  
There have been many examples in the methodological literature and in trial reports of SW-
CRTs following a non-typical design. A SW-CRT may look like the design given in Figure 1.3, 
but it is not a necessity. All clusters switch from the control to the intervention during a SW-
CRT, but this transition may not be instantaneous (19). In these circumstances, clusters may 
not be fully exposed to the intervention, and so the cluster may be considered as being in a 
transition period. This transition period can easily be displayed on an illustration of the 
design (Figure 1.4). Alternatively, the concept of an incomplete design can be used, which 
indicates that at some steps, and for some clusters, data is not collected, or does not 
contribute towards the analysis (9, 10). This can be achieved in a trial by not taking 
measurements, or by not including observations in the analysis, and would allow other 
designs to be considered as incomplete SW-CRTs (20). 
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Since a SW-CRT contains multiple time-periods, it is often suggested that repeated 
observations from a participant is required (11, 12, 21). However, this may not be the case, 
and whilst participants may be followed up for the entire study, it is also possible to recruit 
new participants at each time period. This leads us to define three different design types for 
a SW-CRT: a cross-sectional design, a cohort design, or an open cohort design, which we 
discuss below.  
 
1.4 Cross-sectional, cohort and open cohort designs 
As with other CRTs, observations within a SW-CRT may stem from repeat measurements of 
the same cohort of participants, who are recruited at the start of the study and followed-up 
for the study length (cohort design); from single measurements taken from individual 
participants, with new participants recruited at each step (cross-sectional design); or a 
mixture of the two designs, in which some participants are followed-up for multiple steps, 
but participants are free to join and leave the study (open cohort design) (6, 22, 23). 
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Although the term is not used here, a cross-sectional design may instead be described as a 
continuous recruitment with short-exposure design (19). 
Both a cohort design and a cross-sectional study design can be depicted by a schematic 
representation, which easily allows the difference between the designs types to be seen 
(Figure 1.5). When illustrating a study design in this manner, each block indicates a distinct 
group of participants. In the cross-sectional designs, there is a separate block at each time-
period, indicating a new group of participants at each time-period. In the cohort design, one 
block covers the entire study length, signifying that the same participants are followed-up 
for the study duration. 
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In a SW-CRT that follows a cross-sectional design, the correlation between observations 
within a cluster is assumed to be independent of the timing in which the observations are 
made. However, in a cohort design (or an open cohort design) participants are followed up 
throughout the study, and so there will be a within-participant correlation over time.  
Although the cohort and open cohort designs are commonly used, the methodology 
surrounding the estimation of sample size and post-trial analysis differs from the cross-
sectional design. The assumption of a cross-sectional design for a SW-CRT allows for simpler 
statistical modelling, and so the cross-sectional design has been studied in much more depth 
than the cohort and open cohort design. In this thesis, we focus on the cross-sectional 
design. 
An alternative view of the designs has been presented based upon the exposure and 
measurement of observations in which a SW-CRT can be broken down into three types – 
continuous recruitment with short exposure, closed cohort, and open cohort (19). 
 
1.5 Introduction of terminology and notations 
To create consistency throughout this work, some terminology and basic notation will be 
introduced here. Whilst notations will be explained again, where appropriate, some 
clarification is provided here.  
1.5.1 General notation 
When discussing the total number of clusters that a study involves, we shall denote this as C. 
This is the total number of unique clusters, and not the number of groups of clusters. The 
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number of time-periods in a study is denoted as T. Although in a conventional SW-CRT, this 
is simply the number of clusters plus one, this is not always the case.  
1.5.2 Describing the study design 
When considering the design of a SW-CRT, whilst the schematic representation is easy to 
understand, in some situations it is better represented in matrix form. By denoting the 
design of a study in matrix form, it can be transformed easily for use in power calculations 
(see chapter 5). Throughout this body of work, we denote the matrix that represents the 
study design as the design pattern matrix (DPM). The design pattern matrix typically 
comprises of 0’s and 1’s, where a “0” indicates that the cluster is not exposed to the 
intervention and a “1” indicates that the cluster is exposed to the intervention. If we 
consider the cross-sectional study design given in Figure 1.5, then the corresponding design 
pattern matrix can be given by Figure 1.6. 






















1.5.3 Describing cluster sizes 
Since the SW-CRT is comprised of multiple time-periods, the size of a cluster can relate to 
one of two concepts: the size of a cluster at one time-period (the cluster-period size, 𝑚); or 
the size of a cluster over the whole study period (the total cluster size, 𝑀). The 
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differentiation between the cluster-period size (𝑚) and the total cluster size (𝑀) is 
important when considering whether a SW-CRT is a cross-sectional or cohort design.  
Consider a SW-CRT that may follow either a cohort or cross-sectional design, in which 
observations of participants are made during 5 time-periods and the cluster-period size (𝑚) 
is 50. In a cohort design, participants are followed-up for the study duration, with repeated 
measurements for each participant. Here, each of the 50 participants have 5 observations 
(one per time-period), but the total cluster size will still be 50. Here, 𝑚 = 50 and 𝑀 = 50. In 
a cross-sectional design, new participants are recruited at each time-period, so that at each 
time-period, there are 50 new participants that each have one observation made. Now, the 
total cluster size will be 250 (= 50 x 5). Here 𝑚 = 50 and 𝑀 = 250. 
1.5.4 Summary 
A summary of the terminology and notations that are used throughout this work is given 
below in Table 1.1. 
Table 1.1: Summary of terminology and notation used 
Terminology Notation Definition 
Cluster-period size 𝑚  The size of a cluster during one 
measurement period 
 
Total cluster size M The size of a cluster over the 
study duration 
 
Design pattern matrix DPM A matrix that can represent 
the study design 
 
The number of clusters C The total number of clusters in 
the study 
 
Number of time-periods T The total number of time-
periods in the study 
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1.6 Examples of a SW-CRT 
To provide further understanding, a selection of SW-CRTs are presented below, which are 
reflected on throughout this body of work. For each SW-CRT, we introduce the study aims, 
alongside some basic details of the study, and a schematic representation of the study 
design.  
1.6.1 Example 1 – The WOSLAD trial 
Effect of training doctors in communication skills on women’s satisfaction with doctor-
woman relationship during labour and delivery: a stepped wedge cluster randomised trial 
in Damascus 
The first study we highlight is a SW-CRT to determine the effect of training hospital staff in 
interpersonal and communications skills to improve women’s satisfaction with doctor-
participant relations in labour and delivery room, and we refer to this as the WOSLAD trial 
(5). This cross-sectional SW-CRT involved the randomisation of 4 hospitals (clusters) over 4 
randomisation steps with one additional period following the roll-out (Figure 1.7). Each step 
was 2 months in duration, resulting in a 10 month study. The study contained 5 time-periods 
and a fixed cluster size of 100 participants per cluster per time-period were recruited, 
resulting in 2000 (= 5 x 100 x 4) participants in the study. The included study population 
were women delivering a baby at each of the included hospitals. The intervention was 
educational based, with a training package in communication skills given to all resident 
healthcare professionals at the included hospitals, whilst usual care was conducted in 
unexposed clusters. The primary outcome was women’s satisfaction with interpersonal and 
communication skills of doctors – measured using a Likert scale questionnaire, with higher 
Page | 12 
 
scores indicating higher satisfaction. The cluster sizes were fixed at 100, so that only the first 
100 participants would be included in the study. As such, there was no variation in the 
cluster size. The sample size was carried out using the Hussey and Hughes methods – which 
we discuss in section 2.4.1 – but they did not report a measure of correlation between 
observations within a cluster.  
 





1.6.2 Example 2 – The ICCOT trial 
Introducing Critical Care Outreach: a ward randomised trial of phased introduction in a 
general hospital 
The second study aims to investigate whether critical care outreach teams (CCOTs) impact 
in-hospital mortality and length of stay, and we refer to this as the ICCOT study (24). This 
incomplete cross-sectional SW-CRT involved the randomisation of 16 acute wards (clusters) 
within a hospital over 8 randomisation steps, which included a transition phase (Figure 1.8). 
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Each step was 4 weeks in duration, resulting in a 32 week study. All participants admitted to 
a ward were included, with 2,903 participants contributing to the primary analysis. The 
intervention involved educational support and practical help to existing staff, as well as the 
addition of a team of specialist critical care nurses to provide support. Unexposed clusters 
received usual care. The primary outcome was in-hospital mortality. The study included all 
participants admitted to each of 16 wards within the hospital, but did not describe the 
average ward size or whether the wards were likely to vary in terms of the number of 
included participants. There is no mention of the correlation between observations within 
the power calculation. Noticeably, in this SW-CRT, wards 1 and 2 do not contribute any 
observations to the control period, and wards 15 and 16 do not contribute any observations 
to the intervention period. 
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1.6.3 Example 3 – The ERFIC trial 
A stepped-wedge cluster randomised controlled trial for evaluating rates of falls among 
inpatients in aged care rehabilitation units receiving tailored multimedia education in 
addition to usual care: a trial protocol 
The third study aims to evaluate the effectiveness of patient education on the number of 
falls occurring in a rehabilitation unit, which we refer to as the ERFIC trial (25). This cross-
sectional SW-CRT involves the randomisation of eight rehabilitation units (clusters) over four 
randomisation steps (Figure 1.9), with five time-periods in total. Each step lasted 10-weeks, 
resulting in a 50-week study. The clusters vary in size, and the sizes are known prior to the 
study, as they are the number of beds per unit, and are given in ascending order as: 14, 17, 
20, 20, 24, 30, 36, and 90. This does not correspond to the order the clusters were 
randomised in. Only patients who were over 60 years old, cognitively intact, and likely to 
benefit from the intervention were included in the study. The intervention included patient 
education, delivered by a physiotherapist, alongside a series of follow-up sessions. Clusters 
unexposed to the intervention received usual care. The primary outcome was the number of 
falls made by the patient whilst at the rehabilitation unit. In the power calculation, the 
average cluster size was used, with no discussion of the variation in cluster sizes. A design 
effect appropriate for a P-CRT was used to calculate the sample size. An intra-cluster 
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1.7 Importance of improving methodology in SW-CRTs 
The SW-CRT is still a relatively novel design and there is limited methodological research 
other than into sample size and efficiency, in which a restrictive model framework has been 
used. As such, there are still many gaps in the literature. For example, it is often assumed 
when estimating the power of a SW-CRT that a) the correlation between observations within 
a cluster is independent of the timing of the observations, and b) that the clusters are of 
equal size. As such, it is likely that pre-trial sample size calculations will not report any 
deviation to these two assumptions. This is emphasised by the sample size calculations for 
each of the three example SW-CRTs given in section 1.6. The correlation between 
observations within a cluster was not reported in the sample size calculation in two of the 
examples, whilst the third used the ICC – which assumes that the correlation is independent 
of the timing of the observations. In terms of cluster size in the sample size calculation, of 
the examples given, one uses a fixed sampling rate, and so the size will not vary between 
clusters; one did not report the average cluster size or whether any variation would be 
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present; and one reported the known (and varying) cluster sizes – but did not account for 
this in the power calculation. Recently, the literature has made calls for research into the 
decay of correlation over time in a SW-CRT, with emphasis on the publication of values of 
the correlation for future use (26, 27). Additionally, there has been little evidence of 
research into varying cluster size, and whether the methodology exists to deal with it in a 
SW-CRT.  
 
1.8 Aims and overview of thesis 
The overarching aim of this thesis is to develop the understanding of some key design 
features of a SW-CRT. In particular, there are four key aims that this work seeks to address: 
1. Review the sample size calculations for SW-CRTs to assess whether they are 
sufficiently reported, and whether appropriate methodology has been used.  
2. Evaluate the validity of the assumption that the correlation between observations 
within a cluster is independent of time.  
3. Demonstrate the impact of varying cluster size in a SW-CRT, and make comparisons 
to the impact of varying cluster size in a P-CRT. 
4. Propose a method for estimating power in a SW-CRT when clusters vary in size. 
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1.9 Summary 
The thesis has seven chapters. Chapter 2 reviews the current methodological literature to 
motivate the research aims. Chapter 3 focuses on reviewing published SW-CRTs to assess the 
quality of reporting. Chapter 4 focuses on the correlation structure in CRTs. Chapters 5 and 6 
focus on varying cluster size. A chapter outline is given below. 
Chapter 2 appraises the current methodological literature in SW-CRTs. The main aim is to 
establish the literature already published, and the current knowledge gaps. 
Chapter 3 is a methodological review of SW-CRTs. The CONSORT statement for RCTs and the 
CONSORT extension for CRTs are used to assess the quality of reporting of sample size 
calculations in published SW-CRTs. A selection of SW-CRT specific items is also included. An 
assessment of the methodology is presented to highlight whether previous SW-CRTs have 
adjusted for varying cluster size or used an extended correlation structure.  
Chapter 4 presents a framework for estimating time-dependent correlation in longitudinal 
CRTs, and defines three types of correlation for settings in which the correlation between 
observations is dependent on the timing of them. Estimates of the correlation are illustrated 
for relevant outcomes associated with type-2 diabetes. Also presented is a comparison of 
methods to be used to estimate the correlation between observations within a cluster for 
binary outcomes.  
Chapter 5 uses simulation to determine the impact of varying cluster size in a SW-CRT. 
Particularly, to assess how a SW-CRT with varying cluster size compares to a SW-CRT with 
equal cluster size in terms of precision of a treatment effect estimate. A variety of scenarios 
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are used to fully evaluate the impact. The methodology is extended to P-CRTs, to compare 
how varying cluster size affects a SW-CRT in relation to a P-CRT. 
Chapter 6 proposes a Stata function for estimating power in a SW-CRT, by applying the 
methodology used in Chapter 5. A variety of examples are presented to illustrate how this 
function can be used in practice. 
Chapter 7 includes a discussion of the overall findings from this thesis. This includes the 
implications on current research and recommendations for future work.   
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CHAPTER 2:      LITERATURE REVIEW 
 
2.1 Introduction 
The stepped-wedge cluster randomised trial (SW-CRT) is a relatively new study design, and 
so there is a dearth of literature compared to other trial designs. A SW-CRT generally 
involves an intervention related to education or training, within a health care environment 
(28). The increasing amount of trial publications has led to a growth in the methodological 
literature. Early systematic reviews in this area found few trials using this design (23, 29), but 
this has increased in recent years (30). Below, we discuss the systematic reviews of SW-CRTs 
that have been published. 
2.2 Results from previous systematic reviews 
There have been numerous reviews of the SW-CRT literature in order to evaluate the design. 
Early systematic reviews aimed to give an overview of the SW-CRT (23, 29), whereas recent 
reviews intended to address more specific problems – such as the design rationale (28) and 
the statistical methodology used (31).  
2.2.1 The Brown and Lilford systematic review 
The first systematic review of both randomised and non-randomised stepped-wedge studies 
in healthcare was carried out in 2006 by Brown and Lilford (23). The review identified 12 SW 
trials that used either individual level randomisation (4 studies) or cluster level 
randomisation (8 studies) – of which 3 were cohort designs, and 5 were cross-sectional. Only 
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studies designed with multiple baselines were excluded. It was identified that there was an 
inconsistency in the motivation for using a SW design, but that a SW-CRT could be useful for 
the evaluation of an intervention in developing countries. However, there was an 
inconsistent approach to the reporting of the study, and of the data analysis. None of the 
included studies would have filled the CONSORT requirements for the reporting of items 
related to randomisation. 
2.2.2 The Mdege systematic review 
A 2010 systematic review investigated the motivation for carrying out a SW-CRT (29). As 
such, they excluded studies in which the randomisation was carried out at the participant 
level. They also excluded studies that were retrospectively analysed as a SW-CRT when they 
were not originally designed as one. The 25 included studies highlighted that a SW-CRT may 
be useful the evaluating an intervention that is believed to do more good than harm, but in 
which there is lack of evidence of effectiveness. Additionally, a SW-CRT may be more 
suitable than other trial designs for the evaluation of the routine implementation of an 
intervention with proven efficacy. However, the included studies were generally of low 
reporting quality – particularly whether the trial was randomised or whether a power 
calculation had been used. There was also little reporting of sequence generation, allocation 
concealment, or blinding, and few studies published a flow diagram of participants through 
the study. The review also found a large heterogeneity in the analysis methods used and so 
called for standardised data analysis and reporting. There was no indication of whether trials 
followed a cross-section or cohort design, but many of the studies contained only two 
randomisation steps.  
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2.2.3 The Beard systematic review 
A 2015 systematic review of articles published between 2010 and 2014 identified 37 
relevant publications (28). This review focused on the types of intervention used, what the 
studies primary outcome was (and data type), the rationale for conducting a SW-CRT, and 
whether a sample size calculation was reported. It is shown that SW-CRTs are increasing in 
frequency – particularly in high-income countries. The majority of the included SW-CRTs 
involved a training/education based intervention which made a cross-over design impossible 
as the intervention could not be removed once implemented. It was highlighted that a SW-
CRT was often chosen over a P-CRT to prevent participants randomised to the control arm 
from dropping out, and that a potentially effective intervention should not be withheld from 
participants. The review highlighted a lack of reporting of the trial design and of a sample 
size calculation, and echoed calls for guidance for the reporting of a SW-CRT. 
2.2.4 The Barker systematic review 
A 2016 review included 102 articles, identifying the statistical methods used in the analysis 
and whether the sample size methodology was appropriate (31). Upon highlighting the 
primary outcome, they emphasise the statistical method used in the analysis, and whether 
an adjustment for time was made. There was a large heterogeneity in the analysis methods 
used. Although the majority acknowledged the longitudinal nature of a SW-CRT, there was 
evidence of many studies not including time in the analysis. They also report whether a 
sample size justification was made, and if so, what methodology was used. They also state 
the design type of the included studies. They found that the sample size calculation was 
often done using either a design effect appropriate for a P-CRT, or by the methods 
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recommended by Hussey and Hughes (32) – which we later discuss. However, the methods 
are often only appropriate for cross-sectional designs, and have often been misapplied to 
cohort designs. Nevertheless, the majority of included studies followed a cross-sectional 
design. A large proportion of the included studies contained fewer than 20 clusters, and 
many had fewer than 10 clusters. Due to the small number of clusters in the study, some 
SW-CRTs are using inappropriate methods of analysis, since many methods require more 
clusters to be unbiased. It is highlighted that there was a lack of methodological literature at 
this point in time into cohort designs, and there is often a lack of clarity between a cohort 
design and a cross-sectional design, and so trialists are confusing sample size methods and 
methods of analysis that are appropriate for cross-sectional designs and applying them in 
cohort designs. 
2.2.5 Summary of previous systematic reviews 
Early systematic reviews of SW-CRTs found a large degree of variation in the reporting 
quality and their description of the study design (23, 29). The reporting of sample size 
calculations have changed over time – though are still inadequately reported. Brown and 
Lilford found only 5 of 12 studies (42%) reported a sample size calculation (23). This had 
improved to 77 of 102 (77%) in the most recent review (31). However, whilst the reviews 
assessed whether a sample size was justified, they did not assess individual elements of the 
sample size calculation in detail. 
The reviews have shown there is a lack of consistency in the analysis methods used across 
published trials (23, 29, 31), highlighting the need for a more consistent approach to data 
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analysis. A substandard degree of reporting may stem from the absence of standardised 
CONSORT guidelines for SW-CRTs (28).  
 
2.3 Advantages and disadvantages of a SW-CRT 
As a relatively novel design type, some potential advantages and disadvantages of the SW-
CRT have been explored. Many of these relate to other design types, and whether the SW-
CRT is more (or less) appropriate in some settings (11, 12, 21, 22, 33-35). Below, we highlight 
some of the potential advantages and disadvantages.  
2.3.1 Design advantages 
There are two reasons often cited for conducting a SW-CRT over a P-CRT: the phased 
implementation of the intervention; and the providing of the intervention to all clusters (28, 
36). The logistical argument is often the strongest motivation for performing a SW-CRT (36) – 
particularly in implementation research (37). Randomising half of the clusters to the 
intervention at the beginning of the study is often logistically impossible, and so the 
randomisation of the intervention over multiple steps may be the only feasible approach to 
conducting a randomised trial (6, 23, 29). A key feature of the SW-CRT is that all clusters 
receive the intervention during the study (38) – meaning that in a cohort SW-CRT all 
participants receive the intervention. However, in a cross-sectional SW-CRT, whilst all 
clusters will receive the intervention, not all participants will. The SW-CRT may influence 
study acceptance from the clusters and the participants within them (39). In cohort studies, 
this advantage may provide motivation for participants (40), and clusters (38) that may be 
more inclined to participate under the guarantee of the intervention.  
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2.3.2 Clinical equipoise 
It is commonly suggested that a SW-CRT is beneficial for studies in which the intervention is 
believed to be more beneficial than harmful (23, 29, 41) (i.e. it is believed to be effective) or 
else has been established as effective in a more controlled settings (39) (i.e. efficacy has 
been shown). Whilst closely related, these are two distinct points. A SW-CRT may be useful 
in evaluating the effect of an intervention on a population level, if evidence from an 
individually randomised trial has shown benefits (1) or if a level of efficacy has been shown 
in a controlled research setting (39).  
In all trials, a central tenet is that there is equipoise between the interventions being 
compared. Noticeably, in the context of the SW-CRT, it is often said that the SW-CRT should 
be used when there is a prior belief that the intervention will be superior to the control, and 
so would provide an ethical paradox to withhold participants from a beneficial treatment 
(23, 29, 42). Controversially, it has been stated that the SW-CRT can be used in settings in 
which clinical equipoise is not met, and so would be unethical to withhold the intervention 
(41). However, in the absence of clinical equipoise, others have argued there is no ethical 
justification in conducting a trial or delaying the implementation of the intervention across 
all clusters (37, 43). 
The issues of clinical equipoise may provide a convincing argument in some settings to 
conduct a SW-CRT. However, whilst in cohort designed SW-CRTs, all clusters and participants 
will receive the intervention, in a cross-sectional SW-CRT, only half of the participants will 
receive the intervention (39) – the same as a P-CRT. 
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2.3.3 Number of clusters and observations 
Under the caveat of most methodology for SW-CRTs following the Hussey & Hughes mixed-
effect model framework (32) (see section 2.4.1), there has been much research surrounding 
which, of a P-CRT and a SW-CRT, is more efficient, in terms of requiring fewer observations 
and/or clusters. Early research claimed that a SW-CRT was always more efficient than a P-
CRT in terms of sample size (21), which has created much debate (33, 35). Commonly, it is 
concluded that a SW-CT is more efficient than a P-CRT for larger ICC (22, 44, 45) – due to a 
SW-CRT using both between-cluster and within-cluster comparisons to estimate the 
intervention effect (22, 46-48). This may allow studies with a limited number of clusters to 
obtain sufficient power, rather than conduct a P-CRT that would require an unobtainable 
number of participants (22, 35). In a P-CRT, increasing the cluster size has a plateauing effect 
on the power, whereas this is not the case for a SW-CRT (45).  
Nevertheless, trials with few clusters may contain problems at the analysis stage (27). The 
recommended model for SW-CRTs proposed by Hussey and Hughes (32) requires a minimum 
of ten clusters to adequately estimate the random effects (27). This issue might be amplified 
for cohort SW-CRTs, since the analysis would require a three level model (as participants 
would have repeated observations over time) (31). Furthermore, in the case of a small 
number of clusters, there is an increased risk of confounders being dissimilar between the 
control exposure and the intervention exposure (27). 
2.3.4 Study length 
It is often cited that a SW-CRT will take longer to perform than a P-CRT (12, 21, 23, 29, 32, 
38, 46, 49). This has led to a SW-CRT being considered less feasible and desirable than a P-
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CRT (49). It is likely that this is caused by the inherent requirement to have multiple 
observation periods. It is often argued that the length of one randomisation step in a SW-
CRT is equivalent to the full P-CRT study (11, 38). However, it is clear that this is not always 
the case and often the P-CRT may need to be of longer length than a SW-CRT since it may 
require more participants to achieve the same power (35).  
2.3.5 Data collection 
A common misunderstanding in the literature is the difference between a cohort and cross-
sectional SW-CRT (see section 1.4). If a SW-CRT follows a cohort design (participants are 
followed-up for the duration of the study), then a SW-CRT may create a burden for 
participants by collecting data at each time-period in which a new cluster receives the 
intervention (11, 29). If the outcome is not routinely collected then it could lead to a higher 
trial cost than other designs (29, 46). All SW-CRTs are usually unblinded at some level – since 
the clusters will be aware of the crossover from unexposed to exposed (38). This is also true 
at the participant level in cohort designs. However, blinding may still be able to be done at 
the participant level in a cross-sectional design. 
 
2.4 Statistical considerations 
In P-CRTs, the methodology required for power calculations and for the study analysis is well 
established – but is still developing for SW-CRTs (45). Currently, the focus of statistical and 
methodological research is on the cross-sectional design (23) despite this not being the most 
common design type (28). As such, many trials are using a sample size methodology that 
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does not match the method of analysis (28). Below, we highlight the methodology used to 
estimate power in P-CRTs and SW-CRTs. 
2.4.1 Analysis of a stepped-wedge cluster randomised trial 
Whilst there are publications providing a framework for the analysis of SW-CRTs (9, 32) there 
has been limited research into alternative methods of analysis (31). In a SW-CRT, 
observations in the intervention arm are, on average, made at a later date than observations 
in the control arm and so the design could be biased by any secular changes (37), which 
should be adjusted for in any analysis (6, 23, 31, 39, 40). If there truly is a temporal trend, 
then failing to model the effect of time will produce a biased estimate of the treatment 
effect (6). An appropriate method of analysis has been presented by Hussey and Hughes (32) 
which is discussed further in Chapter 5, but an outline is presented here. Essentially, a 
generalised linear mixed model is recommended, with fixed time effects and random cluster 
effects, which can be given as: 
𝑌𝑖𝑗𝑘 = 𝐴 + 𝛽𝑗 + 𝑋𝑖𝑗𝛿 + 𝛼𝑖 + 𝑖𝑗𝑘 2.1  
Where, 𝑌𝑖𝑗𝑘 is the outcome for participant k in cluster i at time j, A is the mean outcome in 
the unexposed group in the first time-period, 𝛽𝑗 is a time effect, fixed for time-periods j = 
2,…, T (𝛽1 = 0 for identifiability), δ is the treatment effect, 𝛼𝑖 is a random effect for cluster i, 




      
if cluster i is exposed to the intervention at time j
if cluster i is not exposed to the intervention at time j
 
Adaptations to this model for studies with incomplete designs or multiple layers of clustering 
have been presented (9). In cohort designs, short-term and long-term intervention effects 
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can be examined by adjusting for the duration a participant has spent in the intervention 
arm (50).  
2.4.2 Estimating sample size in a cluster randomised trial 
 Sample size in a P-CRT with equal sized clusters 2.4.2.1
When conducting a CRT, the sample size must be inflated over that required for an 
individually randomised controlled trial (RCT) to account for the non-independence of 
observations within a cluster (51-53), using a design effect (DE) (54, 55). For a P-CRT with 
equal cluster sizes, the DE is (56): 
Where M is the cluster size and ρ is the ICC.  
 Sample size in a P-CRT with unequal sized clusters 2.4.2.2
However, CRTs often contain clusters of varying size, and this should be acknowledged 
within the sample size calculation (57). Using the above DE (equation 2.2) would provide an 
inaccurate estimate of the sample size. A number of DEs, appropriate under certain 
conditions, have been derived for P-CRTs with varying cluster size. The DEs to allow for 
varying cluster size can be dichotomised into two groups – those that require the size of 
each cluster to be known; and those that require an estimate of the mean and standard 
deviation of the cluster sizes.  
𝐷𝐸 = 1 + (𝑀 − 1)𝜌 2.2 
Page | 29 
 
Design effects that require size of each cluster to be known 
Several DEs have been published that rely on the size of each cluster to be known prior to 
the study starting. These DEs weight the information that is contributed from each cluster, 
and the weights can be chosen in different ways. 
Equal weight 
When the DE weights the information that is contributed from each cluster equally, the DE is 
given as (58) : 
𝐷𝐸 = 𝜌?̅? +
?̅?
𝑀ℎ̅̅ ̅̅
(1 − 𝜌) 
2.3 
Where 𝑀ℎ̅̅ ̅̅ =
1
∑ 𝑀𝑖
  is the harmonic mean of the number of participants per cluster, and ?̅? is 
the mean cluster size. This DE is appropriate for a cluster level analysis with equal weights. 
The above DE is classified here as a DE that requires the cluster sizes since the harmonic 
mean may be difficult to estimate without the original cluster sizes, and since equation 2.3 is 
derived in the same manner as the below DEs. 
Cluster size weight 
When weighting by the cluster size: the clusters with more participants will be given more 
weight than smaller sized clusters. When weighting by cluster size, the DE is (58): 




− 1) 𝜌 
2.4 
This DE is appropriate for a cluster level analysis weighted by cluster size.   
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Minimum variance weight 
Alternatively, it is possible to use a weighting that is proportional to the inverse of the 










This DE is appropriate for a cluster level analysis using a weighting proportional to the 
inverse of the variance of the cluster mean (58). It is also suitable for an approach using 
generalised estimating equation (GEE) with an exchangeable correlation structure (59). 
Design effects that require mean cluster size and a measure of dispersion 
Whilst useful, the above design effects (equations 2.3, 2.4, and 2.5) require knowledge of the 
exact cluster sizes. In many trials, it is unlikely that the exact cluster sizes will be known pre-
trial. Instead, an a priori estimate of the coefficient of variation of cluster sizes (the ratio of 
the standard deviation of the cluster sizes to the mean cluster size) can be used to estimate 
the sample size without the need for exact cluster sizes. Below we highlight two DEs that 
allow for varying cluster sizes and only require the pre-specification of the mean cluster size 
and the coefficient of variation. 
Design effect using cluster level analysis 
By assuming a cluster level analysis, weighted by cluster size, Eldridge et al. (57) provide a 
design effect, given as: 
𝐷𝐸 = 1 + ([
𝐶 − 1
𝐶
𝑐𝑣2 + 1] ?̅? − 1) 𝜌 2.6 
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Where C represents the number of clusters and 𝑐𝑣 is the coefficient of variation of cluster 
sizes. 
For a trial with a large number of clusters, ignoring 
𝐶−1
𝐶
, allows this design effect to be 
simplified to: 
𝐷𝐸 = 1 + ([𝑐𝑣2 + 1]?̅? − 1)𝜌 2.7 
The design effect given by equation 2.7 is for a cluster level analysis, providing a 
conservative approximation of the true design effect (57) since a mixed effect model at the 
individual level is more efficient (52). The true design effect for a P-CRT with unequal cluster 
size will be between equation 2.2 and 2.7 (57). 
Taylor approximated design effect 
A design effect has been proposed that is appropriate for an analysis using maximum 
likelihood estimation, as (60): 
𝐷𝐸 =
1 + (𝑀 − 1)𝜌
1 − 𝑐𝑣2 × 𝑅(1 − 𝑅)
 
2.8 
Here R is the cluster mean correlation – which is the correlation between the cluster means 
of two repeated sets of observations taken from the same cluster (61) – which is discussed 
further in section 5.2.3.7. 
Two other approximated design effects have been reported that use an equal weighting, and 
a cluster size weighting that both rely on the coefficient of variation (62). However, these are 
not reported here, since it has been established that the above DE (equation 2.8) is a more 
accurate representation of the true inflation factor. Equation 2.8 is also more appropriate 
than the commonly used DE presented by Eldridge et al. (equation 2.7) since equation 2.8 
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refers to an individual level analysis, rather than a cluster level analysis, which may be 
inefficient when the cluster sizes vary. 
Overview of design effects for a P-CRT 
When designing a P-CRT, many studies assume equal cluster size. When there is evidence of 
variability in the cluster sizes, failure to acknowledge this variability would lead to an over-
estimate of the power. Studies should use a DE that includes an adjustment for varying 
cluster size. The selection of the DE will crucially depend on whether the size of each cluster 
is known in advance, or only a measure of the dispersion is known (52). Each DE is directly 
linked to a post-trial analysis method, and so only appropriate in some circumstances. CRTs 
are commonly analysed at the individual level through mixed effect models, and so the use 
of a DE appropriate for a cluster level analysis (such as equation 2.7) may produce a 
conservative estimate of the power. The most appropriate DEs are given by equations 2.5 
and 2.8 as they are appropriate for individual level analysis, rather than cluster level analysis.  
 Sample size in a SW-CRT 2.4.2.3
Multiple methods exist to estimate the sample size in a SW-CRT (31) that stem from the 
Hussey and Hughes (32) framework described in section 2.4.1 – which is appropriate for 
cross-sectional designs. This framework involves a multilevel mixed-effect model with a 
random cluster effect and fixed time effect. An additional random effect for participants can 
be included for cohort designs (6). Since the estimation of sample size varies depending on 
study design, below we discuss the methods separately for cross-sectional and cohort 
designs.  
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A coherent unified framework has been set out for cross-sectional SW-CRTs for complete 
and incomplete designs, including multiple layers of clustering (9, 45). This has been 
implemented in a Stata function (63). However, there are also a number of DEs that are 
applicable for SW-CRTs based upon the design type – cross-sectional or cohort.  
There has been much confusion surrounding the implementation of a design effect for cross-
sectional SW-CRTs (45). For designs in which participants are observed once per step, and 
one baseline measurement period is made, a simplified version of the design effect can be 
given as a function of the ICC (𝜌), the number of steps (𝑠), the number of time-periods (𝑇) 
and the cluster-period size (size of a cluster at one time-period) (𝑚) as (21): 
𝐷𝐸𝑆𝑊 =
1 + 𝜌(𝑠𝑚 + 𝑚 − 1)
1 + 𝜌 (
1









To estimate the number of patients needed for a SW-CRT (SSSW), the sample size should then 
be modified as follows: 
𝑆𝑆𝑆𝑊 = 𝑆𝑆𝑅𝐶𝑇 × 𝐷𝐸𝑆𝑊 
Where SSRCT is the sample size needed for an individually randomised trial. 
In this design effect (equation 2.9), the correlation between observations within a cluster is 
independent of the time-period in which the observations are made, which is often assumed 
when following the Hussey & Hughes methodology for cross-sectional designs (32). 
However, recent research suggests a cluster by time interaction should be included (49), to 
allow for a different correlation structure over time (26) – see Box 2.1.  
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Box 2.1: Extended statistical model for stepped-wedge cluster randomised trials 
 
𝒀𝒊𝒋𝒌 = 𝝁 + 𝒕𝒋 + 𝜶𝒊 + 𝝎𝒊𝒋 + 𝜺𝒊𝒋𝒌 
 
Where 𝑌𝑖𝑗𝑘 is the outcome for patient k in cluster i at time j, 𝜇 is the mean outcome, 𝑡𝑗 is a 
fixed effect for time point 𝑡, 𝛼𝑖is the cluster effect, 𝜔𝑖𝑗 is a random effect for cluster i at time 
j, and 𝑖𝑗𝑘is the residual error. 







This methodology allows for two different measures of clustering – within cluster, and 
between cross-sections within a cluster, and leads to an adapted design effect (26): 
𝐷𝐸𝑆𝑊 =
3𝑠(1 − 𝜋)(1 + 𝑠𝜋)
(𝑠 − 1)(2 + 𝑠𝜋)





 , so that 𝜋 is a function of the inter-period correlation (IPC) and the 
within-period correlation (WPC). Equation 2.10 simplifies to equation 2.9 if there is no time 
by cluster interaction.  
A design effect for cohort SW-CRTs has been reported (26, 64) using the cluster (𝜌𝑐) and 
subject (𝜌𝑠) autocorrelation:  
𝐷𝐸𝑆𝑊 =
1 + (𝑚 − 1)𝜌(𝑠)(𝜌𝑠 + (𝜌𝑐 − 𝜌𝑠)𝜌)
1 + (𝑚 − 1)𝜌 (
1
2 𝑠)
(𝜌𝑠 + (𝜌𝑐 − 𝜌𝑠)𝜌)
×






The DEs can be used to determine the sample size for a fixed power, and the DEs 
appropriate for a SW-CRT all follow a similar model framework, and so follow the same set 
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of assumptions. Each design effect is only appropriate for studies with clusters of equal size 
(44) and it is assumed that the SW-CRT will have an identical number of clusters crossover at 
each step, since designs in which unequal number of clusters crossover at each step will lead 
to variations in the design effect (65). However, the Hussey and Hughes approach using 
matrices does not make this assumption, and can be used to estimate the power for a fixed 
sample size (32). 
Irrespective of the methodology used to estimate the sample size, any misspecification of 
the time effect in the model (when a time effect is present) would falsely lead to an inflated 
power (44). A recommended alternative method is the simulation of expected trial data 
under the same underlying model used in the analysis, which can allow the power to be 
estimated for more complex designs – such as cohort and open cohort designs, count and 
binary outcomes, and studies with cluster specific variations in the intervention effect (44).  
 
2.4.3 Design features that impact the power 
 Effect of the correlation between observations on the power 2.4.3.1
A defining feature in CRTs is the correlation between participants in a cluster – usually 
described by the intra-cluster correlation coefficient (ICC) – which must be incorporated into 
pre-trial power calculations. However, in longitudinal CRTs (CRTs with repeated cross-
sections), the inter-period correlation (IPC) and within-period correlation (WPC) are also 
important. 
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The ICC is known to impact the power in SW-CRTs (6, 9, 21, 38, 66) and the decision of 
whether a P-CRT or a SW-CRT is more efficient, in terms of the number of participants or 
clusters, typically hinges on the ICC and the cluster sizes (45, 61). The power of a SW-CRT is 
mainly determined by the within-cluster variation (38, 66), and so is more efficient than a P-
CRT for larger values of the ICC (37, 61). A set of cut off values of the ICC for which a SW-CRT 
would have greater power than a P-CRT has previously been presented (47) – in which the 
value is dependent on the size of clusters (45). The ICC follows a monotonic relationship with 
power for P-CRTs (power decreases as ICC increases), but exhibits a non-linear relationship 
with power for SW-CRTs (9). 
Recently, it has been suggested that the power in a SW-CRT is influenced by values of the IPC 
and WPC (48) – which are describe in more depth in Chapter 4. If the correlation between 
participants from the same cluster at different periods is less than the correlation between 
participants from the same cluster at the same time-period, then ignoring the IPC and WPC 
would lead to an underpowered study (48). There has been no previous reporting of the IPC 
and WPC in the literature – which has led to a call for values to be published (26). 
 Effect of the design structure on the power 2.4.3.2
The power of a SW-CRT is influenced by the number of clusters, the cluster size, and the 
number of steps in the design (6) – which are often derived from logistical and financial 
considerations. A SW-CRT may require fewer participants than a P-CRT as the cluster sizes or 
number of steps increases (21), with the optimal power achieved in SW-CRTs in which each 
cluster is assigned a unique randomisation step (32). It has been claimed that a SW-CRT will 
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always require fewer clusters than a P-CRT (47). In some settings, only a SW-CRT would meet 
the minimum power requirements for a study with few clusters (22).  
 Varying cluster size in stepped-wedge cluster randomised trials 2.4.3.3
The majority of methodological literature for the SW-CRT has focussed on the analytical 
framework given in section 2.4.1 – which is also used in this thesis. Whilst there has been 
slight variations to the framework reported in the literature (6, 26), there is a distinct lack of 
coverage of varying cluster sizes in all topical papers. Currently, the most readily accessed 
material for sample size calculations for SW-CRTs (21, 26, 63), do not allow for variability in 
cluster sizes. As such, authors often assume that the number of participants per time-period 
does not vary (6). A more comprehensive discussion of varying cluster size in SW-CRTs can 
be found in Chapter 5. 
 
2.5 Summary 
The methodological literature for the SW-CRT is slowly increasing, with additional design 
features being considered and examined. However, the literature is much sparser than for P-
CRTs, which often provides difficulties when designing a trial. The lack of reporting 
guidelines for SW-CRTs has led to a poor quality of reporting in published SW-CRTs.  
An increasing number of SW-CRTs are being conducted, typically in healthcare, and involving 
an education or training based intervention (28). Generally, the methodological focus has 
been on cross-sectional designs – which were originally the most common design type (23). 
More recently, it seems that studies follow a cohort or open cohort design (28). Whilst there 
has been some recent developments surrounding the methods for cohort SW-CRTs (26) 
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many studies have incorrectly applied cross-sectional methods to cohort designs. The cross-
sectional framework was originally proposed by Hussey and Hughes (32), and has been 
adapted for variations in the design (9). However, it is often assumed that there is no cluster 
by time interaction, and that the clusters are equal in size. The absence of a cluster by time 
interaction would indicate that the correlation within a cluster does not decay over time, but 
there has been little research into whether this is expected to be true. Within the literature, 
it is often assumed that the clusters in a study are equal size (44), and it is not known what 
impact cluster size variation would have on the power of a SW-CRT.     
Previous systematic review have highlighted that the reporting of a sample size justification 
is often poor. However, it not been assessed as to whether the justified sample size 
calculation were well reported in terms of reproducibility or whether the sample size 
methodology included any additions to the Hussey and Hughes model given by equation 2.1 
– such as varying cluster size, or the inclusion of the IPC and WPC. 
In the following chapter, a methodological review of published SW-CRTs is performed, to 
assess the quality of reporting of sample size calculations in published SW-CRTs. This will 
include an assessment of the methodological quality of the sample size calculations. This will 
give an indication of whether the sample size calculation of previous SW-CRTs have reported 
an adjustment for varying cluster size or a decay in correlation over time (through the IPC 
and WPC).  
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CHAPTER 3:      METHODOLOGICAL 
REVIEW OF THE QUALITY OF REPORTING 
OF STEPPED-WEDGE CLUSTER 
RANDOMISED TRIALS 
A paper based on the work from this chapter has been published. 
Citation: Martin J, Taljaard M, Girling A, Hemming K. Systematic review finds major 
deficiencies in sample size methodology and reporting for stepped-wedge cluster randomised 





Previous systematic reviews have been conducted to examine past stepped-wedge cluster 
randomised trials (SW-CRTs) (23, 28, 29, 31). These reviews have considered the types of 
intervention used, the motivation for employing the stepped-wedge design, and the 
statistical methods used in the analysis (see Chapter 2). It has been highlighted that there is 
a large heterogeneity between methods used in the analysis of the SW-CRT (23, 29). Since 
recommendations regarding the analytical approach for SW-CRTs have been published (6, 
32), it is likely that this variation will have reduced over time. However, further 
recommendations may need to be made to fully address the issue. Additionally, it has been 
noted that the sample size calculations differ greatly between studies (23, 28, 29). Often, the 
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sample size methodology employed in the design stage is inappropriate, and frequently 
under reported (28, 29). The first systematic review of SW-CRTs found only 5 of 12 studies 
reported a sample size calculation (23). A second systematic review of SW-CRTs found that 
the sample size calculation was reported in 8 of 15 studies, with only 3 accounting for 
clustering (29). A more recent review highlighted that a greater number of SW-CRTs are 
reporting a sample size calculation but the methodology used differs (28). Within these 
reviews, some consideration has been made to the quality of reporting, with the lack of 
clarity and consistency often highlighted. However, no review has considered the quality of 
reporting in relation to published recommendations. Indeed, the reviews have only 
considered whether a sample size calculation was reported, and whether it accounted for 
clustering. Here, we will consider in more depth, the quality of reporting in published SW-
CRTs and whether the methodology used is appropriate. 
3.1.2 Reporting of sample size calculations 
To allow for the critical appraisal of a study, the reporting of the study design, including the 
derivation of the sample size, and the results, should be transparent. Study reports that are 
difficult to comprehend or impossible to recreate may add less to the literature than they 
may otherwise have. To ensure that sufficient information was reported in trial reports, the 
consolidated standard for reporting (CONSORT) statement for individually randomised 
controlled trials was created (67). Clear reporting of clinical trials can allow for a critical 
appraisal and ensures that the results can be assessed for robustness (67).   
In relation to the sample size calculation of trials, recommendations are given for the 
minimum number of items that should be reported to allow the sample size calculation to be 
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reproducible (68, 69). It recommends that authors report: the level of significance; the 
power of the study; the estimated treatment effect; and whether an allowance was made 
for attrition or non-compliance. Following this, an extension to the CONSORT statement for 
cluster trials was published, which made additional recommendations for cluster trials (70). 
It recommends that authors of a cluster trial additionally report: the cluster size; a measure 
of its variation; an estimate of the clustering (e.g. ICC); and a measure of the uncertainty of 
the estimate of the clustering (70). In addition to this, the reporting of the method used to 
determine the sample size should be made. Without a clear specification of the 
methodology used, it may otherwise be difficult to comprehend whether an allowance has 
been made for clustering and for variation of cluster sizes. By fully explaining the methods 
used, the methodological rigor of the study can be assessed. Although there are currently no 
published reporting guidelines for a SW-CRT, an extension to the CONSORT statement for 
SW-CRTs is in development (71). Prior to this extension, several items have been 
recommended for reporting (6). However, even excluding these extension items, since the 
SW-CRT is a form of cluster randomised trials, the authors should report, as a minimum, 
items from the CONSORT statement and the CONSORT extension for cluster trials. 
Perhaps somewhat understandably, early CRTs were often underpowered and analysed 
incorrectly (72). However, the literature surrounding these trial types has now advanced 
dramatically. Now, sample size methodology, and reporting guidelines, is well established for 
parallel cluster randomised trials (P-CRTs). However, recent systematic reviews relating to 
the reporting of items from the CONSORT statement in P-CRTs highlight that the quality of 
reporting is still inadequate (72-74).  
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Whilst it is expected that early SW-CRTs will not conform to the recommendations made in 
the proposed CONSORT extension for SW-CRTs, it should be expected that publications 
made post 2001 should adhere to the recommendations made in the original CONSORT 
statement (69). Similarly, studies published post 2010 should follow recommendations made 
in the CONSORT extension for CRTs (68). Previously little evidence existed on the quality of 
reporting, or the methodological rigor, of published SW-CRTs. Previous reviews of SW-CRTs 
have either been small (23, 29), or have considered other areas of interest (28, 31). Whilst 
they have identified whether studies have reported a sample size calculation and briefly 
considered the methods used, no previous review has considered the adherence of 
reporting of the sample size calculations, or indeed the methodological rigor of these 
calculations. Here, we seek to identify mistakes regularly made in the reporting of SW-CRTs 
in the literature, to prevent these errors from becoming common practice.  
3.1.3 Methodological requirements in sample size calculations 
In P-CRTs, it is well established that clustering should be accounted for in both the sample 
size calculations and the analysis (53, 75). It is recognised that failing to account for 
clustering in the sample size calculation can lead to an underestimate of the sample size 
required. Likewise, an analysis conducted without adjusting for clustering would produce an 
over precise estimate of the treatment effect, that is, the confidence interval would be too 
narrow. When conducting a P-CRT, it is conventional to utilise a design effect to obtain the 
sample required for a cluster trial from a sample size required under the assumption of 
individual randomisation (53, 57, 58, 60, 75, 76).  
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When conducting a SW-CRT, an integral part of the design is the randomisation of clusters 
over multiple time-periods (or steps). Since time is a potential confounder in the analysis of a 
SW-CRT, sample size calculations should account for time, in addition to the effects of 
clustering. Time should also be adjusted for in the analysis of a SW-CRT. In the topical paper 
by Hussey and Hughes, one method for estimating the power in a SW-CRT is discussed, in 
which allowances are made for both the effects of time and clustering (32).  
3.1.4 Analytical methods used in cluster randomised trials 
Upon conducting a CRT, the analytical approach used to evaluate the intervention should 
acknowledge the clustered nature of the data. Failing to do so will lead to an over-precise 
treatment effect estimate. A simple method to achieve this is to estimate an appropriate 
summary statistic for each cluster individually, before performing a statistical test on the 
pooled cluster summary measures. For example, the average BMI may be calculated for each 
cluster, before a linear regression is fitted to analyse the cluster level means. However, this 
cluster level analysis approach is often not appropriate in trials, since individual level 
covariates cannot be adjusted for. One potential approach for analysis at the individual level 
is a generalised linear mixed model (GLMM). This methodology allows for adjustment of 
individual level covariates, in addition to the effect of clustering. 
Since in a SW-CRT, calendar time may impact the treatment effect, the analytical approaches 
used for a P-CRT may not be appropriate. In the seminal paper by Hussey and Hughes, they 
propose a methodology appropriate for the analysis of a SW-CRT (32). They recommend a 
mixed effects model with a random cluster effect and a fixed effect for time (see section 
2.4.1). Conducting an analysis of a SW-CRT via this approach allows for both between cluster 
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and within cluster information to be used to estimate the treatment effect. By following this 
approach, authors can allow for the effect of clustering and the confounding effect of time. 
In fact, failing to model the effect of time will result in a biased treatment effect estimate, 
unless there is truly no underlying temporal trend (6). 
3.1.5 Chapter aim 
The main aim of this chapter is to review the sample size calculation for published SW-CRTs 
to assess whether they are sufficiently reported and whether appropriate methodology has 
been used. As part of this, we seek to: 
1. Determine adherence to reporting of nine sample size items recommended in the 
extension to the CONSORT statement for cluster trials. 
2. Determine the reporting standard of additional items relevant to SW-CRTs. 
3. Identify methodology used in the estimation of power or sample size and determine 
whether appropriate methodology is being used – such as whether an allowance has 
been made for clustering and time effects. 
4. Identify methodology used in the analysis and determine whether appropriate 
methodology is being used – such as whether clustering and time effects have been 
accounted for. 
 
To achieve these aims, a methodological review of SW-CRTs is presented, with an evaluation 
of the adherence to the CONSORT statement and the cluster extension. Additionally, an 
assessment was made of the methodological rigor of sample size methodology used. Finally, 
the methods used to analyse full studies was critically evaluated, noting whether studies had 
correctly accounted for clustering and time effects. 
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3.2 Methods 
3.2.1 Search strategy and inclusion and exclusion criteria 
The search strategy was an adaptation of the search strategy used in two previously 
published systematic reviews in SW-CRTs (23, 29). The phrases used to generate the search 
were:  
 Stepped wedge 
 Step wedge 
 Experimentally staged introduction 
 Delayed intervention 
 One directional cross over (& crossover) design 
 All possible permutations of the following terms: 
o Incremental, phased, staggered stepwise, step wise, delayed and recruitment, 
introduction, implementation 
This search strategy is given in full in Appendix A and was conducted in October 2014. 
Early systematic reviews of SW-CRTs considered randomised and non-randomised designs, 
or were limited to healthcare studies only (23, 29). Here, we included randomised studies 
only, but considered both healthcare and non-healthcare studies. To inflate our sample size, 
we consider both full trials and protocols. However, the analytical methods were extracted 
from full trials only, since the methodology reported in a protocol may be subject to change 
for the final analysis. As per our definition of a SW-CRT, the study had to be randomised, 
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with the randomisation at the cluster level, and all clusters had to be randomised to receive 
the intervention over two or more steps. 
The search strategy was conducted using Medline, Embase (including Embase classic) and 
PsycINFO and all identified studies were extracted into a database. The titles and abstracts 
were screened by two authors to ensure an agreement subject to the inclusion criteria. From 
this, full text articles were obtained for all studies that seemed eligible for the review. 
Studies that were subsequently deemed to be ineligible were excluded, with the reasons 
tabulated, with any disagreements between authors resolved via discussion. To ensure all 
possible studies were included, the reference list of studies that met the inclusion criteria 
were screened, as well as the reference list of any previous systematic reviews in SW-CRTs. 
Since our primary motive was to assess the quality of reporting of studies, no contact was 
made to the authors of any study to request any additional information.  
Only fully published trials and protocols were included in the review. Any unpublished trials 
or protocols that were cited or related to an included study were not included or assessed 
for information. Since this review aims to assess the quality of reporting in relation to the 
CONSORT statements, it is expected that these items should be reported in the full trial 
reports, and so additional information should not need to be extracted from related trial 
protocols. Study protocols, for which a full report was not available or the study was not yet 
completed were included in some aspects of the review. Table 3.1 illustrates the categories 
that were used to group the excluded studies.  
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Table 3.1: An elaboration of the exclusion criteria groupings 
Exclusion category Explanation 
Duplicate  
 
If multiple copies of a study had been included, then one copy of it 





All studies that the randomisation was conducted at the individual 
level, regardless of design type were excluded.  
 
Not a SW-CRT  
 
This included all cluster trials that were not a SW-CRT. This could 
have included studies in which the intervention was given to some 
clusters after the trial, or trials in which the intervention was 
removed during the study (e.g. Cross-over designs).  
 
Not a trial  
 
This included any articles that were not a trial report or a study 
protocol. This included conference abstracts, discussion of trials, 





This included any studies that used the stepped-wedge design, but 
for whom the intervention was not given out in a random manner. 
 
Secondary analysis:  
 
Any secondary analysis of a SW-CRT that had already been included 
in the review were excluded. 
 
Unable to access:  
 
Any paper that could not be accessed was excluded.  
 
Protocols of an 
included full trial 
report:  
 
Full trial reports were included in the review, so the related 




This includes any article that did not fall into one of the above 
categories. This included process evaluations, reviews of a trial, and 
studies not published in English. 
 
 
3.2.2 Data abstraction 
A data abstraction form was used to extract data in a fair and unbiased manner. Following 
testing on a small number of studies, refinements were made, with the final form given in 
Appendix B. To ensure a high level of consistency across the review, data was extracted for 
each study by two independent reviewers. Any differences were listed, and a discussion 
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between all authors allowed a consensus decision to be made. The order in which data was 
extracted from studies was produced by a random number generator. If the order is not 
randomised, there is the potential for bias in the reporting. The reviewer may adapt how the 
extraction form is seen for latter papers, altering their response in light of the experience 
they have gained in completing earlier extraction forms. Additionally, the reviewer may spot 
the reporting better at the beginning, but fail to spot them as fatigue sets in. Randomising 
the order should minimise bias. All data were abstracted and saved in Microsoft Access. 
Table 3.2 highlights the categories that have been used to group the extracted data.  
Table 3.2: Categories used to group extracted data 
Data extraction categories Description 
Trial demographics 
 
This included basic trial demographics and characteristics to 
describe the SW-CRT, alongside realised design 




This included the justification for using a cluster trial, 
alongside the justification for conducting a SW-CRT. 
 
Quality of reporting of 
sample size elements 
 
This includes the reporting of sample size elements from the 
2010 CONSORT statement for individually randomised 
controlled trials; reporting of cluster sample size items from 
the 2012 CONSORT extension for CRTs; reporting of sample 
size elements that relate to a SW-CRT. 
 
Methodological rigor of 
sample size calculations 
 
This includes the methodology used to determine sample 
size. 
 
Methodological rigor of 
analysis methods used 
 
For full trial reports, data was also abstracted on the 
methods of analysis used.  
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3.2.3 Trial demographics 
When extracting data on trial demographics, we consider both general trial demographics 
and realised design characteristics. General trial demographics were obtained for both 
complete trial reports and protocols. Realised design characteristics were extracted for full 
trial reports only. 
General trial demographics included year of publication, country, journal impact factor, 
cluster type, healthcare or non-healthcare setting, number of interventions, randomisation 
process and primary outcome data type (Table 3.3). The journal impact factor was taken 
from the Web of Science, JCR Science Edition 2013.  
Table 3.3: Brief description of extracted items on general trial demographics 
Item  Explanation  
Journal impact factor  Taken from Web of Science, JCR Science Edition 2013 
 
Year  What was the year of publication of the report? 
 
Country  What country did the study take place in? 
 
Cluster What was the cluster (i.e. hospital, ward, general practice, 
residential area, health professional)? 
 
Study setting  Was the study conducted in a health care or non-health 
care setting?  
 
Number of arms  How many interventions were being compared? 
 
Method of randomisation  What was the method of randomisation used (i.e. 
unrestricted, paired, stratified)? 
 
Primary outcome What data type was the primary outcome? (i.e. 
continuous, binary, count, categorical) 
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For complete trials only, realised design characteristics were extracted. By this, general items 
related to CRTs were extracted, such as the duration of the study, number of clusters and 
average cluster size. Details of design features specific to the SW-CRT were also extracted, 
such as the number of randomisation points (or steps), the number of clusters randomised 
per step, the average step length, design type (cross-sectional, cohort, or open cohort) and 
whether any variations of a traditional SW-CRT were used (such as a transition period). The 
average step length was calculated as the median duration between two successive 
randomisation points, and so did not account for extra time-periods that may have been 
included pre or post intervention.  
All values obtained related to an intention to treat analysis. As such, if a study began with 10 
clusters, but one dropped out post randomisation, then it was noted that the trial had 10 
clusters. Details were not obtained from trial protocols since the outcomes may have been 
subject to change, and so may not truly reflect the trial to be conducted. Whilst the 
protocols may indicate a planned number of steps, or cluster-period size, for example, 
factors may influence this during the trial and so these values may be adapted during the 
study. Because of this, only details pertaining to full trial reports were included when 
summarising design characteristics. A list of the items in which data was abstracted from, 
along with a brief description of them can be found in Table 3.4. 
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Table 3.4: Brief description of extracted items on realised design characteristics 
Item Explanation 




If reported how many measurement periods were there? 
Clusters  If reported, how many clusters were there? 
 
Clusters per step If reported, how many clusters were randomised at each step? 
 
Cluster size If reported, what is the median cluster size across all 
measurement points? 
 
Duration of study If reported, how long did the study run for (not including 
outcome follow-up times or retrospective data collection)? 
 
Duration of each step If reported, how long what was the median duration of the 
time between each step? 
 
Design type If reported, did the study use repeated cross-sectional 
sampling, cohort design or open cohort design? 
 
Transition periods  Did the design include transition periods during which the 
intervention is embedded into practice and the cluster 
considered neither exposed nor unexposed? 
 
Variation on design Did the design include any variation on the conventional SW-
CRT, such as extended pre and post periods? 
*Information was extracted on the realised design characteristics of full trial reports only and this might in some cases be different to that 
which was actually planned. 
 
3.2.4 Design justification 
When conducting a clinical trial, it is important that the most appropriate trial type is used. 
As such, item 2a of the 2012 extension for cluster trial highlights that authors should detail 
why they conducted a cluster trial (70). For SW-CRTs, this is also essential. By establishing 
the rationale for a design choice, an assessment can be made as to whether any increase to 
the sample size is warranted. We extracted justification of both the sample size calculation, 
and the study design. 
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Firstly, information was gathered on the justification for the sample size of the study. This 
justification may stem from a statistical approach, in which a clinically important effect size 
was used to determine the sample size, or based on a pragmatic approach of using all 
available participants. To prevent confusion, a study was said to use a pragmatic rationale of 
the sample size if the authors clearly stated that the sample size calculation was limited by 
logistical or pragmatic constraints.  
Now, information pertaining to the motivation of the trial type choice was extracted. Firstly, 
the rationale for choosing a cluster trial over an individually randomised trial was noted, and 
then the motivation for conducting a SW-CRT (Table 3.5). Since studies may provide generic 
statements of the advantages of a SW-CRT, only motivation relative to the study was 
included. 
Table 3.5: Brief description of extracted items on design justification 
Item Explanation 
Justification of sample size  Did the sample size stem from a statistical calculation or a 
pragmatic approach based on including all available 
participants. 
 
Cluster trial rationale What rationale was reported for using a cluster 
randomised trial over an individually randomised design? 
This could include: the possibility of contamination; 
practical reasons; or a cluster level intervention. 
 
Stepped-wedge trial rationale  What rationale was reported for using a stepped-wedge 
cluster randomised trial over a parallel cluster randomised 
trial? This could include: desire for all clusters to receive 
the intervention; need for sequential implementation; 
prior evidence of effectiveness; or ethical issues. 
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3.2.5 Quality of reporting of sample size calculations 
The reporting of sample size calculations allows other trialists or reviewers to understand 
the statistical methodology behind a study, and helps in the critical appraisal of a study. 
Transparent reporting ensures that the calculation is easily replicable. Data was extracted 
identically for both full trial reports and trial protocols. Primarily, the interest is surrounding 
the adherence to reporting of items relating to the CONSORT statement, and the CONSORT 
extension for cluster randomised trials. This is then extended to consider items 
recommended for reporting in SW-CRTs – though the absence of a CONSORT extension for 
SW-CRTs may lead to poor reporting.  
In relation to the CONSORT statement, the following items should be reported: 
i. Power of the study. 
ii. Significance level used. 
iii. Treatment effect sufficiently reported. 
iv. Consistency between outcome in sample size calculation and primary outcome. 
v. Whether attrition was allowed for. 
A treatment effect was deemed to be sufficiently reported if any of the following criterions 
were reported:  
a) Mean in both arms and standard deviation. 
b) A mean difference and standard deviation. 
c) Proportion in both arms. 
d) Proportion in one arm and a relative (or absolute) difference. 
Page | 54 
 
e) Standardised effect size 
For studies in which there was a lack of clarity surrounding the primary outcome, or else it 
was not clear what outcome had been used for the sample size calculation, then it was 
reported as unclear. If a full trial report utilised more clusters or participants than they had 
planned in the sample size calculation, but there was no explanation that this was due to 
attrition or non-compliance, they it was not reported as having allowed for attrition (Table 
3.6).  
Table 3.6: Sample size reporting explanation – assessment of quality of reporting of basic 
sample size elements 
Item Explanation 
Sample size justification  Was a sample size justification reported? 
 
Level of significance Was the level of significance reported? 
 
Power Was the level of power reported? 
 
Treatment effect Was the treatment effect used in the sample size 
calculation sufficiently reported? Sufficient reporting of 
the treatment effect consists of either a standardised 
effect size; a mean difference and standard deviation; 
means in both arms and standard deviation; proportions 
in both arms; proportion in one arm and a relative or 
absolute difference. 
 
Primary outcome  Was the outcome used in the sample size calculation 
consistent with the primary outcome of the trial? 
 
Attrition  Was attrition allowed for in the sample size calculation?  
 
In addition to these basic sample size elements, CRTs should be reporting items related to 
the CONSORT extension for cluster trials. These items pertain specifically to cluster trials, 
and include the reporting of: 
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i. The number of clusters 
ii. The cluster size 
iii. The variation of cluster sizes 
iv. The ICC (or equivalent) 
v. Measure of uncertainty surrounding estimate of ICC (or equivalent) 
The number of clusters and cluster size was extracted and reported separately. However, 
when considering the number of items reported by a trial, they are combined, since for a 
given sample size, one item is deducible from the other (Table 3.7).  
Table 3.7: Sample size reporting explanation – assessment of quality of reporting cluster 
sample size elements 
Item Explanation 
Measure of variation of 
outcomes across clusters (i.e. 
ICC) 
Was a measure of variation in outcomes across clusters 
reported? Measures of variation include the ICC, 
coefficient of variation (of the outcome) or a design 
effect. 
 
Measure of uncertainty of 
measure of variation (i.e. ICC) 
Was a measure of uncertainty of the ICC (or equivalent) 
reported; or was sensitivity to power considered under 
alternative ICCs? 
 
Number of clusters Was the number of clusters explicitly reported or 
deducible? 
 
Cluster size Was the cluster size explicitly reported or deducible? 
 
Measure of variation of 
cluster sizes 
Was a measure of variation in cluster sizes reported (or 
it clear that there was not variation), such as a 
coefficient of variation (of cluster size) or standard 
deviation of cluster sizes? 
 
For SW-CRTs, it has been recommended that the following items are reported (6): 
i. The number of steps 
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ii. The number of clusters randomised per step 
iii. Design type 
iv. Clarity between total cluster size and cluster size per measurement period 
v. Schematic representation 
Since the number of clusters randomised per step can vary, the authors should state the 
number randomised per step, to allow the sample size calculation to be replicable.  
Authors should report the design type, that is, whether the design was cross-sectional, 
cohort or open cohort (section 1.3.1). The reporting of this item allows for clarity as to 
whether patients were followed-up for the study duration or for only part of it. This follows 
on to item iv. When reporting the sample size calculation, it is vital that there is clarity 
between the total cluster size and the cluster size per measurement period. Failure to clearly 
report this would increase the difficulty in replicating any sample size calculation. 
The inclusion of a schematic representation may seem unintuitive in relation to a sample size 
calculation. However, it is a simple way to display some of the reporting items for a SW-CRT. 
For example, a diagram such as Figure 3.1, taken from the ICCOT study (section 1.6.2), 
clearly shows that the study has 16 clusters, with 2 clusters randomised per step and a total 
of 8 time-periods (24). This may help to decipher whether any additional methodological 
features should have been included in the sample size calculation, such as transition periods. 
As such, we include here whether a schematic representation was included in the trial 
report. Furthermore, data items that were not reported in the text but could be clearly 
identified from a schematic diagram of the study were classified as reported. 
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A summary of the reporting items related to sample size elements for the SW-CRT are given 
in Table 3.8. 
Table 3.8: Sample size reporting explanation – assessment of quality of reporting of 
stepped-wedge sample size elements 
Item Explanation 
Number of steps Was the number of randomisation steps reported? 
 
Number of clusters per step Was the number of clusters randomised per step 
reported? 
 
Measurement points Was the number of measurement points reported? 
 
Clarity of cluster size  Was there clarity between cluster size per measurement 
point or period and total cluster size? 
 
Design type Was it clear whether the design was cross-sectional, 
cohort or open (i.e. mixture)?  
 
Schematic illustration  Was the design represented using a schematic 
illustration? 
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To classify the studies using the number of items reported, only the adherence to the 
CONSORT statement and the cluster extension were used, so that there were 9 items 
relating to the quality of reporting. These were (i) the power, (ii) the significance level, (iii) 
treatment effect sufficiently reported, (iv) consistency between outcome in sample size 
calculation and primary outcome, (v) whether attrition was allowed for, (vi) the number of 
clusters (or cluster size), (vii) the variation of cluster sizes, (viii) the ICC (or equivalent), (ix) a 
measure of uncertainty surrounding the ICC. 
All items were categorised as reported, not reported, or unclear. Items were reported as 
unclear if there was a lack of distinctness in the reporting of said item, or if reviewers could 
not fully agree. For some items, reporting was sub-branched into explicitly reported or 
deducible. Items were classified as explicitly reported if they were stated clearly in the text, 
whilst classified as deducible if they could be obtained from calculations via other reporting 
items or via intuition from other items. For some reporting items, it may be enough that 
they can be deduced, such as cluster size, whereas for other items, it is more important that 
they are explicitly reported, such as the design type.  
 
3.2.6 Methodological rigor of sample size calculations 
There are published guidelines for an appropriate method to estimate the sample size for a 
SW-CRT (9, 32, 63). Previous reviews have shown that the methodology used in previous 
SW-CRTs varies greatly. As such, it is vital to highlight the number of studies who are using 
correct methods, and highlight the areas in which improvements should be made. 
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To establish whether the methodology used in a sample size calculation had allowed for 
cluster and time effects, the underpinning information was extracted. Adjustments for time 
should be made to allow for any underlying secular trend, which may influence the outcome, 
irrespective of whether the observations is from the exposed or unexposed period. 
Adjustments for time effects are likely to use the methodology set by Hussey and Hughes 
(32), else perhaps the design effect provided by Woertman et al. (21). Since the design effect 
proposed by Woertman et al. requires an inflation factor to account for the nature of the 
design, it is possible that studies may have been powered with or without this correction. 
The recent DE for cohort SW-CRTs (26, 64) was published after this review, and so no studies 
would have used it. 
Additional design features may be present in a SW-CRT. Depending on the intervention in 
question, it is possible that a transition period may be required, which should be included in 
the power calculation. Also, there is potential for an interaction between the intervention 
effect and time, which is noted as a time by treatment interaction. By this, it is possible for 
the intervention effect to be influenced by the length of time since it was implemented. 
Most importantly, it is possible for the within-cluster correlation to differ between 
measurement periods – that is, the correlation can decay over time. This is referred to as an 
inter-period correlation. It was noted as to whether any additional design features had been 
allowed for in the power calculation. Allowing for these items would be a deviance from the 
norm, so it is expected that allowing for such items would be clearly reported. As such, if 
they were not mentioned, it is assumed that an allowance for them did not take place.  
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 Information was extracted as to whether any allowance was made for varying cluster size. 
However, it was not recorded as to what methods were used to account for this variability. 
For both cohort and open cohort study designs, it was reported as to whether an allowance 
had been made to account for the repeated measurements of the same participant. A full list 
of the methodological assessment elements, accompanied by a short narrative describing 
the item can be found in Table 3.9. 
 
Table 3.9: Sample size reporting information - methodological assessment elements 
Item Explanation 
Method used to 
compute power 
Was the methodology used to determine the power reported? If so, was 
this using a parallel cluster method; Hussey and Hughes; Woertman; 
simulation methods (and did this allow for time effects); or was no 




If the trial included a variation on the typical design, such as transition 
periods, or extra pre and post measurement periods, or repeated 
measures on the same individual, or varying cluster sizes, were these 




Was the trial powered for any interactions, such as for example and 
interaction between calendar time and the treatment effect; or an 





Was the trial powered for an allowance for any extended correlation 
structures, such as a different correlation between observations within a 
cluster over time? 
 




What method was used to describe the between cluster heterogeneity 
(i.e. ICC, coefficient of variation or design effect)?  
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3.2.7 Methodological rigor of analysis methods used 
For trialists employing a SW-CRT, there are only a limited number of published articles that 
offer advice for the analytical methods that should be used. Whilst the seminal paper by 
Hussey and Hughes (32) and a recent paper by Hemming et al. (6) offer some statistical 
guidance, there has been limited work comparing potential methods of analysis. As such, it is 
likely that the methodology utilised in past trials will vary greatly.  
In order for the methodology to be assessed, it is first vital to highlight the necessary items 
that should be reported in the analysis. As a minimum, all analysis of a SW-CRT should allow 
for clustering. This may be via mixed effect model, robust standard errors, or by including 
fixed cluster effects, for example. It is therefore of interest to indicate the framework that 
was utilised. It is also necessary for the analysis of a SW-CRT to include the additional effects 
of time (32). Failing to account for time effects could produce misleading results and lead to 
an over-estimate of the precision of the treatment effect. Due to the complex design of the 
SW-CRT, it is possible that other additional features may have been included in the model. 
This may include a time by treatment effect interaction term. Since a large proportion of the 
included studies were cohort or open-cohort, the analysis should include an allowance for 
repeated measurements. Failing to adjust for this would produce an over-precise treatment 
effect estimate. 
An overview of the items relating to the methods of analysis and a short descriptive passage 
can be found in Table 3.10.  
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Table 3.10: Analytical methods - item description 
Item Explanation 
Allowance for clustering Was an allowance made for clustering? 
 
Model framework What model choice did they use for the 
analysis? 
 
Allowance for time effects Did the analysis make allowance for time 
effects? 
 
Framework for time effects What framework was used to allow for 
time effects 
 
Interaction terms Were any interaction terms included in the 
primary analysis model? 
Extended clustering Were any extended correlations added to 
allow for correlation within a time-period 
and between time-periods?   
 
Allowances for repeated measurements Were allowances made for repeated 
measurements of individuals? 
 
3.2.8 Impact of CONSORT statement and CONSORT cluster 
extension 
The primary analysis consists of the reporting of items only. However, a secondary interest is 
the impact of the CONSORT 2012 extension for cluster trials on the quality of reporting in 
SW-CRTs. Since the CONSORT extension to cluster trials was published in 2012, it is expected 
that reporting of items should have improved after this. To allow for the bedding in of this 
publication, and to allow for publications that may have been made in the same year prior to 
the publication of the cluster extension, studies will be dichotomised using 2013 as the cut-
off point, and we compare publications made prior to 2013 to those published in 2013 or 
later. 
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3.2.9 Methods used for analysis of included studies 
When presenting results, each item of interest with respect to the quality of reporting is 
given first as a number and percentage. This will simply indicate the number of studies that 
have reported the item, along with the accompanying percentage of the total studies. For 
continuous outcomes (such as journal impact factor), a median and inter quartile range is 
given.  
When considering the difference in reporting between subgroups, the differences were 
described using absolute difference and a corresponding 95% confidence interval. Although 
convention may dictate that only a p-value is chronicled to highlight whether there is a 
significant difference, the CONSORT statement recommends that a more clinically 
meaningful interpretation is included (68, 69). For dichotomous outcomes, we report a 
confidence interval for the mean difference, which is given as: 








Where P1 and P2 are the probabilities of the outcome in groups 1 and 2, and N1 and N2 
represent the number of observations within groups 1 and 2. For dichotomous outcomes 
with sufficient number of observations in each group, a chi-squared test was used to 
produce a p-value, whilst Fishers exact test was used for outcomes with a small number of 
observations. A small number of observations were deemed as the expected number of 
outcomes less than 5. For all dichotomous outcomes with a small number of observations, 
exact confidence intervals were calculated and reported. 
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Continuous outcomes were compared using a t-test and confidence intervals were formed 
assuming normality. The differences were also tested using a Mann-Whitney U test for 
continuous data in which the data seemed to be non-normal. In order to test whether there 
has been an increase in the quality of reporting over time, for some items, a linear test for 
trend was conducted. This is simply the fitting of a logistic model, in which the outcome 
variable is the reporting item in question. The year of publication is then added as an 
independent variable. A positive parameter value that corresponds to the year of publication 
will typically indicate that the reporting is, on average, increasing over time. Likewise, a 
negative parameter will correspond to a decrease in reporting over time.  
 
3.3 Results 
The search strategy (section 3.2.1) found 3214 studies. After de-duplication, 1996 studies 
were screened leaving 300 items for assessment. During this assessment, an additional 34 
items were included. These papers were identified from other sources, such as the reference 
list of relevant papers. As such, there were 334 full text articles assessed for eligibility (Figure 
3.2). The full texts were screened by two independent reviewers, to identify whether they 
were suitable for inclusion. Any disagreements were discussed, before an agreement made. 
274 studies were excluded, with the reasons categorised into the following types: duplicate, 
individually randomised study, not a SW-CRT, not a trial, non-randomised designs, secondary 
analysis, unable to access, protocols of included full trial reports, and other. There were 60 
studies left for inclusion in the review. A flowchart of the studies from the search strategy is 
given in Figure 3.2. 
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Studies from search   
(n = 3214) 
Studies from other 
sources (n = 34) 
Total studies (n = 3248) 
Studies screened (n=2030) 
Duplicates removed (n = 1218) 
Results excluded (n = 1753) 
Full texts assessed for eligibility (n = 334) 
Assessed for eligibility but excluded: 
Duplicates removed 12 
Individually randomised trials 118 
No trial conducted 52 
Not a SW-CRT 45 
None randomised design 9 
Secondary analysis 8 
Cannot access 5 
Protocols of an included full trial 5 
Other 20 
 
Total included studies (n = 60) 
 
Full trial reports n = 32 
Protocols n = 28 
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3.3.1 Trial demographics 
 General trial demographics 3.3.1.1
The trial demographics of all included studies are summarised in Table 3.11. These have 
been dichotomised via report status into full trial reports and trial protocols. Of the 60 
studies included in the review, 32 were full trial reports and 28 were study protocols. Over 
half of the included studies were published during or after 2013. The majority of trials were 
conducted in high income countries, with Australia, the British Isles, and North America the 
most common countries conducting a SW-CRT. Whilst only one full trial had been conducted 
in Australia, there were numerous protocols detailing planned trials, with over 20% of 
published protocols relating to planned SW-CRTs in Australia. Most of the included studies 
(83.3%) were carried out in a healthcare environment. Non-healthcare settings included an 
intervention to reduce absenteeism in the workplace (77), an evaluation of the effect of free 
school meals on academic achievement (78) and an intervention designed to reduce risk of 
dyslexia (79). Only 7% of the studies compared 3 or more trial arms, indicating that the 
majority of studies compared only two trial arms. Typically this included the testing of an 
intervention versus control or standard care. Over half of the studies utilised a simple, 
unrestricted form of randomisation. Stratification was carried out in 14 (23%) of studies, but 
only in 4 (13%) of the included full trial reports. 15 (25%) of studies used a continuous 
outcome, with binary outcomes being much more common (57%). Only 5 (16%) of the full 
trial reports had an accompanying trial protocol. 
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Values are numbers (percentages) unless stated otherwise. IQR: Inter Quartile Range. 
  
 Total 
N = 60 
Protocols 
N = 28 
Full reports 
N = 32 
Year of publication     
   1987-2012 28 (47) 12 (43) 16 (50) 
   2013-2014 32 (53) 16 (57) 16 (50) 
Journal Impact Factor    
   Median [IQR] 2.6 [2.0 - 3.5] 2.3 [2.1 - 4.8] 3.3 [2.0 - 4.8] 
Country of study     
   Australia  7 (12) 6 (21) 1 (3) 
   Canada or US 15 (25) 4 (14) 11 (34) 
   UK or Ireland 11 (18) 3 (11) 8 (25) 
   Other higher income country 15 (25) 9 (32) 6 (19) 
   Middle income country 9 (15) 4 (14) 5 (16) 
   Low income country 3 (5) 2 (7) 1 (3) 
Type of setting     
   Health-care 50 (83) 25 (89) 25 (78) 
   Non health-care 10 (17) 3 (11) 7 (22) 
Cluster     
   General practice 7 (12) 6 (21) 1 (3) 
   Hospital/Ward/Specialities 12 (20) 5 (18) 7 (22) 
   Other health cluster  20 (33) 9 (32) 11 (34) 
   Geographical unit 11 (18) 5 (18) 6 (19) 
   Other / Unclear 10 (17) 3 (11) 7 (22) 
Number of study arms     
   Two 56 (93) 25 (89) 31 (97) 
   Three or more  4 (7) 3 (11) 1 (3) 
Randomisation type    
   Simple 35 (58) 15 (54) 20 (63) 
   Paired 4 (7) 0 (0) 4 (13) 
   Stratified 14 (23) 10 (36) 4 (13) 
   Other / Unclear 7 (12) 3 (11) 4 (13) 
Primary Outcome type    
   Continuous 15 (25) 10 (36) 5 (16) 
   Binary 34 (57) 13 (46) 21 (66) 
   Other  5 (8) 2 (7) 3 (9) 
   Unclear/not reported 6 (10) 3 (11) 3 (9) 
Published protocol  N/A 5 (16) 
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 Realised design characteristics 3.3.1.2
The realised design characteristics of the full trial reports are summarised in Table 3.12. 
Clusters were randomised over two time-periods in 9 (28.1%) of the included studies. The 
median number of randomisation points was 4 (IQR 2 – 6). Over a quarter of the studies 
(28.1%) contained less than ten clusters. The median number of clusters included was 17 
(IQR 8 – 38). The median cluster size was 21.5 (IQR 15 – 30) for cohort studies, 288.5 (IQR 
43.8 – 493) for open cohort studies, and 326 (IQR 182 – 500) for cross-sectional studies. The 
median duration of the included studies was 17 months (IQR 8 – 24), with a median step 
length of 2 months (IQR 1 – 4). Only 5 (15.6%) of the completed trial reported contained a 
design that was cross-sectional in nature. In contrast, 12 (37.5%) and 10 (31.3%) of the 
designs were cohort or open cohort. Whilst not reported here, the design type was recorded 
for protocols also. Of the protocols, 11 (39.3%) were planned to be cross-sectional in nature, 
5 (17.9%) cohort studies, 7 (25%) open cohort designs and 5 (17.9%) did not report the 
planned design type. Of the full trial reports, 14 (43.8%) included a variation on a traditional 
SW-CRT. The most common variation was an extension to the pre or post periods of the 
study whilst all clusters remained unexposed or exposed (10 studies). Of the 6 studies in the 
“other” category, there were 3 trial reports in which not all clusters were exposed to the 
intervention at the end of study (though the intention was for them to receive the 
intervention). An additional 3 studies contained no period in which all clusters were 
unexposed to the intervention.  
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Table 3.12: Summary of the realised design characteristics of included full trial reports 
 Full trial report  
N = 32  
Number of steps1  
     Two 9 (28.1) 
     Three or four 8 (25.0) 
     More than four 14 (43.8) 
     Not reported 1 (3.1) 
     Median [IQR] 4.0 [2.0 - 6.0] 
Number of clusters  
     Less than ten 9 (28.1) 
     Ten or more 22 (68.8) 
     Not reported 1 (3.1) 
     Median [IQR] 17.0 [8.0 - 38.0] 
Total cluster size2  
     Median [IQR] 55.0 [24.0 - 326.0] 
Number of clusters randomised per step  
     Median [IQR] 3.0 [1.0 - 8.0] 
Number of measurement points3  
     Median [IQR] 5.0 [3.0 - 7.5] 
Study duration (months)   
     Median [IQR] 17.0 [8.0 - 24.0] 
Step duration (months)  
     Median [IQR]   2.0 [1.0 - 4.0] 
Design type4  
     Cross-sectional 5 (15.6) 
     Cohort 12 (37.5) 
     Open cohort 10 (31.3) 
     Unclear 5 (15.6) 
Variations on design  
     Transition periods  1 (3.1) 
     Extended pre or post periods  11 (34.4) 
     Other 6 (18.8) 
Values are numbers (percentages) unless stated otherwise. 
1
:steps are points at which clusters are randomised; 
2
: for cohort studies this is the total number of observations made within the cluster, it includes the size of 
clusters in which there was lack of clarity of cluster size and cluster size per measurement period but for which a 
judgement was made;
 3
:measurement points are the number of separate periods or points in time in which 
outcome data are collected; 
4
:Design type includes those for which there was lack of clarity but for which a 
judgement was made; IQR: Inter Quartile Range 
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3.3.2 Design justification 
Over 75% of the included studies incorporated a justification of their sample size. Only a 
small number of studies (5 trials, 8%) were identified that used a pragmatic argument to 
justify sample size, with the majority of studies (41, 68%) using statistical reasoning (Table 
3.13). The majority of studies (72%) did not divulge the rationale for randomisation at the 
cluster level over the individual level. Of the 17 studies that reported the reasons for using a 
cluster randomised design, the most common motives were to avoid contamination and 
because of a cluster level intervention. The reporting of rationale for choosing a SW-CRT was 
better than simply the rationale for a cluster design. Only 18 (30%) studies provided no 
justification of design choice. The most common justification provided was the need for 
staggered implementation (37%). Other common justifications included the intention (or 
desire) for all clusters to receive the intervention (28%), and to mitigate ethical concerns 
that may arise from withholding an intervention (18%). Examples of rationale contained in 
the other category include the evaluation of a routine roll-out, operational simplicity and the 
requirement of fewer clusters than a P-CRT.   
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Table 3.13: Summary of the design justification for included SW-CRTs 
Values are numbers (percentages) unless stated otherwise. P-value is for the comparison of full trials to protocols using a chi-squared test for proportions or (*) using 
Fisher’s exact test. 
 All reports 
N = 60 
Protocols 
N = 28 
Full reports 
N = 32 
Absolute difference 
(95% confidence interval 
P-value 
Sample size justification       
     Pragmatic* 5 (8) 3 (11) 2 (6) 4.5 (-9.7 to 18.7) 0.657 
     Statistical 41 (68) 24 (86) 17 (53) 32.6 (11.0 to 54.2) 0.007 
     No justification* 14 (23) 1 (4) 13 (41) -37.1 (-55.4 to -18.7) 0.001 
Motivation for cluster randomisation 
     Contamination* 9 (15) 6 (21) 3 (9) 12.1 (-6.2 to 30.3) 0.281 
     Cluster level intervention* 9 (15) 5 (18) 4 (13) 5.4 (-12.9 to 23.6) 0.721 
     Practical reasons* 3 (5) 3 (11) 0 (0) 10.7 (-0.7 to 22.2) 0.096 
     Other * 1 (2) 0 (0) 1 (3) -3.1 (-9.2 to 2.9) 1.000 
     None reported 43 (72) 17 (61) 26 (81) -20.5 (-43.1 to 2.1) 0.078 
Motivation for stepped-wedge design 
     Ethical concerns* 11 (18) 5 (18) 6 (19) -0.9 (-20.5 to 18.7) 1.000 
     Sequential implementation 22 (37) 12 (43) 10 (31) 11.6 (-12.8 to 36.0) 0.352 
     Social acceptability*  5 (8) 4 (14) 1 (3) 11.2 (-3.1 to 25.5) 0.175 
     Resource Constraints* 9 (15) 6 (21) 3 (9) 12.1 (-6.2 to 30.3) 0.281 
     Methodological reasons* 6 (10) 6 (21) 0 (0) 21.4 (6.2 to 36.6) 0.008 
     Clusters act as own control* 7 (12) 4 (14) 3 (9) 4.9 (-11.5 to 21.3) 0.695 
     Adjust for temporal trends* 5 (8) 3 (11) 2 (6) 4.5 (-9.7 to 18.7) 0.657 
     Desire for all clusters to receive intervention  17 (28) 10 (36) 7 (22) 13.8 (-9.0 to 36.6) 0.235 
     Expect to do more good than harm*  10 (17) 6 (21) 4 (13) 8.9 (-10.1 to 28.0) 0.491 
     Other*  11 (18) 4 (14) 7 (22) -7.6 (-26.9 to 11.7) 0.519 
     None reported 18 (30) 6 (21) 12 (38) -16.1 (-38.7 to 6.6) 0.259 
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3.3.3 Quality of reporting of sample size calculation 
 Quality of reporting of items recommended by CONSORT 3.3.3.1
A comparison of the adherence to the reporting of the 9 CONSORT items for trials published 
in 2013 and 2014 compared to those published prior to 2013 is given in Table 3.14. Of the 60 
studies included in the review, 45 (75%) reported a sample size justification.  
Generally, the reporting has improved over time, with an increase in the sample size 
justification (p = 0.073) and recent studies reporting on average 1.22 items more (95%CI: 
0.07 to 2.36) than those published pre-2013. On average, studies were reporting 5 of the 9 
CONSORT items [IQR: 2 to 6], though no study reported all 9. Assuming normality, a t-test of 
group means would correspond to a significant difference (p=0.037) but a Mann-Whitney U-
test assuming non-normality leads to a non-significant result at the 5% level (p=0.067). As 
expected, almost all studies (97%) reported the number of clusters in the study. The 
expected power of the trial was reported in 45 (75%) of the studies, but the treatment effect 
was only sufficiently reported in 33 (55%). Almost half (55%) described the variation in 
outcomes across clusters, but few reported the uncertainty surrounding this value. An 
allowance for attrition was reported in only 30% of studies. Notably, the reporting of 
clustering (often by the ICC) has improved from 29% pre 2012 to 69% post 2013 (p = 0.022).  
A linear test for trend, to examine whether the reporting of each item has improved over 
time, was fitted to the data. This highlighted that as time has progressed, the likelihood of 
reporting the variation in outcomes across cluster has increased (p = 0.025). For all other 
reporting items, whilst it showed a positive trend, there were no other statistically significant 
results at the 5% level. 
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Table 3.14: Sample size reporting quality from CONSORT statements 
Values are numbers (percentages) unless stated otherwise. 1: a sufficient reporting of the treatment effect consists of either a standardised effect size; a mean difference and SD; means 
in both arms and SD; proportions in both arms; proportion in one arm and a difference. IQR: Inter-quartile range. ICC: Intra Cluster Correlation. P-value is for the comparison of 1987-
2012 publications and 2013-2014 publications using a 𝜆2test for proportion  or Mann-Whitney U test, or (*) using Fisher’s exact test. 
 All studies 
N = 60 
1987-2012 
N = 28 
2013-2014 
N = 32 
Absolute difference (95% 
confidence interval) 
P-value 
Sample size justification      
    Reported  45 (75) 18 (64) 27 (84) 20.1 (-1.7 - 41.8) 0.073 
ITEM 1:      
   Level of significance 39 (65) 16 (57) 23 (72) 14.7 (-9.3 - 38.8) 0.233 
ITEM 2:       
   Power  45 (75) 18 (64) 27 (84) 20.1 (-1.7 - 41.8) 0.073 
ITEM 3:       
   Treatment effect 1 33 (55) 15 (54) 18 (56) 2.7 (-22.6 - 27.9) 0.835 
ITEM 4:       
   Consistency with primary outcome 38 (63) 14 (50) 24 (75) 25.0 (1.2 - 48.8) 0.045 
ITEM 5:       
   Allowance for attrition  18 (30) 7 (25) 11 (34) 9.4 (-13.6 - 32.4) 0.429 
ITEM 6:      
   Number of clusters   58 (97) 27 (96) 31 (97) 3.4 (-67.0 - 73.9) 0.923 
   Median cluster size   39 (65) 15 (54) 24 (75) 23.4 (-2.3 - 49.2) 0.083 
ITEM 7:       
   Variation in cluster size*    6 (10) 1 (4) 5 (16) 12.1 (-2.3 - 26.4) 0.201 
ITEM 8      
   Variation in outcomes across clusters (i.e. ICC) 33 (55) 11 (39) 22 (69) 29.5 (5.3 - 53.7) 0.022 
ITEM 9:       
   Uncertainty of ICC (or equivalent)*  8 (13) 3 (11) 5 (16) 4.9 (-12.1 - 21.9) 0.712 
All ITEMS      
   Number items reported Median [IQR] 5 [2 – 6] 4 [1 – 6] 6 [5 – 6] 1.22 (0.07 - 2.36) 0.067 
   Reporting all 9 items  0 (0) 0 (0) 0 (0)   
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 Quality of reporting of items relevant to a SW-CRT 3.3.3.2
The reporting of items relevant to the SW-CRT by year of publication is given below (Table 
3.15). The number of steps was well reported, either explicitly (90%) or deducible (98%), and 
almost all trials reported the number of clusters randomised per step (93%). Over 75% of 
studies included a schematic representation of the design. Although it was possible to 
deduce the design type in 72% of studies, only 27% explicitly reported the design. In almost 
50% of studies, it was unclear whether the cluster size reported in the sample size 
calculation indicated the total cluster size or the cluster size per measurement period. 
Although there is some indication of an increase in the quality of reporting over time, it is 
not substantially different between the groups. When fitting a linear test for trend, though 
on average it seems that there is an increase in reporting over time, there were no 
statistically significant results. 
There is some evidence of a difference in sample size reporting of the 9 CONSORT items 
between full trials and protocols (Appendix C), with protocols generally reporting a greater 
number of items. However, there is no evidence of a difference in the reporting of SW-CRT 
items. 
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Table 3.15: Reporting of SW-CRT sample size elements 
 All 
studies 
N = 60 
1987-
2012 
N = 28 
2013-
2014 
N = 32 
Absolute difference  
(95% confidence interval) 
P-value 
Number of steps      
   Explicitly reported 54 (90) 23 (82) 31 (97) 14.7 (-0.7 - 30.1) 0.058 
   Reported or deducible 59 (98) 27 (96) 32 (100) 3.6 (-3.3 - 10.4) 0.281 
Number clusters randomised per step      
  Reported  56 (93) 25 (89) 31 (97) 7.6 (-5.4 - 20.5) 0.240 
Schematic representation       
   Reported 46 (77) 20 (71) 26 (81) 9.8 (-11.7 - 31.3) 0.370 
Design type (i.e. cross-
sectional/cohort) 
     
   Explicitly reported 16 (27) 6 (21) 10 (31) 9.8 (-12.3 - 31.9) 0.391 
   Reported or deducible 43 (72) 19 (68) 24 (75) 7.1 (-15.8 - 30.0) 0.540 
Clarity of cluster size1      
   Total cluster size  17(28) 8 (29) 9 (28) -0.4 (-23.3 - 22.4) 0.969 
   Cluster size per measurement period  25 (42) 10 (36) 15 (47) 11.2 (-13.6 - 35.9) 0.382 
   Unclear/not reported 28 (47) 15 (54) 14 (44) -9.8 (-35.1 - 15.4)  0.448 
Values are numbers (percentages) unless stated otherwise. 
1
: some studies reported both total cluster size and cluster size per measurement period; P-value is for the comparison of 
1987-2012 publications and 2013-2014 publications using a chi-squared test for proportions. 
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3.3.4 Methodological rigor of sample size calculations 
When considering the studies published pre 2012 to those published in 2013 & 2014, it 
seems that the methodology is improving (Table 3.16). A large majority of studies (73%) 
allowed for clustering, though only one-third allowed for time effects. However, the 
proportion seems to have increased over time, with a linear test for trend showing some 
evidence of this. Of the 45 included studies, 24 should have allowed for repeated measures, 
though only 3 (13%) acknowledged this in the sample size calculation. Whilst this seems to 
have decreased over time, there are too few studies to make a conclusive judgement. 
The reporting of the methodology used is quite poor, with one-third of studies not reporting 
the method used to estimate the sample size. There has been in an increase over time in the 
number of studies using the Hussey and Hughes methodology (17% to 41%). When treating 
time as continuous, this corresponds to a p-value of 0.074. Pre 2012, the majority (83%) of 
studies did not account for time effects. Whilst this proportion has decreased over time 
(p=0.004), there are still a large proportion (56%) who have not accounted for time effects in 
the sample size calculation, with methodology appropriate for a P-CRT or a before and after 
CRT often used.  
Whilst it is not surprising that such few studies acknowledger additional design features in 
the sample size calculation, it should be noted that several studies included a transition 
period in the schematic representation of the study, but did not account for this in the 
sample size calculation.  
The variation in the outcome across clusters was commonly described using the ICC (20/33) 
and CV (10/33), with the proportion using the CV increasing in recent studies.  
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Table 3.16: Methodological assessment of sample size calculations 
Values are numbers (percentages) unless stated otherwise.
  1
among those with a cohort design. P-value is for the comparison of full reports and protocols using a chi-
squared test for proportions (categorical outcomes) or Mann-Whitney U test (where medians are reported). 
2
As a percentage of studies for which this was 
appropriate. *using fishers exact test.  
 All reports 
N = 45 
1987-2012 
N = 18 
2013-2014 
N = 27 
Absolute difference (95% 
confidence interval) 
P-value 
Allowance for clustering       
   Number (%) 33 (73) 11 (61) 22 (81) 20.4 (-6.5 to 47.2) 0.130 
Allowance for time effects      
   Number (%)* 15 (33) 3 (17) 12 (44) 27.8 (2.3 to 53.2) 0.063 
Allowance for repeated measurements1      
   Number (%)* 3/24 (13) 2/11 (18) 1/13 (8) -10.5 (-37.5 to 16.5) 0.576 
Power methodology       
   Hussey and Hughes* 14 (31) 3 (17) 11 (41) 24.1 (-1.2 to 49.4) 0.111 
   Other, allowing for time effects * 2 (4) 0 (0) 2 (7) 7.4 (-2.5 to 17.3) 0.509 
   Other, not allowing for time effects* 14 (31) 10 (55) 4 (15) -40.7 (-67.3 to -14.2) 0.007 
   Not stated*  15 (33) 5 (28) 10 (37) 9.3 (-18.3 to 36.8) 0.748 
Power methodology for additional features      
   Transition periods 0 (0) 0 (0) 0 (0)   
   Interactions (e.g. lag effects) 0 (0) 0 (0) 0 (0)   
   Extended correlations*    2 (4) 2 (11) 0 (0) -11.1 (-25.6 to 3.4) 0.155 
   Varying cluster size * 3 (7) 1 (6) 2 (7) 1.9 (-12.6 to 16.3) 1.000 
Variation in outcomes across clusters2      
   Reported using ICC* 20/33 (61) 8/11 (73) 12/22 (55) -18.2 (-51.7 to 15.4) 0.456 
   Reported using CV* 10/33 (30) 2/11 (18) 8/22 (36) 18.2 (-12.2 to 48.6) 0.430 
   Reported using DE* 1/33 (3) 1/11 (9) 0/22 (0) -9.1 (-26.1 to 7.9) 0.333 
   Reported using between cluster variation* 2/33 (6) 0/11 (0) 2/22 (9) 9.1 (-2.9 to 21.1) 0.542 
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3.3.5 Methodological rigor of the analysis methods used 
Of the 32 full trial reports, the majority of them (75%) made allowances for clustering in the 
data analysis (Table 3.17). Typically this was done using a generalised linear mixed model 
(GLMM), though there were instances of studies using generalised estimating equations 
(GEE) and generalised linear model (GLM) with fixed cluster effects. However, only 53% of 
the studies acknowledged the confounding effect of time in the analysis. Of the 17 studies 
that accounted for time effects, this was most often done using a fixed effect, whilst 6 
studies acknowledged that they adjusted for time, but did not specify clearly how it had 
been done. One study recognised that time should be adjusted for, but argued that it was 
not significant in the analysis. The majority of studies were not clear as to whether 
allowances had been made on repeated individuals, with only 9/24 studies correctly allowing 
for repeated measures. None of the included studies reported an allowance for the within-
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Table 3.17: Methods of analysis used in full trial reports 
 Full trial report  
N = 32 
Allowance for clustering  
   Yes 24 (75) 
   No  7 (22) 
   Unclear 1 (3) 
Model framework with clustering  
   GLM with robust SEs* 0 (0) 
   GLM with fixed cluster effects 2 (6) 
   GLMM 16 (50) 
   GEE 3 (9) 
   Other 3 (9) 
   Unclear 2 (6) 
Allowance for time effects  
   Yes 17 (53) 
   No 15 (47) 
Framework for time effects  
   Fixed effects 7 (22) 
   Other 4 (13) 
   Not specified 6 (19) 
   Linear time effect 0 (0) 
   Unclear 4 (13) 
   No, but argued not significant 1 (3) 
   No allowance 10 (31) 
Interactions  
   Time by treatment  0 (0) 
Extended clustering  
   Allowance for within-period and inter-period correlations 0 (0) 
Allowance for repeated measures on same individuals1   
    Yes 9 (28) 
    No 3 (9) 
    Unclear 12 (38) 
    N/A 8 (25) 
Values are numbers (percentages) unless stated otherwise.
 1
: Study designs that were cross-sectional in nature 
were categorised as n/a. GLM: generalised linear model. SE: standard errors. GLMM: generalised linear mixed 







Page | 80 
 
3.4 Discussion 
Here, we have described a methodological review that assessed the quality of reporting of 
sample size calculations and of the methods of analysis used in full trial reports. The 
adherence to the CONSORT statement for randomised trials and the extension for cluster 
trials were reported for each study. Following this, the methodological rigor of both the 
sample size calculation and the analytical method used were assessed.  
It is clear that the quality of reporting in SW-CRTs in sub-optimal. Only 33% of the studies 
allowed for time effects in the sample size calculation, despite it being an item that 
distinguishes it very clearly from a P-CRT. Failing to acknowledge the presence of time 
effects could lead to an under-estimate of the sample size needed to detect a relevant 
treatment effect. Similarly, in the analysis stage of a study, failing to adjust for time effects 
could lead to an over precise estimate of the treatment effect.  
Whilst it seems apparent that a SW-CRT is used mainly by studies that are following a cohort 
or open cohort design, that is that some (or all) patients are followed-up for multiple time-
periods, there is a distinct lack of clarification for the sample size for these studies. In fact, of 
the 24 studies who should have accounted for repeated measurements, only 3 (13%) made 
an allowance. Similarly, in the analysis stage, only 9/24 studies allowed for repeated 
measures.  
In previous methodological papers considering estimating the power or sample size of a SW-
CRT, it has often been assumed that the outcome is continuous, or else can be approximated 
via a normal distribution. However, it has not been tested how accurate the methods are if 
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the outcome variable does not exhibit normality. It is therefore interesting that only 25% of 
studies used a continuous outcome, highlighting the fact that the majority used 
methodology that has been developed for a different outcome type. There is therefore an 
urgent need to develop sample size methodology for use in studies employing a binary 
outcome, as well as for other outcome types.  
Noticeably, very few studies reported an extended correlation. One cohort SW-CRT protocol 
reported a correlation coefficient of repeated measurements (80) and a cross-sectional SW-
CRT protocol reported a within-patient correlation over time (81) and powered as a before 
and after study. As such, the IPC and WPC have not previously been reported in a sample 
size calculation for a SW-CRT. However, since there is a dearth power methodology with 
reference to the IPC and WPC, it was expected that few studies would allow for any 
enhancement of previous sample size methodology. 
Several studies reported a variation in cluster size within the report. However, some of these 
studies either did not report a sample size calculation (82) or did not report the method used 
to obtain the sample size (83). Two studies used DEs appropriate for a P-CRT, with one using 
the average cluster size (25) and the other using an adjusted DE acknowledging the 
coefficient of variation of cluster sizes (84). Only one study that reported a variation in 
cluster size used the Hussey and Hughes method to obtain the sample size (85) – but they 
did not report how they adjusted for the varying cluster size. 
Many of the studies published most recently were protocols, and so some of the 
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3.4.1 How does this review differ to those already carried out  
Although there exists other systematic reviews that have considered the SW-CRT, and 
indeed the sample size calculation used, there are numerous differences between them and 
this review (23, 28, 29). Indeed, whilst previous reviews have broadly considered the 
methodology used to determine the sample size, none have systematically assessed the 
quality of reporting of SW-CRTs against the existing CONSORT statements. Furthermore, no 
previous review has assessed the methodological rigor of the sample size calculations, and 
investigated whether current standards are sufficient. Additionally, of the two earliest 
reviews in SW-CRTs, one review focused solely on health care interventions, whilst the other 
included non-randomised studies (23, 29). Since randomised studies differ greatly from non-
randomised studies, the objective of this review was to assess the quality of randomised 
studies only. Moreover, since the CONSORT statements are related to randomised studies, 
studies published employing a non-randomised design may not adhere to the CONSORT 
guidelines.  
In the area of P-CRTs, there exist numerous methodological reviews that assess the quality 
of reporting of the sample size calculations in relation to a smaller number of items 
recommended in the 2004 extension to the CONSORT statement (73, 74). In this review, 
assessments are made versus the 2012 extension for cluster trials. Although many trials may 
have been designed, or published, before the reporting guidelines were published, it is vital 
that we considered the most recent recommendations. Also, since the primary outcome is 
the quality of reporting, and not the adherence to guidelines, the most recent CONSORT 
extension was chosen.  
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3.4.2 Implications 
In P-CRTs, it is well known that failing to acknowledge clustering in the sample size 
calculation will lead to an underpowered trial. Similarly, in the analysis stage, failing to adjust 
for clustering will lead to a treatment effect estimate that is overly precise. Since a SW-CRT is 
a type of cluster trial, similar consequences will occur if clustering is not accounted for in the 
sample size calculation and in the post-trial analysis. Unlike a P-CRT, the design and analysis 
of a SW-CRT should take temporal trends into account. 
Whilst analytical methods for P-CRTs have been explored in more detail than the SW-CRT, it 
is clear that some methods cannot be easily transposed. For example, if a P-CRT has been 
conducted with equal cluster sizes, then one possible method of inference is to conduct an 
analysis of cluster means. Whilst for a P-CRT, this would lead to valid inferences, in a SW-
CRT; an analysis of cluster level means would not take into account any time effects, and so 
would lead to invalid inferences. 
In CRTs that follow a cohort design, participants have multiple observations over time. 
Methods for estimating the sample size in a P-CRT with a cohort design, such as a pre-post 
design, have previously been presented (52). Repeated measurements on the same 
participant can be acknowledged at the analysis stage through an additional random effect. 
This results in an additional correlation term that depicts the correlation between 
observations made on the same participant over time (87). As shown in previous reviews, 
SW-CRTs often follow a cohort design, but use methods of design and analysis appropriate 
for a cross-sectional design – so do not include this additional random effect. The 
implications of a cohort design on the sample size calculation for a SW-CRT are now being 
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considered (26). Nevertheless, the additional complexities of a cohort design need to be 
stressed further to make sure correct methods are used in the design and analysis of cohort 
CRTs, ensuring that methods for cross-sectional and cohort designs are not conflated. In this 
piece of research, the cohort design is not considered further. Instead, the focus is solely on 
the cross-sectional SW-CRT. 
3.4.3 Study limitations 
This review assesses the reporting of items from both the CONSORT statement for 
individually randomised trials and the extension for cluster randomised trials. However, 
whilst relevant, some items from these statements are not naturally extendable to a SW-
CRT. For example, it is recommended in the CONSORT statement for individually randomised 
trials that authors report whether attrition has been accounted for in the sample size 
calculation. However, it is often reported that SW-CRTs are useful study designs for studies 
that are using routinely collected data, in which case, attrition would not be relevant. In this 
review, 20% of studies were using routinely collected data, and so attrition would not have 
been an issue. However, rather than record this item as not applicable, it was still recorded 
as reported or not. As such, trials that are utilising routinely collected data may not report 
attrition as they feel it is irrelevant for their study design, rather than be a lack of reporting.  
Whilst the most appropriate methodology currently derived for SW-CRTs is that proposed by 
Hussey and Hughes – which was the most used methodology – it has some limitations. There 
are a few key design features that are not immediately powered for. For example, it is 
assumed that the correlation between two observations within a cluster is the same 
regardless of measurement point. In reality, it is likely that there will be some variation. In 
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this review, two studies allowed for a variation in the ICC across time, whilst no studies 
included a time by treatment effect interaction in their power calculation.  
3.5 Conclusions 
Whilst it has been acknowledged for P-CRTs that failing to account for clustering will lead to 
under estimates of the power, it should be highlighted that sample size calculations in SW-
CRTs that fail to account for time effects may affect the power of the trial, and so lead to too 
few or too many participants being included. Many recent methodological developments 
mean it is now possible to determine the cluster size for specified design constraints, or 
determine the number of clusters or steps needed.  
Although the SW-CRT is a very flexible design that allows for a pragmatic evaluation 
determined by the number of available clusters or participants, properly designed 
evaluations should include a robust justification of the sample size.  
As expected, the quality of reporting of sample size calculations is sub-optimal. Although 
there is evidence to suggest that the quality is increasing over time, there is still need for 
further improvement. Furthermore, there is a distinct difference between the quality of 
reporting of full trials compared to protocols. Whilst it is known that methodological 
developments are needed to address areas of this complicated design, it is vital that studies 
currently using the design are using appropriate methodology. Of particular note, less than 
half of the included studies accounted for temporal trends in the sample size calculation, 
very few allowed for the repeated measurements of participants and studies were not 
clearly identifying whether the design was cross-sectional or cohort. As such, the majority of 
 
 
Page | 86 
 
studies may be using sample size methodology that does not match the study design. This is 
also highlighted when considering the study outcome types. The primary outcome for the 
majority of studies was binary, whereas the most common methodology used assumes a 
continuous outcome. This emphasises the need for methodological development in these 
areas.  
There are two key issues that emanate from this review. Firstly, despite the knowledge that 
clusters are likely to vary in size, there is little evidence that sample size calculations are 
accounting for varying cluster sizes. Indeed, those that mention varying cluster size are not 
then adjusting for it in the sample size calculation. Secondly, despite the SW-CRT being a 
longitudinal design, there has been little indication of SW-CRTs considering an extended 
correlation structure within the sample size calculation – and no indication of the IPC and 
WPC being included. However, there is little evidence in the methodological literature of the 
likely impact of these two issues on the sample size calculations for a SW-CRT.  
The next chapter considers an extended correlation structure and establishes the methods 
required to estimate the inter-period correlation (IPC) and the within-period correlation 
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CHAPTER 4:      CORRELATION IN CLUSTER 
TRIALS 
A paper based on the work from this chapter has been published. 
Citation: Martin J, Girling A, Nirantharakumar K, Ryan R, Marshall T, Hemming K. Intra-
cluster and inter-period correlation coefficients for cross-sectional cluster randomised 
controlled trials for type-2 diabetes in UK primary care. Trials. 2016;17:402. 
 
4.1 Introduction 
Typically in healthcare research, observations used in the evaluation and analysis of an 
intervention may stem from individuals, but the intervention is often aimed at the cluster 
level – such as hospitals, clinicians, or GP surgeries (88-92). In an individually randomised 
controlled trial (RCT), the patients themselves are randomised to the intervention or control 
arm. Increasingly, interventions are being evaluated using cluster randomised trials (CRT) 
(90, 91, 93). In a CRT, the clusters are the unit of randomisation, rather than the individuals 
within them. In an RCT, it is assumed that all participants are independent (92). This 
assumption may not be valid in a CRT (56). For example, in the WOSLAD study (section 1.6.1) 
(5), participants within a hospital share common staff and facilities, in addition to likely 
geographical and socio-economic similarities. As such, they are likely to be more similar than 
participants from different hospitals (89, 90). The similarities between participants may be 
relevant or irrelevant to the trial, but leads to a lack of independence between observations 
within a cluster (90, 92). The design and analysis of CRTs should recognise this within pre-
trial sample size calculations and post-trial analysis (92, 94-97).  
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4.1.1 Design effects 
In a RCT, pre-trial sample size calculations are straightforward, but without adjustment 
would produce an inaccurate sample size for a CRT (98). Sample sizes required under cluster 
randomisation (SSCRT) are inflated over that required under individual randomisation (SSRCT) 
to achieve the same power, through the use of a design effect (DE) (53), so that:  
SSCRT = SSRCT x DE 
For a CRT with equal cluster sizes, the design effect required is well established (53), and is 
given as:  
1 + (𝑚 − 1)𝜌 
4.1 
Here m represents the cluster size and ρ is the correlation between two randomly chosen 
observations within a cluster. The value of ρ has important implications on the sample size 
requirements in a CRT (56, 99). This design effect should only be used for studies with equal 
sized clusters. Studies with unequal cluster sizes using the above design effect may obtain an 
underestimate of the necessary sample size (57). Alternative design effects for studies with 
varying cluster size are discussed further in Chapter 2. 
4.1.2 Correlation between observations within a cluster 
The most common type of CRT is a parallel CRT (P-CRT). In this study design, clusters are 
randomised to either intervention or control and this allocation is maintained over the study 
duration. However, alternative study designs are being increasingly used – such as the 
stepped-wedge design (6, 23), the cluster cross-over design (100, 101), and the dog-leg 
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design (20, 48). These designs are longitudinal in the sense that observations are made over 
multiple time-periods. 
Traditionally, in the analysis of a CRT, the models fitted to the data assume an exchangeable 
correlation structure. That is, the observations belong to one study-period, and the 
correlation between any two observations within a cluster is constant over time (time 
independent). However, in longitudinal designs, observations may be taken from different 
time-periods, and so the correlation may not be constant over time (time dependent), and 
an exchangeable correlation structure may not be appropriate. That is to say, ρ, which is 
necessary for a DE, is reliant on whether a time-dependent model or a time-independent 
model is fitted to the data.  
Throughout this work, a cross-sectional design is assumed, so that participants contribute 
only one observation to the analysis. In a setting with correlation treated as exchangeable 
(time independent model), we define the intra-cluster correlation coefficient (ICC) as the 
correlation between two randomly selected participants within a cluster. In a setting with a 
time dependent model fitted to the data, we define the within-cluster correlation coefficient 
(WCC) as the correlation between two randomly selected participants within a cluster. As 
such, both the ICC and WCC are equivalent to ρ, but are only defined when an appropriate 
model is fitted.  
 Intra-cluster correlation coefficients 4.1.2.1
The ICC is defined as the correlation between two randomly selected observations from two 
participants within the same cluster (102) and is equivalent to ρ in a model with 
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exchangeable correlation. In this context, there are three fundamental assumptions that are 
made:  
1) Any two observations from participants within the same cluster are correlated. 
2) The correlation is the same for all pairs of participants from within the same 
cluster regardless of the duration between the participants.  
3) Any two observations made on participants from different clusters are 
independent. 
To ensure a sufficiently powered study, an accurate estimate of the ICC is necessary. 
Dependent on the outcome type, there are numerous methods that can be used to estimate 
the ICC. Many previous trials in UK primary care have failed to report the ICCs in the post-
trial analysis (73). As such, planned trials often use ad-hoc ICCs in the estimation of sample 
size (103), which may lead to an underpowered trial. Several papers have recommended 
that ICCs should be published routinely following the completion of a trial (54, 104). The 
CONSORT extension for cluster randomised trials recommends that authors report the ICCs 
in the post-trial analysis in addition to reporting the ICC used in the pre-trial sample size 
calculation (70). There are also examples of ICCs being presented from the analysis of large 
patient databases (105, 106). 
 Within-cluster correlation coefficient 4.1.2.2
In alternative study designs with repeated cross-sections, it is recognised that the correlation 
between observations made from within the same cluster and the same period will differ 
from the correlation between observations made from participants in the same cluster but 
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at different periods (27, 61, 87, 107). In this context, the correlation is not exchangeable and 
the correlation is dependent on the timing of the observations. As shown by Figures 4.1 and 
4.2, time is split into a number of (equal) time-periods. Within this framework, several 
assumptions are made: 
1) Any two observations from the same cluster are correlated. 
2) There is a constant correlation between any two observations within a cluster 
from the same time-period. 
3) There is a constant correlation between any two observations within the same 
cluster but from different time-periods. 
4) Any two observations from different clusters are independent. 
Here, we define the within-cluster correlation (WCC) as the correlation between two 
randomly chosen observations within a cluster in this setting. Therefore, the WCC is 
equivalent to ρ when fitting a time-dependent model. Since the correlation between two 
observations within the same cluster and the same time-period is different to the correlation 
between observations within the same cluster at different time-periods, we conceptualise a 
within-period cluster correlation (WPC) and an inter-period cluster correlation (IPC).  
The WPC is defined as the correlation between two randomly selected observations taken 
from the same cluster and the same period (Figure 4.1). The IPC is defined as the correlation 
between two randomly selected observations taken from participants in the same cluster 
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Figure 4.1: Comparing observations within 
the same cluster within the same period – 
the within-period correlation – in a cross-
sectional SW-CRT 
Figure 4.2: Comparing observations within 
the same cluster at different periods - the 
inter-period correlation – in a cross-
sectional SW-CRT 
  
The “.” indicates an observation and the circle highlights the observations being compared. 
 
In cluster cross-over trials, it has been established that the IPC influences the power of a 
design (100). In SW-CRTs, it has been shown that the IPC may impact the sample size and the 
number of clusters required (27). 
 Correlation between observations with binary outcomes 4.1.2.3
If the primary outcome for a trial is dichotomous, there is a lack of clarity surrounding the 
definition and calculation of the ICC. For dichotomous outcomes, the ICC can be estimated 
on a proportion scale or on a logistic scale (108) and the ICC may differ greatly between the 
two scales. 
4.1.3 Why are estimates of the correlation important 
CRTs crucially depend on values of the ICC for accurate sample size calculations (102). For 
continuous outcomes, the framework required to estimate the ICC is relatively 
straightforward. In longitudinal studies, the ICC may not be sufficient to describe the 
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correlation between participants in a cluster, and the WCC should be used to replace ρ in a 
design effect. Early research suggests the IPC and WPC play a pivotal role in the power of a 
repeated cross-sectional CRT (27, 61, 87, 107). Moreover, a recent DE appropriate for SW-
CRTs requires estimates of the IPC and WPC in order to estimate the sample size (26). 
Nevertheless, there is a lack of empirical literature in this area (27, 48), and so no published 
estimates of the IPC or the WPC exist, which has led to calls for values of the IPC and WPC to 
be published (26, 27). Furthermore, for binary outcomes, there is much confusion 
surrounding what type of ICC should be presented and used in sample size calculations. It is 
essential that the correct approach is underlined to ensure future sample size calculations 
are performed with the appropriate ICC. 
4.1.4 Chapter aim 
The main aim of this chapter is to highlight the different types of correlation that can be 
calculated in a longitudinal CRT. This includes evaluating the validity of the assumption that 
the correlation between observations within a cluster is independent of time. To this end, 
we will: 
1. Demonstrate how the correlation between observations within a cluster can be 
described in time-dependent and time-independent settings. 
2. Outline a method to estimate the IPC and WPC. 
3. Illustrate using a case study what these correlations may look like in practice. 
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In this chapter, we begin with the framework for estimating ICCs for continuous outcomes. It 
is then shown how the IPC and the WPC can be estimated. For illustrative purposes, 
estimates of the ICC, IPC and WPC are presented in relation to outcomes associated with 
type-2 diabetes. The methodology for the differing approaches to the ICC for binary 
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4.2 Methods 
4.2.1 Intra-cluster correlation coefficient 
Typically, P-CRTs assume exchangeable correlation – that is, observations are identically 
correlated regardless of the duration between them. The ICC – defined as the correlation 
between two randomly selected observations from participants within the same cluster – is 
defined only when fitting this time independent model. For any two observations k and k’ in 
cluster i, the correlation between them can be given as: 
𝐼𝐶𝐶 = 𝑐𝑜𝑟𝑟(𝑌𝑖𝑘 , 𝑌𝑖𝑘′) 
It is assumed that this correlation is independent of the time in which the observations are 
made. This concept is consistent with a decomposition of the total variance into two 
independent components – signifying variation between cluster (𝜎𝑏
2) and between subjects 
(within clusters) (𝜎𝑤
2). Below, we highlight the differences between ICCs for continuous and 
dichotomous outcomes. 
 Continuous outcomes 4.2.1.1
For continuous outcomes, the ICC provides a measure of the homogeneity of the outcome 
within clusters. In this setting, the ICC can alternatively be defined as the proportion of the 
total variance that is attributable to the between-cluster component. Assuming that the 
total variance in a CRT is equal to the sum of the between-cluster variance (𝜎𝑏
2) and the 
between-subject (within cluster) variance (𝜎𝑤
2), the ICC is given as:  
 
 








 (See Appendix D). 
In the standard analysis of a CRT (assuming exchangeable correlation), an ICC calculated 
using equation 4.2 is equivalent to ρ and can be used in the DE for a CRT (equation 4.1). 
The analysis of a cluster trial is typically undertaken using a multi-level linear model (See Box 
4.1 and section 4.2.4 for model details). Ratio of variances is then used to estimate the ICC. 
Throughout this work, this approach is taken whenever an estimated ICC is reported. 
Box 4.1: Time-independent model for the analysis of a continuous outcome 
 
𝒀𝒊𝒌 = 𝝁 + 𝜶𝒊 + 𝜺𝒊𝒌 
 
Where 𝑌𝑖𝑘 is the outcome for patient k in cluster 𝑖, 𝜇 is the mean outcome, 𝛼𝑖 is a cluster 
effect, and 𝑖𝑘is the residual error. 
It is assumed that the following distributions apply: 
𝛼𝑖~𝑁(0, 𝜎𝑏
2)  𝑖𝑗𝑘~𝑁(0, 𝜎𝑤
2) 
 
 Binary outcomes 4.2.1.2
In clinical trials, outcome data is often dichotomous – usually the presence or absence of a 
particular clinical outcome. The ICC is more complex for binary outcomes, which can lead to 
a lack of clarity in its definition (102, 105, 108-111). Following our earlier definition, the ICC 
is a measure of the correlation between two dichotomous outcomes from two randomly 
selected participants within the same cluster, estimated on the proportions scale. Sample 
size calculations for trials with a binary outcome classically involve a normal approximation 
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to the binomial distribution of grouped data. Nonetheless, multi-level logistic models are 
commonly used for the post-trial analysis of dichotomous outcomes in a CRT.  
Latent intra-cluster correlation coefficient 
Hypothetically, the observed binary outcome for a multi-level logistic model may be 
obtained via the dichotomisation of a continuous latent scale. Upon fitting a multi-level 
logistic model (See Box 4.2) in a statistical package (e.g. STATA); a type of ICC is reported. 
However, this ICC relates to the unobservable latent scale, and not to the observed binary 










2 is the between cluster variance (on the latent scale) and 
𝜋2
3
 refers to the variance 
of the logistic distribution which is used to generate the binary model (108).  
Throughout this work, we refer to an ICC estimated in this manner as a latent ICC - to reflect 
that it refers to the unobservable latent scale, rather than the correlation between the 
dichotomous outcomes of two participants from within the same cluster.  





) = 𝝁 + 𝜶𝒊 
 
Where 𝑝𝑖𝑘 is the probability of the outcome for patient k in cluster 𝑖, 𝜇 is the mean outcome, 
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Natural intra-cluster correlation coefficient 
The latent ICC should not be used directly in the computation of a design effect for use in a 
sample size calculation, since it refers to the unobservable latent scale. An ICC in a design 
effect should refer to the correlation between observations in a cluster. For binary 
outcomes, we refer to this as the natural ICC (𝜌𝑁). The natural ICC is estimated on the 








Box 4.1: Time-independent model for the analysis of a continuous outcome 
 
𝒀𝒊𝒌 = 𝝁 + 𝜶𝒊 + 𝜺𝒊𝒌 
 
Where 𝑌𝑖𝑘 is the outcome for patient k in cluster 𝑖, 𝜇 is the mean outcome, 𝛼𝑖 is a cluster 
effect, and 𝑖𝑘is the residual error. 
It is assumed that the following distributions apply: 
 
𝛼𝑖~𝑁(0, 𝜎𝑏
2)  𝑖𝑗𝑘~𝑁(0, 𝜎𝑤
2) 
 
By considering the prevalence of the outcome, the latent ICC can be converted into a natural 
ICC for the raw data – see, for example, the table presented by Eldridge et al. (1). 
Throughout this work, a clear distinction between the natural ICC and the latent ICC is 
maintained for binary outcomes.  
4.2.2 Correlation in longitudinal studies 
In longitudinal CRTs, the difference in time between two observations is likely to impact the 
degree of correlation and the assumption of exchangeable correlation may not hold. When 
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observations are not identically correlated independent of time, a time dependent model 
can be fitted to the data. In this context, we define the within-cluster correlation (WCC) as 
the correlation between two randomly chosen observations within a cluster. In a time 
dependent model setting, the WCC is equivalent to ρ and can be used in a design effect. 
In a time-dependent model setting, time is split into a number of (equal) periods. In this 
design, constant correlations are assumed for:  
a) For any two observations within a cluster from the same time-period (WPC) 
b) For any two observations from within the same cluster but from different time-
periods (IPC). 
These assumptions are consistent with a variance-decomposition into three independent 
components: between clusters (𝜏2), between time-periods (within clusters) (𝜎𝑝
2) and 
between-subjects (within time-period and cluster) (𝜎𝑡
2). The time-dependent model fitted is 
given in Box 4.3 
Box 4.3: Time-dependent model for continuous outcomes 
 
𝒀𝒊𝒋𝒌 = 𝝁 + 𝜶𝒊 + 𝝎𝒊𝒋 + 𝜺𝒊𝒋𝒌 
 
Where 𝑌𝑖𝑗𝑘 is the outcome for patient k in cluster i at time j, 𝜇 is the mean outcome, 𝛼𝑖is the 
cluster effect, 𝜔𝑖𝑗 is a random effect for cluster i at time j, and 𝑖𝑗𝑘is the residual error. 
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In a framework with a time dependent model, the WCC can be calculated using the IPC and 
the WPC, as: 
𝑊𝐶𝐶 = 𝐼𝑃𝐶 +
1
𝑇
(𝑊𝑃𝐶 − 𝐼𝑃𝐶) 
4.5 
See Appendix E. 
Here T is the number of time-periods in the study. It is assumed that each time-period 
contains an equal number of observations.  
 Within-period cluster correlation 4.2.2.1
The WPC is the correlation between two randomly selected observations from within the 
same cluster and from within the same time-period. For two participant’s k and k’ in cluster i 
at time j, the correlation between them can be given as: 
𝑊𝑃𝐶 = 𝑐𝑜𝑟𝑟(𝑌𝑖𝑗𝑘, 𝑌𝑖𝑗𝑘′) 
Now, the WPC can be written as: 
𝑊𝑃𝐶 = 𝑐𝑜𝑟𝑟(𝑌𝑖𝑗𝑘, 𝑌𝑖𝑗𝑘′) =
𝜏2 + 𝜎𝑡
2
𝜏2 + 𝜎𝑝2 + 𝜎𝑡2
 
4.6 
(See Appendix F) 
 Inter-period cluster correlation 4.2.2.2
The IPC indicates the correlation between two randomly selected observations from within 
the same cluster but from different time-periods. As such, it provides the correlation 
between participant’s k and k’ from cluster i at times j and j’, and can be given as: 
𝐼𝑃𝐶 = 𝑐𝑜𝑟𝑟(𝑌𝑖𝑗𝑘, 𝑌𝑖𝑗′𝑘′) 
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Now, the IPC can be written as: 
𝐼𝑃𝐶 = 𝑐𝑜𝑟𝑟(𝑌𝑖𝑗𝑘, 𝑌𝑖𝑗′𝑘′) =
𝜏2
𝜏2 + 𝜎𝑝2 + 𝜎𝑡2
 
4.7 
(See Appendix G) 
 Cluster autocorrelation 4.2.2.3
The IPC and WPC describe the correlation of participants within a cluster. This has previously 
been presented as a cluster autocorrelation (CA) (27) and has been established as vital to 
sample size formulae in cluster cross-over designs (112). The CA is defined as the correlation 
between the cluster level outcome from two different time-periods from a fixed cluster (i.e. 
conditional on cluster) (48, 112). The CA can be calculated as the ratio of the within-cluster 
within-period variance to the within cluster variance, and can also be viewed as the ratio of 








In the absence of period effects, the CA = 1 (since 𝜎𝑡
2 = 0), indicating that the time-
dependent model is unnecessary. In this setting, WCC = WPC = IPC. Otherwise it follows from 
the definitions that WPC > WCC > IPC. 
 Summary of correlation structures 4.2.2.4
To summarise, the ICC, defined only for a time-independent model (see Box 4.1), is the 
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The WCC, defined only for a time-dependent model (see Box 4.3), is the correlation between 
two randomly selected observations and is calculated as: 
𝑊𝐶𝐶 = 𝐼𝑃𝐶 +
1
𝑇
(𝑊𝑃𝐶 − 𝐼𝑃𝐶) 
The WPC, defined only for a time-dependent model (see Box 4.3), is the correlation between 





𝜏2 + 𝜎𝑝2 + 𝜎𝑡2
 
The IPC, defined only for a time-dependent model (see Box 4.3), is the correlation between 
two observations within the same cluster but from different periods and is calculated as: 
𝐼𝑃𝐶 =
𝜏2
𝜏2 + 𝜎𝑝2 + 𝜎𝑡2
 
4.2.3 Estimating correlation between observations for type 2 
diabetes 
In section 4.2.1, we have discussed the methodology required to estimate the time 
independent correlation between participants within a cluster (the ICC). An extension to this 
methodology has been presented in section 4.2.2 for estimating the correlation between 
observations in longitudinal designs (the WPC and IPC) which may appropriate for SW-CRTs. 
Now, we introduce a scenario for which this methodology can be illustrated. Here, estimates 
of the ICC, IPC, and WPC are presented for typical outcomes related to type-2 diabetes. 
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Below, the necessity for these estimates is discussed, alongside a patient database that will 
allow for these estimates to be calculated. 
Diabetes is progressively becoming a more influential disorder, and is a significant health 
issue (113). To overcome this, an increasing number of clinical trials are being conducted 
with the aim of lowering the risk of diabetes (114) or to improve care for pre-existing 
sufferers (91, 115, 116).  
 When conducting a trial related to diabetes, typical outcomes might be clinical 
measurements such as HbA1c (both as a continuous and dichotomised outcome) (116), body 
mass index (BMI) (117), cholesterol (118), blood pressure (119) or the incidence of 
macrovascular and microvascular outcomes (120). Regardless of the outcome, pre-trial 
sample size calculations require an accurate estimate of the correlation of the outcomes 
within a cluster (56, 121). As such, we provide estimates of the ICC, IPC, and WPC for typical 
trial outcomes related to type-2 diabetes. These are made using routinely collected data, 
obtained from The Health Improvement Network (THIN) database (122). This is a large 
archive of anonymised patient records from UK general practices. Using THIN database, data 
was obtained for a retrospective cross-section of patients with type-2 diabetes. Participating 
general practices contributed anonymised demographic, prescribing information and clinical 
data for more than 3.7 million patients throughout the UK (122).  
 Inclusion criteria 4.2.3.1
A set of practice level and patient level inclusion criteria was used. In order for data from the 
GP practices to be included, they were required to use the Vision computer system, and this 
must have been used for a minimum of one year. An acceptable mortality reporting date can 
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be used to indicate whether a practice is reporting data sufficiently (123), and so all GP 
practices were required to have an AMR date recorded. Patients were included if a diagnosis 
of type-2 diabetes was made before the measurement period began. A diagnosis was 
indicated by the appropriate Read codes - a coded thesaurus of clinical terms (124). Read 
codes allow for the recording of clinical information in primary care electronic medical 
records in the UK (125). Generally, trials within diabetes focus on type-2 diabetes patients, 
as these make up the majority of diabetic patients (126), and so the focus here is on patients 
with type-2 diabetes only. Patients were required to be over 18 to ensure a correct diagnosis 
of type-2 diabetes, rather than a misdiagnosis of type-1 diabetes. 
 Outcome variables 4.2.3.2
All variables clinically relevant to a trial in type-2 diabetes that are routinely recorded were 
included. The variables were divided into three distinct categories: clinical measures, 
medication prescription, and clinical outcomes. Clinical measures included: HbA1c; systolic 
blood pressure; diastolic blood pressure; body mass index (BMI); total cholesterol level; and 
high-density lipoprotein (HDL) cholesterol level. Medication measurements involved the 
prescribing of: Insulin; and other hypoglycaemic medications. The clinical outcomes deemed 
relevant were: atrial fibrillation; chronic kidney disease; chronic obstructive pulmonary 
disease; ischaemic heart disease; peripheral vascular disease; and stroke.  
Whilst it is advisable to keep continuous outcomes in their raw form, trialists often 
dichotomise a continuous measure (127, 128). Since primary outcomes are more likely to be 
binary than continuous (74), cut-points have been chosen for each continuous outcome that 
reflects a clinically relevant value. This ensures that the results of this work will be useful for 
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all trialists. A summary of the cut-points used in the dichotomisation of the clinical measures 
is given below in Table 4.1, and then discussed further. 
Table 4.1: Cut points for dichotomising clinical measures 
Outcome Cut-point 
Clinical measure   
     HbA1c (>) 7.5 
     Systolic blood pressure (>) 140.0 
     Systolic blood pressure (>) 130.0 
     Diastolic blood pressure (>) 80.0 
     BMI (>) 30.0 
     BMI (>) 25.0 
     Total cholesterol (>) 4.0 
     HDL Cholesterol (<) 1.2 
 
For HbA1c, a threshold value of 7.5% was selected as NICE guidelines state that levels above 
7.5% indicate inadequate control (129). A threshold value of 7.5% has additionally been used 
in previous studies (130). Recommendations have been made that HDL cholesterol level 
should be above 1.2mmol/L (131). Equally, levels of total cholesterol should be below 
4.0mmol/L (131). For systolic blood pressure (SBP), two values were chosen – 140mmHg is 
the upper limit recommended for patients with type-2 diabetes (129), whilst 130mmHg is 
the target who patients who have suffered a stroke, or those who suffer from kidney and 
eye problems (129). Two thresholds were chosen for BMI to match to the groupings of 
overweight (25kg/m2) and moderately obese (30kg/m2) (132).  
 Measurement period used to estimate the ICC 4.2.3.3
To estimate ICCs, a cross-section of patients was identified for use in the analysis. A 15 
month cross-section was chosen, as this reflects the NICE quality and outcomes framework 
(QOF) (133), for which the measurements taken during a 15 month period is monitored. 
Since QOF offers a financial incentive to GP surgeries who exhibit high levels of care, a 15 
 
 
Page | 106 
 
month period should provide measurements for a large subset of the total patients in the 
database. Observations are taken from 1st February 2009 to 30th April 2010. If multiple 
observations were made for a patient’s outcome during this period then the measurement 
closest to the end date was included in the analysis.  
However, in 2009, the measuring unit for HbA1c changed to mmol/mol from % HbA1c. 
Naturally, the reporting consistency is likely to be poor around this period. To prevent 
confusion and irregularity, it is logical to include a different cross-section of measurements. 
To this end, a cross-section of HbA1c observations are taken from the period 1st January 
2008 to 31st December 2008. A 12 month period, rather than a 15 month period, was 
included due to data limitations.  
 Measurement period used to estimate time-dependent 4.2.3.4
correlation 
To estimate the IPC, and WPC, the study must be divided into a number of (equal) periods. In 
a real-world SW-CRT, these periods will be derived by the repeated cross-section design. 
Since data here originates from a patient database, the period lengths are not fixed. The 
study design we therefore chose is an extension of the design used for estimation of the ICC. 
It consists of two-periods – with each period lasting 15 months – resulting in a 30 month 
study. Measurements taken between 1st November 2007 and 30th April 2010 contribute to 
the analysis. The 15 month period from 1st November 2007 to 31st January 2009 refers to 
period one, and observations from the 15 month period 1st February 2009 to 30th April 2010 
contribute to period two. For HbA1c, observations from 1st January 2007 to 31st December 
2007 contribute to period one, and from 1st January 2008 to 31st December 2008 to period 
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two. Patients could contribute only one measurement to the analysis, with the 
measurements closest to the end date used.  
Study length and period length 
The IPC and WPC are based upon the dissection of a study into (equal) periods. Since they 
are measuring the correlation between participants in the same cluster within a period and 
between periods, the length of the period, and the length of the study, may influence their 
value.  
Study length 
To evaluate the impact of study duration on the IPC and WPC, we extend the 2-year cross-
section used to evaluate HbA1c and use incremental year increases (but with a fixed 1-year 
period length) up to a 6-year study period. This provides IPC and WPC estimates that 
correspond to studies that are 2-years, 3-years, 4-years, 5-years, and 6-years in study length. 
In a 6-year study period (with 1-year period length) the WPC will measure the correlation 
between two observations in the same cluster and during the same year. The IPC will 
measure the correlation between two observations in the same cluster, but with one 
observation in one year, and the other observation from any of the other five years. The 
dates used to define each period are given on Table 9.3 in Appendix H.  
Period length 
To assess whether period length influences the estimates of IPC and WPC, we consider the 
15-month cross-section 1st February 2009 to 30th April 2010 used to estimate the ICCs. This 
cross-section is then divided into a number of (equal) time-periods. Four sets of estimates of 
the IPC and WPC are calculated, corresponding to a design with 2 (equal) periods, 3 (equal) 
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periods, 4 (equal) periods, and 5 (equal) periods. In a 5-period study (with 15-month study 
length) the WPC will measure the correlation between two observations in the same cluster 
and during the same time-period. The IPC will measure the correlation between two 
observations in the same cluster, but with one observation in one time-period, and the other 
observation from any of the other four time-periods. Details of the dates used to define each 
period are given on Table 9.4 in Appendix H. 
 Data summary 4.2.3.5
Patient and practice level characteristics were summarised using suitable summary statistics. 
General Practice (GP) characteristics include the total number of practices, location (country) 
of the practice and practice inclusion size (the number of patients from each practice 
satisfying the entry criteria). Patient characteristics included number of participants, age 
(years), gender, location (country of residence), deprivation quintiles (IMD score) and 
number of deaths. Potential trial outcomes were summarised using appropriate summary 
statistics. Outcomes included clinical measurements, the prescribing of medication and the 
onset of clinical outcomes.  
4.2.4 Statistical models 
In this section, we highlight the statistical models that are used to estimate the ICC, IPC, and 
WPC. 
 Time-independent model for continuous outcomes 4.2.4.1
In order to estimate ICCs, generalised linear mixed models are fitted to the data, with cluster 
modelled as a random effect. The model is fitted as: 
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Where ikY  is the outcome for patient k in cluster i,  is the mean outcome, i  is a random 
cluster effect, and ik is the residual error. It is assumed that the following distributions 
apply: 
 
Following the fitting of equation 4.8, the ICC was estimated as the ratio of the between 
cluster variance (of the outcome) to the total variance (of the outcome) (equation 4.2).  
 Time-independent model for binary outcomes 4.2.4.2
For binary outcomes, a mixed effects linear model (as given above by equation 4.8) was 
fitted to estimate the natural ICC. To estimate the latent ICC, a mixed effects logistic 




) = 𝜇 + 𝛼𝑖 
4.9 
 
Where 𝑝𝑖𝑘 is the probability of the outcome occurring for participant k in cluster i, 𝜇 is the 
mean outcome, 𝛼𝑖 is a random cluster effect, where: 
𝛼𝑖~𝑁(0, 𝜎𝐿
2) 
The latent ICC can then be estimated using equation 4.3.  
 Time-dependent model for continuous outcomes 4.2.4.3
To estimate time-dependent correlations, the generalised linear mixed model given in 
section 4.2.4 must be extended to include an additional random effect. To this end, a 
random effect for cluster by period is included in the model. Now, the model is fitted as: 
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𝑌𝑖𝑗𝑘 = 𝜇 + 𝛼𝑖 + 𝜔𝑖𝑗 + 𝑖𝑗𝑘 4.10 
 
Where 𝑌𝑖𝑗𝑘 is the outcome for patient k in cluster i at time j, 𝜇 is the mean outcome, 𝛼𝑖is the 
cluster effect, 𝜔𝑖𝑗 is a random effect for cluster i at time j, and 𝑖𝑗𝑘is the residual error. 






The WPC is then estimated as the ratio of the between-cluster variance (of the outcome) 
and between-subject variance (of the outcome) to the total variance (of the outcome) 
(equation 4.6). The IPC is estimated as the ratio of the cluster variance (of the outcome) to 
the total variance (of the outcome) (equation 4.7). 
 Implementation of models 4.2.4.4
When estimating ICCs, IPCs and WPCs for typical outcomes related to type-2 diabetes, both 
unadjusted and adjusted models were fitted to the data. Adjustments were made for age, 
sex, location, and deprivation quintiles. All analysis was performed using Stata 13 (StataCorp, 
Texas, USA). Linear models were fitted using the “mixed” command, fitted via a maximum 
likelihood, and logistic models using the “melogit” command. All point estimates and 
confidence intervals of the ICC, WPC, and IPC were calculated using the default version of 
“estat icc”. The “estat icc” function estimates the latent ICC when a logistic model (equation 
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4.3 Results 
4.3.1 Included patient and cluster demographics 
Included patient characteristics from THIN database are summarised at the practice level 
(Table 4.2) and at the patient level (Table 4.3) for the 15-month period (1st February 2009 to 
30th April 2010). All patients satisfying the inclusion criteria contributed to the analysis - with 
112,633 patients from 430 contributing GP surgeries included. The majority of both practices 
(75%) and patients (79%) were from England.  
 
Table 4.2: Summary of practice level characteristics of THIN study population for the 15-
month study period 01/02/2009 to 30/04/2010  
Practice Characteristics 
     Number of GP Practices 430 
     GP Size1, Median [IQR] 241 [150-351] 
Location, N (%) 
     England 322 (75) 
     Northern Ireland 21 (5) 
     Scotland 56 (13) 
     Wales 31 (7) 
1
: Here GP size corresponds to the number of patients within the GP practice who have satisfied the entry 
criteria (patients who had C10F Read (version 2) code for diabetes entered on the Vision GP patient 
management system or other codes specifying type-2 diabetes) 
 
 
When considering HbA1c, it is usually described assuming normality. Here, the mean (7.35) 
was greater than the median (7.05) – emphasising the positive skewness that HbA1c 
exhibits. A large proportion (59.1%) were reported as being prescribed insulin, whilst 29.4% 
were taking other hypoglycaemic medication – though some patients may have been taking 
this in addition to insulin. When considering the first incident of clinical outcomes, chronic 
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Table 4.3: Summary of patient level characteristics of THIN study population for the 15-
month study period 01/02/2009 to 30/04/2010 
Patient Characteristics 
     Number of patients 112,633 
     Age, Median [IQR] 70 [60 -78] 
     Sex (Male), N (%) 61,944 (55) 
     Death, N (%) 4,237 (4) 
Location, N (%) 
     England 88,838 (79) 
     Northern Ireland 3,464 (3) 
     Scotland 12,461 (11) 
     Wales 7,870 (7) 
Deprivation quintiles, N (%) 
     1 (most affluent) 23,853 (21) 
     2 23,106 (21) 
     3 23,031 (20) 
     4 22,054 (20) 
     5 (most deprived) 16,352 (15) 
     Unknown 4,237 (4) 
Clinical measures 
     HbA1c (%), Median [IQR]  7.05 [6.4-7.9] 
     HbA1c (%), Mean (SD) 7.35 (1.41) 
     Systolic blood pressure (mmHg), Mean (SD) 134 (16) 
     Diastolic blood pressure (mmHg), Mean (SD) 75 (10) 
     BMI (kg/m2), Median [IQR] 29.9 [26.4 - 34.2] 
     Total cholesterol (mmol/L), Median [IQR] 4.1 [3.5 - 4.7] 
     HDL cholesterol (mmol/L), Median [IQR] 1.19 [1.00 - 1.40] 
Medication, N (%) 
     Insulin 66,520 (59.1) 
     Other hypoglycaemic medication 33,061 (29.4) 
Clinical outcomes, N (%) 
     Atrial fibrillation 1075 (1.034) 
     Chronic kidney disease 362 (0.332) 
     Chronic obstructive pulmonary disease 848 (0.804) 
     Ischaemic heart disease 924 (1.061) 
     Peripheral vascular disease 566 (0.537) 
     Stroke 441 (0.410) 
BMI: Body mass index. Note: The percentage corresponds to the number of applicable patients, and 
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Table 4.4 presents the number of patients who exceed the dichotomised value that was 
deemed clinically relevant. Over one third (34.2%) of patients had a HbA1c value exceeding 
7.5%. The lower recommendation for systolic blood pressure (130mmHg) was surpassed by 
58.4% of patients, whilst over one quarter (27.0%) had a systolic blood pressure greater than 
140mmHg. When describing BMI in categorical terms, 0.54% were underweight (BMI<18.5), 
15.92% were normal weight (18.5<BMI<25), 34.38% were overweight (25<BMI<30), 27.46% 
were obese (30<BMI<35) and 21.71% were morbidly obese (BMI>35). 
 
Table 4.4: Number of participants exceeding the clinical measures cut off during the 15-








     HbA1c (%) (>7.5) 101,412 34,723 (34.2) 
 
     Systolic blood pressure (mmHg) (>140) 105,147 28,415 (27.0) 
     Systolic blood pressure (mmHg) (>130) 105,147 61,423 (58.4) 
 
     Diastolic blood pressure (mmHg) (>80) 105,147 25,307 (24.1) 
 
     BMI (kg/m2) (>30) 97,469 47,922 (49.2) 
     BMI (kg/m2) (>25) 97,469 81,429 (83.5) 
 
     Total cholesterol (mmol/L) (>4) 101,108 50,813 (50.3) 
 





Page | 114 
 
4.3.2 Intra-cluster correlation coefficient 
 Continuous outcomes 4.3.2.1
In Table 4.5, estimates of the ICC, along with a 95% confidence interval, are presented for all 
continuous outcomes. The median unadjusted ICC was 0.026 [IQR: 0.020 – 0.032], whilst 
adjusting for covariates had little effect (median = 0.025 [IQR: 0.020 – 0.032]). The main 
outcome for trials relating to type-2 diabetes is HbA1c. Here, the unadjusted ICC was 
estimated as 0.032 (95% CI: 0.027 to 0.037), and 0.032 (95% CI: 0.028 to 0.037) after 
adjusting for covariates. 
 
Table 4.5: Intra-cluster correlation coefficients (ICCs) for continuous outcomes associated 
with type-2 diabetes from THIN database for study period 01/02/2009 to 30/04/2010 
Outcome Unadjusted model Adjusted model1 
ICC 95% CI ICC 95% CI 
Clinical measures 
     HbA1c 0.032 0.027 to 0.037 0.032 0.028 to 0.037 
     Systolic blood pressure 0.030 0.026 to 0.035 0.028 0.024 to 0.033 
     Diastolic blood pressure 0.039 0.034 to 0.045 0.039  0.034 to 0.045 
     BMI 0.019 0.016 to 0.023 0.022  0.018 to 0.026 
     Total cholesterol 0.020 0.017 to 0.024 0.020  0.016 to 0.023 
     HDL cholesterol 0.021 0.018 to 0.025 0.020 0.017 to 0.024 
1
: Adjusted for age, sex, location, and deprivation quintiles.CI: Confidence interval. 
 
 Dichotomous outcomes 4.3.2.2
Estimates of the ICC and corresponding 95% confidence interval for the dichotomous 
outcomes are reported in Table 4.6. Estimates of the ICC from a logistic model (latent ICC) 
and from a linear model (natural ICC) are both presented. For HbA1c, the latent unadjusted 
ICC was estimated as 0.0350 (95% CI: 0.0298 to 0.0410), whilst the natural ICC was 0.0260 
(95% CI: 0.0222 to 0.0304).  
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The median natural ICC for all binary outcomes was 0.0150 (IQR: 0.0023 to 0.0366) and 
median latent ICC was 0.0456 (IQR: 0.0255 to 0.1135). For clinical measures only, the 
medium natural ICC was 0.0274 (IQR: 0.0178 to 0.0368) and medium latent ICC was 0.0353 
(IQR: 0.02365 to 0.0538). Clinical outcomes a medium natural ICC of 0.0021 (IQR: 0.0009 to 
0.0042) and medium latent ICC was 0.0930 (IQR: 0.0256 to 0.1330). The latent ICC has 
noticeable greater values than the natural ICC. This is highlighted further in Figure 4.3. 
Natural ICCs were smaller than latent ICCs for all outcome variables, and also contained 
within a smaller range (Figure 4.3 and Table 4.6). The results are predominantly similar when 
adjusting for covariates (Table 9.6 in Appendix I). 
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Table 4.6: Intra-cluster correlation coefficients (ICCs) for binary outcomes (medication 
prescribing, clinical outcomes, and dichotomised clinical measures) associated with type-2 








Clinical measures    
HbA1c (>7.5) 0.34240 0.035 0.026 
    (0.030 to 0.041) (0.022 to 0.030) 
Systolic blood pressure (>140) 0.27024 0.062 0.0369 
    (0.054 to 0.072) (0.032 to 0.043) 
Systolic blood pressure (>130) 0.58416 0.046 0.037 
    (0.039 to 0.053) (0.032 to 0.043) 
Diastolic blood pressure (>80) 0.24068 0.082 0.046 
    (0.071 to 0.095) (0.040 to 0.053) 
BMI (>30) 0.49166 0.0186 0.015 
    (0.016 to 0.022) (0.013 to 0.018) 
BMI (>25) 0.83543 0.0218 0.010 
   (0.018 to 0.027) (0.008 to 0.013) 
Total cholesterol (>4) 0.50256 0.0255 0.0205 
    (0.022 to 0.030) (0.017 to 0.024) 
HDL cholesterol (<1.2) 0.50389 0.0356 0.029 
    (0.030 to 0.042) (0.024 to 0.034) 
Medication    
Taking of Insulin 0.59059 0.1135  0.081 
    (0.010 to 0.129)  (0.071 to 0.093) 
Clinical outcomes    
Atrial fibrillation 0.01034 0.0135 0.001 
    (0.004 to 0.047) (0.000 to 0.002) 
Chronic kidney disease 0.00332 0.133 0.002 
    (0.089 to 0.193) (0.002 to 0.003) 
 Chronic obstructive pulmonary disease 0.00804 0.0617 0.002 
    (0.0387 to 0.097) (0.001 to 0.003) 
Ischaemic heart disease 0.01061 0.0256 0.001 
    (0.0107 to 0.060) (0.000 to 0.002) 
Peripheral vascular disease 0.00537 0.124 0.004 
    (0.090 to 0.1688) (0.003 to 0.006) 
Stroke 0.00410 0.2786 0.011 
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4.3.3 Correlation in longitudinal studies 
Estimates of the WPC, the IPC, and the CA, for a 30-month study period are given in Table 
4.7. The IPC is lower than the WPC (median IPC: 0.0188, median WPC: 0.0259), indicating the 
presence of a period effect. This is further highlighted by the CA (median CA 0.5910). The CA 
is smallest for total cholesterol, reflected the large difference between the WPC (0.021) and 
the IPC (0.010). This seems to indicate that total cholesterol is the outcome most affected by 
period effects. The IPC for HbA1c is 0.019 (95% CI 0.014 to 0.026) which indicates that the 
correlation between two participants within the same cluster at different time-periods is 
0.019. The WPC for HbA1c is 0.035 (95% CI 0.030 to 0.040) which signifies that the 
correlation between two participants in the same cluster at the same period is 0.035. The 
results are predominantly similar when adjusting for covariates (Table 9.6 in Appendix I).  
Table 4.7: Estimates of the within-period correlation and inter-period correlation for 
continuous outcomes associated with type-2 diabetes from THIN database for study period 
01/11/2007 to 30/04/2010 
Outcome Unadjusted model 
WPC IPC CA 
(95% CI) (95% CI)   
     HbA1c (%) 1 0.035 0.019 0.546 
(0.030 to 0.040) (0.014 to 0.026)   
     Systolic blood pressure (mmHg) 2 0.030 0.019 0.626 
(0.026 to 0.035) (0.014 to 0.026)   
     Diastolic blood pressure (mmHg) 2  0.039 0.0297 0.760 
(0.034 to 0.045) (0.024 to 0.037)   
     BMI (kg/m2) 2  0.022 0.012 0.556 
(0.018 to 0.026) (0.009 to 0.017)   
     Total cholesterol (mmol/L) 2  0.021 0.010 0.492 
(0.018 to 0.025) (0.007 to 0.016)   
     HDL cholesterol (mmol/L) 2  0.021 0.0186 0.870 
(0.018 to 0.025) (0.015 to 0.023)   
WPC: Within-period correlation. IPC: Inter-period correlation. CA: Cluster autocorrelation. CI: Confidence 
interval. BMI: Body mass index 
1
: Two consecutive 12-month periods were used (01/01/2007 – 31/12/2007 & 
01/01/2008 – 31/12/2008). 
2
: Two consecutive 15-month periods were used. 
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 Impact of study length on the IPC and WPC 4.3.3.1
Table 4.8 highlights the impact of study length on the WPC and IPC for HbA1c%. Here, a fixed 
1-year period length was used, and the overall study length was changed. The results show 
that increasing the study length does not affect the IPC, whereas the WPC increased slightly 
(0.035 to 0.041) – which is reflected in the CA which decreased as the study length increased 
(0.5462 to 0.4366). That is, with a fixed period-length, increasing the study length does 
affect the correlation between participants in the same cluster at different time-periods, but 
increases the correlation between participants in the same cluster at the same time-period. 
The results are predominantly similar when adjusting for covariates (Table 9.7 in Appendix I).  
 
Table 4.8: Impact of increasing the study length on the within-period correlation and inter-
period correlation for HbA1c from included participants from THIN database when 










2 2 0.035 0.019 0.546 
(0.030 to 0.040) (0.014 to 0.026)   
3 3 0.038 0.018 0.480 
(0.033 to 0.045) (0.014 to 0.025)   
4 4 0.040 0.019 0.468 
(0.039 to 0.047) (0.014 to 0.025)   
5 5 0.040 0.018 0.441 
(0.034 to 0.048) (0.013 to 0.024)   
6 6 0.041 0.018 0.437 
(0.035 to 0.048) (0.013 to 0.024)   
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 Impact of time-period length on the IPC and WPC 4.3.3.2
The impact of period length on the WPC, IPC, and CA is presented in Table 4.10. Here, the 
15-month study period is split into 1-month, 3-month, 3.75 month, 5-month, and 7.5-month 
time-periods. The median WPC for a 7.5-month period was 0.023, with a median IPC of 
0.018. The WPC and IPC increased as the period length decreased. That is, for a fixed study 
length, decreasing the period length leads to an increase in the correlation between two 
observations from the same cluster and the same time-period – the WPC – and an increase 
in the correlation between two observations from the same cluster and at different time-
period – the IPC. The CA remains relatively high for all outcomes, highlighting that there are 
only small differences between the IPC and WPC for all period lengths. This would indicate 
that for this 15-month study period; there are only minimal period effects. The WPC, IPC, 
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Table 4.9: Impact of period length on the within-period correlation and inter-period 
correlation for continuous outcomes associated with type-2 diabetes from THIN database 
for study period 01/02/2009 to 30/04/2010 from an unadjusted model 
Period Length WPC (95% CI) IPC (95% CI) CA 
    
7.5 month period length    
   Systolic blood pressure (mmHg)  0.040 (0.035 to 0.045) 0.016 (0.011 to 0.022) 0.395 
   Diastolic blood pressure (mmHg)  0.040 (0.035 to 0.046) 0.036 (0.030 to 0.042) 0.886 
   BMI (kg/m2) 0.022 (0.019 to 0.026) 0.016 (0.013 to 0.020) 0.742 
   Total cholesterol (mmol/L) 0.021 (0.018 to 0.025) 0.018 (0.015 to 0.022) 0.855 
   HDL cholesterol (mmol/L) 0.023 (0.020 to 0.027) 0.019 (0.016 to 0.024) 0.846 
Median  0.023 0.018 0.846 
    
5 month period length    
   Systolic blood pressure (mmHg)  0.042 (0.037 to 0.047) 0.021 (0.017 to 0.027) 0.512 
   Diastolic blood pressure (mmHg)  0.041 (0.035 to 0.047) 0.037 (0.032 to 0.043) 0.911 
   BMI (kg/m2) 0.024 (0.020 to 0.027) 0.016 (0.013 to 0.020) 0.699 
   Total cholesterol (mmol/L) 0.021 (0.018 to 0.025) 0.019 (0.016 to 0.023) 0.881 
   HDL cholesterol (mmol/L) 0.024 (0.021 to 0.028) 0.020 (0.017 to 0.024) 0.826 
Median 0.024 0.020 0.826 
    
3.75 month period length    
   Systolic blood pressure (mmHg)  0.043 (0.038 to 0.048) 0.023 (0.019 to 0.028) 0.538 
   Diastolic blood pressure (mmHg)  0.040 (0.035 to 0.047) 0.038 (0.032 to 0.044) 0.933 
   BMI (kg/m2) 0.023 (0.020 to 0.027) 0.018 (0.015 to 0.021) 0.748 
   Total cholesterol (mmol/L) 0.022 (0.019 to 0.026) 0.019 (0.016 to 0.022) 0.852 
   HDL cholesterol (mmol/L) 0.025 (0.021 to 0.029) 0.020 (0.017 to 0.024) 0.819 
Median 0.025 0.020 0.819 
    
3 month period length    
   Systolic blood pressure (mmHg)  0.044 (0.039 to 0.049) 0.024 (0.020 to 0.029) 0.543 
   Diastolic blood pressure (mmHg)  0.041 (0.035 to 0.047) 0.038 (0.033 to 0.044) 0.928 
   BMI (kg/m2) 0.025 (0.022 to 0.029) 0.018 (0.015 to 0.021) 0.703 
   Total cholesterol (mmol/L) 0.022 (0.019 to 0.026) 0.019 (0.016 to 0.023) 0.866 
   HDL cholesterol (mmol/L) 0.026 (0.022 to 0.030) 0.020 (0.017 to 0.025) 0.802 
Median 0.026 0.020 0.802 
    
1 month period length    
   Systolic blood pressure (mmHg)  0.046 (0.042 to 0.052) 0.028 (0.023 to 0.032) 0.593 
   Diastolic blood pressure (mmHg)  0.043 (0.037 to 0.049) 0.038 (0.033 to 0.044) 0.897 
   BMI (kg/m2) 0.027 (0.024 to 0.032) 0.018 (0.015 to 0.022) 0.674 
   Total cholesterol (mmol/L) 0.022 (0.019 to 0.026) 0.020 (0.016 to 0.023) 0.880 
   HDL cholesterol (mmol/L) 0.026 (0.022 to 0.030) 0.021 (0.018 to 0.025) 0.829 
Median 0.027 0.021 0.829 
WPC: Within-period correlation. IPC: Inter-period correlation. CA: Cluster autocorrelation. CI: Confidence interval. 
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4.4 Discussion 
The key difference between a CRT and a RCT is the correlation between observations within 
a cluster – denoted as ρ – which is needed for pre-trial sample size calculations. In the 
absence of period effects, the ICC is sufficient to denote the correlation between patients in 
a cluster – for which there is a lack of reporting of in post-trial analysis (73). The lack of 
clarity of the ICC for binary outcomes has led us to differentiate between the latent ICC 
(from a logistic model) and a natural ICC (from a linear model). Nonetheless, the decay of 
this correlation structure over time may be equally important (27, 31) – leading us to the 
WCC, IPC, and WPC. This chapter has highlighted the methodology required to estimate the 
IPC (alongside the WPC and CA) in addition to the ICC, and reported estimates of these 
correlations using data from The Health Improvement Network for outcomes associated to 
type-2 diabetes. It has shown that in longitudinal studies, researchers should consider time-
dependent models to fully depict the correlation between participants over multiple time-
periods. 
4.4.1 Intra-cluster correlation coefficient 
When publishing a CRT, it is recommended that the ICC used in the sample size calculation 
and the ICC relating to the primary outcome in the analysis are reported (70). However, the 
number of studies that comply to this is still sub-optimal (73). To ensure a CRT is sufficiently 
powered, trialists rely heavily on accurate estimates of the ICC being available. A 
substandard quality of post-trial reporting of the ICC will inevitably lead to trialists using ad-
hoc estimates. When considering a continuous outcome, the estimation of the ICC – as a 
ratio of variances – is relatively straightforward and the formula is well established (102).  
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 Dichotomous outcomes 4.4.1.1
The differing approaches to estimating the ICC for a dichotomous outcome has led to 
previous methodological articles and trial reports using both natural ICCs (estimated from a 
linear model) and latent ICCs (from a logistic model) (105, 106, 108-111, 134-137). There is 
often a lack of clarity as to whether a natural ICC or latent ICC has been presented.  
A latent ICC refers to an unobservable latent scale, opposed to the correlation between 
observations within a cluster – which is needed for a sample size calculation. In its raw form, 
the latent ICC is presented on a log-odds scale – rather than the natural scale used by the 
natural ICC (105, 108) – and so must be converted into a natural ICC for use in a sample size 
calculation. A sample of conversions has been presented by Eldridge et al. (102).  
The results of this chapter are similar to previous research, highlighting that the natural ICC 
is generally smaller than the latent ICC (20). Furthermore, it has also been established that 
dichotomous outcomes with small prevalence’s will have small natural ICCs (105, 138, 139). 
In light of this, clinical outcomes (e.g. stroke) which have low prevalence are likely to have 
small natural ICCs. In contrast, clinical measures dichotomised using clinically relevant cut-
points will have a higher prevalence and so will have larger natural ICCs. The results of this 
chapter agree with existing research in this area (106, 140). One of the other noticeable 
differences between the latent ICC and natural ICC observed in this chapter was the 
increased variation in the values of the latent ICC. This is perhaps because ICCs follow the 
same pattern as proportions, whereby there is a greater scope for variability in values as 
they increase towards 0.5. As such, since the latent ICC is larger than the natural ICC, it also 
has a greater scope for variability in its values.  
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Although the prevalence influences the natural ICC – which may make the latent ICC 
preferable (139) – since the natural ICC refers to the correlation between observations 
within a cluster, it should be reported. If a reported natural ICC reflects a prevalence 
different to a planned trial, it could be converted to a latent ICC before being back 
transformed to a natural ICC using the appropriate prevalence (102). Reporting of ICCs 
should be presented on the natural scale for continuity with continuous outcomes.  
 Alternative databases of intra-cluster correlation coefficients 4.4.1.2
In some settings, it may be relatively simple to obtain an ICC from a previously published 
trial. Yet, in many settings, this may not be possible. The concept of using a large database of 
patient information to estimate ICCs is increasing in practice. One such database that has 
been established is the Health Service Research Unit, who have combined ICCs from 
previous trials and databases (141). ICCs are presented for a variety of continuous and 
dichotomous outcomes using GP surgery, hospital, and physician as the level of clustering. 
When limiting to only GP surgery as the cluster level, the mean ICC was 0.042 (SD: 0.042) for 
continuous outcomes and 0.064 (SD: 0.062) for dichotomous outcomes. Since the ICCs are 
collated from multiple sources, it is unclear whether they refer to latent ICCs, natural ICCs, or 
a combination of both. The ICCs were generally lower for continuous outcomes than 
dichotomous outcomes, which may suggest logistic regression was used to estimate a latent 
ICC.  
 Confidence interval for intra-cluster correlation coefficients 4.4.1.3
For all estimates of the ICC, a 95% confidence interval is reported. This confidence interval is 
calculated using a logit transformation to the ICC to ensure that the interval is contained 
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between zero and one. Nevertheless, it is possible to calculate a confidence interval for the 
ICC on the natural scale (142). Standard statistical packages (e.g. Stata) report as default, a 
confidence interval that has been calculated using a logit transformation. As such, it may not 
be appropriate to simple report an estimate of the standard error of the ICC, since this value 
may be used by future trialists assuming that the ICC is on the natural scale, and not on the 
logit scale. It is possible that alternative methodology should be implemented when 
estimating a confidence interval for an ICC when fitting a model that contains covariate 
adjustment (142). 
4.4.2 Correlation in longitudinal studies 
In longitudinal CRTs, there is a necessity to describe the decay of correlation over time 
within a cluster. This can be done using the IPC and WPC. Currently, there is little or no 
empirical literature to inform likely values for these parameters at the design stage (27, 48). 
As such, many sample size formulae assume that they are equal (32). Here, we have shown 
that for all outcomes, there was evidence of decay of correlation over time – indicating the 
presence of a period effect that should be accounted for in the design of a CRT.  
As the IPC and WPC are parameters to describe a time dependent correlation, it is likely that 
both the study length and the period length will influence their values. This is the first piece 
of research to investigate what impact the study and period duration has on the IPC and 
WPC. 
Increasing the study length (whilst maintaining the period length) leads to a slight decrease 
in the IPC. Increasing the study duration would lead to observations that can now originate 
from further apart in time, and so it is likely that these observations would be less correlated 
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than observations made closer together in time. Furthermore, the CA becomes smaller as 
the study length increases – highlighting a greater disparity between the IPC and WPC. 
Perhaps unexpectedly, the WPC increases slightly as the study length increases, despite 
maintaining the period length.  
Decreasing the length of the period leads to an increase in both the IPC and WPC. As 
observations will now stem from a shorter period of time, it is expected that they will be 
greater correlated – highlighted by the increasing WPC. Consequently, observations from 
different periods can be relatively closer together in time if the period length is shorter – 
reflected in the greater IPC for smaller study period lengths. The impact of altering the 
period length affects the IPC and WPC relatively equally, and so the CA is not greatly affected 
by changes in period length.  
A summary of these key results is presented below (Table 4.10). Since it is known that SW-
CRTs are more efficient for greater values of the ICC (37, 61), it is likely that they will perform 
better for greater values of the WPC and IPC. It is therefore likely that decreasing the period 
length (where possible) will lead to an increase in power.  
 
Table 4.10: Impact of increasing study and period length on the inter-period correlation, 
within-period correlation, and cluster autocorrelation 
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The decay of correlation over time has previously been reported as a cluster autocorrelation 
(48). The CA directly influences the sample size in studies employing a cluster cross-over 
design (112). Expected values of the CA are not readily available, but an expected value of 
0.8 has been reported previously (48). However, within the SW-CRT, current formulae 
assume a CA of 1 (32), which may be an underestimate of the decay of correlation over time.  
Within the study designs highlighted here, it has been shown that the study design has vital 
influences on the estimates IPC and CA. Failure to acknowledge the IPC or the CA in the 
sample size calculation of a study with a repeated cross-section design may produce an 
overestimate of the power of the study (48), else lead to an incorrect estimate of the 
required number of clusters for a CRT (27) . 
The methodology for estimating the power in a SW-CRT has been established (9, 32, 45) and 
is discussed in detail elsewhere (see Chapter 6). However, this methodology considers a 
time-independent correlation, and so does not currently allow for the inclusion of the IPC or 
CA when estimating the power in a SW-CRT. Furthermore, it is not known what impact their 
inclusion would have and whether it would be beneficial or detrimental to power. Simulation 
methods may provide a solution to include this additional correlation. 
As a minimum, if the IPC differs to the WPC, then studies should ensure that the estimate of 
ρ for use in a DE (equation 4.1) stems from the WCC (estimated via equation 4.5), and not 
from the ICC (estimated via equation 4.2).  
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4.4.3 Future research 
It has been well established that the ICC is vital for sample size calculations for CRTs. Now, it 
is becoming increasingly recognised that the IPC and CA are vital for designs with repeated 
cross-sections. In P-CRTs, the decay of clustering over time is typically ignored. However, this 
deterioration of correlation should be acknowledged within sample size calculations. As the 
correlation deteriorates over time, a P-CRT naturally increases in power. Recognising this 
decay in the framework will therefore increase power if period effects are acknowledged in a 
P-CRT. However, there has been no research previously into the degree of this increase. 
4.4.4 Limitations 
Using routine data from a large patient database allows for the estimation of the correlation 
between patients for a multitude of outcomes. However, some limitations are present when 
using data in this form. One such example is the difficulty in establishing the difference 
between follow-up care for the first instance of a clinical event (e.g. stroke) from a second 
event. Patient databases rely on the coding of events, and it may be challenging to 
distinguish between events coded in an identical manner without further consultation. To 
prevent confusion and to eradicate this problem, all patients whom had suffered an event 
prior to the study inclusion period were excluded from the analysis for that event. Naturally, 
patients excluded may have suffered a second (or more) event during the inclusion period, 
but to ensure accurate results consistency, they were excluded. Only the first instance of an 
event was considered. The reliance of a coding system can also lead to misclassification of 
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The Health Improvement Network data stems from patient information collated from GP 
surgeries. As such, only data recorded by the practices is available. When considering a 
model framework that includes covariate adjustment, the choice of covariates is limited by 
the reporting of each practice. The quality of reporting and coding is likely to differ between 
practices. This can also create inconsistencies in terms of the recording of clinical 
measurements, and the degree of patient monitoring. The inclusion of a minimum 
acceptable mortality reporting date was done to ensure practice level reporting was of a 
sufficient standard.  
The study period length used in this analysis ranged from 15 months to 72 months. In the 
context of a P-CRT, the 15 month closed cohort may be a shorter period than is normal for a 
trial in diabetes. The extension up to 72 months was considered in the context of the SW-
CRT, but only for HbA1c.  
In the analysis of a trial, the primary aim is to assess whether a treatment performs 
differently to a control – usually performed by including a fixed effect for the treatment arm. 
When estimating ICCs from this model, the treatment arm is a covariate of interest. A large 
patient database can allow for the estimation of ICCs. However, adjustments cannot be 
made for treatment arm as there is not one present. As such, the model framework differs 
between analyses used on a large patient database to that used in a trial. In some settings, 
the intervention may influence the degree of clustering, which would create an ICC that 
differs in the treatment arms. The differing degree of clustering in the trials arms has 
previously been described as differential clustering (143, 144). Should the intervention 
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influence the ICC, it is not known whether an ICC obtained from patient data would lead to 
an accurate estimate of the sample size required. 
The estimates of the IPC and WPC in this chapter are limited to continuous outcomes in a 
cross-sectional study framework. Many SW-CRTs employ a cohort design and consist of 
dichotomous outcomes (see Chapter 3). The estimation of correlation for dichotomous 
outcomes is more complex than for continuous outcomes, due to the necessary 
transformation from a latent scale to a proportion scale. The use of a cohort design would 
require an additional random effect for the within-participant correlation over time, and so 
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4.5 Conclusions 
In CRTs, the ICC is required for an accurate sample size calculation (54, 94, 102, 140). In CRTs 
with repeated cross-sections – such as a SW-CRT – observations are taken over multiple 
time-periods. In such designs, it is possible that two observations within the same cluster 
and from the same time-period will be greater correlated than two observations from within 
the same cluster but from different time-periods. As such, the ICC may not be sufficient to 
describe the correlation, and additional correlation types are required – the IPC, the WPC, 
and the WCC. The WPC is defined as the correlation between two observations within a 
cluster and within the same time-period. The IPC is defined as the correlation between two 
observations within the same clusters but from different time-periods. Together the IPC and 
WPC can be used to calculate the WCC – the correlation between two random observations 
in a cluster – and give an indication of the decay of correlation over time. The IPC and WPC 
are becoming increasingly recognised as important to SW-CRTs and other longitudinal 
designs (26, 48). Nevertheless, there has been no evidence of the publication of any 
empirical values, and so it has been repeatedly reported that a ratio of the IPC to the WPC 
can be expected to be 0.8 (27, 48). This chapter is the first reporting of the IPC and WPC and 
shows that the ratio of the IPC to the WPC may be smaller in some instances than previously 
expected. This emphasises that SW-CRTs should acknowledge the decay of correlation over 
time. Furthermore, the results of this chapter are a useful resource that be used in future 
methodological work, and in the sample size calculation of future CRTs.  
 The methodological review (Chapter 3) highlighted that no published SW-CRTs had 
acknowledged the IPC and WPC in the sample size calculation. The results of this chapter 
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have shown that the ICC alone may not be sufficient to describe the correlation within a 
cluster and that the IPC and WPC should be accounted for. The review also highlighted that 
varying cluster size is poorly reported in pre-trial sample size calculations and no study has 
used appropriate methods to adjust for varying cluster size. This may stem from a lack of 
research into unequal cluster sizes in a SW-CRT. In the next chapter, we present a simulation 
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CHAPTER 5:      THE IMPACT OF VARYING 
CLUSTER SIZE IN STEPPED-WEDGE 
CLUSTER RANDOMISED TRIALS 
5.1 Introduction 
A large focus of the methodological research in cluster randomised trials (CRTs) centres on 
the assessments of power (52, 57, 74, 145-147). Equally important is the precision of the 
treatment effect estimate, which is independent of the treatment effect estimate, but is 
used to derive the power. The precision indicates how wide the confidence interval for a 
treatment effect estimate will be – the larger the precision, the narrower the confidence 
interval. It has been established that the correlation between observations within a cluster 
impact the precision (and power) in a parallel CRT (P-CRT) (55). Also associated with the 
precision is the variability in the cluster sizes (52, 148). Often, CRTs are planned supposing 
that an equal number of participants are present in each cluster (equal cluster size) – which 
is evident in the methodological review in Chapter 3. Nevertheless, without limiting the 
number of participants per cluster, it is unlikely in practice that each cluster will contain the 
same number of participants. As such, the majority of CRTs contain unequal sized clusters 
(58, 146).  
In P-CRTs, varying cluster size can be accounted for in the design stage through an adjusted 
design effect (DE), examples of which have been presented earlier (Chapter 2). However, 
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these conventional methods may be conservative (57), and always assume a fixed value of 
the precision by assuming a balance in the number of observations in the control and 
intervention arms (60, 62). Nevertheless, it has been shown that the degree of variation in 
cluster size has an inverse relationship with the precision (57, 145) – so that the greater the 
degree of variation in cluster sizes, the smaller the precision (62).  
Current DEs for SW-CRTs (21, 26) are only applicable for designs with equal sized clusters – 
and so may not be appropriate when clusters vary in size. However, the matrix approach 
shown by Hussey and Hughes (32) can be used to estimate the power for varying cluster size 
if the cluster sizes are known, but this has not been investigated. The absence of an appraisal 
of varying cluster size in a SW-CRT consequently implies that it is unknown whether the SW-
CRT is more (or less) robust than a P-CRT when the cluster sizes vary. 
When clusters vary in size in a SW-CRT, the randomisation order of the clusters is likely to 
affect the precision – since a different number of observations will be contributing to the 
intervention and control conditions. As such, the precision is likely to be better represented 
as a distribution of values, rather than a single value. This thought has led us to consider 
whether the precision in a P-CRT should also be represented as a distribution of values, 
rather than a single value – which is usually assumed.  
5.1.1 Chapter aim 
The main aim of this chapter is to investigate the impact of between-cluster variability in a 
SW-CRT. Results will also be compared to a P-CRT to assess whether a P-CRT and a SW-CRT 
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1) Examine the precision in a SW-CRT with between-cluster variability in size and compare 
it to the precision of a SW-CRT with equal cluster size to highlight:  
a) The average precision in a design with unequal cluster sizes. 
b) The variation in precision in a SW-CRT with unequal cluster size. 
c) The impact of the design on the precision (i.e. number of steps, number of clusters, 
etc.). 
2) Examine the precision in a P-CRT with between-cluster variability in size and compare it 
to the precision of a P-CRT with equal cluster size to assess:  
a) The average precision in a design with unequal cluster sizes. 
b) The variation in precision in a SW-CRT with unequal cluster size. 
c) The impact of the design on the precision (i.e. number of steps, number of clusters, 
etc.).  
3) Investigate how a SW-CRT with varying cluster size compares to a P-CRT with varying 
cluster size. 
4) Examine the precision in a SW-CRT with between-cluster variability in size and within-
cluster variability in size over time and compare it to the precision of a SW-CRT with 
equal cluster size to evaluate:  
a) The average precision in a design with unequal cluster sizes. 
b) The variation in precision in a SW-CRT with unequal cluster size. 
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c) The impact of the design on the precision (i.e. number of steps, number of clusters, 
etc.).  
 
In this chapter, we seek to fully assess the influence of varying cluster size in a SW-CRT, and 
how this compares to a P-CRT. To do this, we begin with the analytical framework used to 
analyse P-CRTs and SW-CRTs, and describe how the precision of a treatment effect estimate 
can be estimated for both trial designs. We then describe a simulation study that allows the 
precision in a SW-CRT to be estimated when clusters vary in size. The precision is then 
compared back to a SW-CRT with equal cluster size to form a relative efficiency. We 
investigate the impact of unequal cluster size on the average relative efficiency. It is then 
discussed whether an average value of the relative efficiency is sufficient, or whether the full 
distribution of possible efficiency values is required. An extension to the SW-CRT framework 
is also presented, that considers both between-cluster variation in size and within-cluster 
variation in size over time. Throughout this chapter, we are assuming that the SW-CRT and 
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5.2  Methods 
In this section, we present established methodology used in the design and analysis of P-
CRTs and SW-CRTs and discuss how they can be extended to evaluate the impact of cluster 
size variation in a SW-CRT. Models used in the analysis of P-CRTs and SW-CRTs are 
presented, alongside the methods used to estimate the precision of the treatment effect 
estimate. Different types of variation in cluster size are described alongside the necessary 
adaptations to estimate the precision when these variations are present. We then discuss 
the simulation process and the factorial design that is used to evaluate the impact of cluster 
size variation on the efficiency of a SW-CRT.  
 
5.2.1 Analytical model used to analyse SW-CRTs 
In a SW-CRT, clusters exposed to the intervention provide, on average, observations at a 
later period of time. As such, calendar time must be accounted for in the model – by 
adopting a fixed effect for each time-period, independent of the cluster. To account for 
correlation between participants within a cluster, a random effect for cluster is included. A 
model has been proposed by Hussey and Hughes (32) to analyse a SW-CRT, given as: 
𝑌𝑖𝑗𝑘 = 𝐴 + 𝛽𝑗 + 𝑋𝑖𝑗𝛿 + 𝛼𝑖 + 𝑖𝑗𝑘 5.1 
Where, 𝑌𝑖𝑗𝑘 is the outcome for participant k in cluster i at time j, A is the mean outcome in 
the unexposed period in the first time-period, 𝛽𝑗 is a time effect, fixed for time-periods j = 
2,…, T (𝛽1 = 0 for identifiability), δ is the treatment effect, 𝛼𝑖 is a random effect for cluster i 
𝛼𝑖~𝑁(0, 𝜎𝑏
2), 𝑖𝑗𝑘 is the residual error (~𝑁(0, 𝜎𝑤









      
if cluster i is exposed to the intervention at time j
if cluster i is not exposed to the intervention at time j
 
When using this framework, there are some assumptions that are being made:  
i. Constant correlation over time:  
That is, two observations from within the same cluster will have the same 
correlation, regardless of the time-period in which the observations are 
made. That is, it is assumed the cluster-by-period variance component 
discussed in Chapter 4 is zero, and so the ICC is sufficient to describe the 
correlation between observations within a cluster. 
ii. Single layer of clustering: 
Only one level of clustering is included – participants within clusters. We do 
not discuss the framework for multi-level clustering designs.  
iii. The full intervention effect is realised in the same time interval in which the 
intervention is introduced: 
This implies that there is no delay in the treatment effect and so the effect is 
visible immediately.  
iv. Common secular trend across clusters: 
Each cluster follows the same underlying trend in the outcome over time.  
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5.2.2 Estimating precision in a SW-CRT 
In any trial, a measure of the uncertainty surrounding a treatment effect estimate should be 
presented (68, 149). The precision – the inverse of the variance of the treatment effect 
estimate – is one such measure of uncertainty. As the variability in the estimate decreases, 
the estimate becomes more accurate (precise) and the precision increases. The precision is 
independent of the treatment effect, and reflects only the study design, allowing direct 
comparisons of differing study designs without the requirement of a treatment effect. 
Before formulae are presented to estimate the precision for a SW-CRT, we outline some 
terminology.  
The design of a SW-CRT can be depicted by a design pattern matrix (DPM). This matrix 
indicates whether a cluster is in the control (0) or intervention (1) for any given time-period. 
An example of a DPM for a SW-CRT with 3 clusters (C1, C2, and C3) and 4 time-periods (t1, t2, 
t3, and t4) is presented in Figure 5.1. 
 


































This DPM can be converted into a design matrix, denoted as Z. This matrix contains 𝑇 + 1 
columns, and 𝐶 × 𝑇 rows, where T is the number of time-periods, and C the number of 
clusters. The first column indicates whether a cluster is in the control (0) or intervention (1), 
and the remaining T columns indicate the time-period that is being referred to (1 if yes, 0 if 
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no). The 𝐶 × 𝑇 rows can be split into C groups of T rows, where each row refers to a 
particular cluster at one time-period. For the DPM given in Figure 5.1, the design matrix Z 
can be given by Figure 5.2. In this example, row 7 indicates that the second cluster (since it’s 
in the second set of C rows) is in the intervention (since the first column is a 1) during the 
third time-period (since the 1 in the remaining T columns correspons to 𝑡3). 
 



































































Now, we refer to matrix V, which is the variance-covariance matrix of the cell means ordered 
by time within cluster (9, 32). V is a 𝐶𝑇 × 𝐶𝑇 block diagonal matrix, made up C blocks – each 
called Vi and each 𝑇 × 𝑇 in size. Here each 𝑇 × 𝑇 block refers to a particular cluster (i) and 
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Here 𝑚𝑖𝑗 represents the size of cluster i at time j which we refer to as the cluster-period size. 
Matrix V can then be summarised as a 𝐶 × 𝐶 block diagonal matrix (Figure 5.4), in which 
each entry Vi is itself a 𝑇 × 𝑇 matrix given by Figure 5.3:  
































The zeroes in this matrix refer to the independence of participants between clusters 
 
If assuming the random effects are known, when fitting model 5.1, there are T unknown 
parameters – the intervention effect (𝛿) and a time effect for each time-period (excluding 
the first period for identifiability) (𝛽2, 𝛽3, … , 𝛽𝑇). These estimates can be obtained from a 
weighted least squares approach (32). The variance-covariance matrix for the estimated 
values of these parameters can be calculated as (𝑍′𝑉−1𝑍)−1. The variance of the treatment 
effect estimate is given by the entry in the first column and first row (denoted as [1, 1]) of 
this variance-covariance matrix. As such, the precision of the treatment effect estimate can 
be calculated as: 
 
 








When designing a study, the precision is vital for two reasons, as it influences: (i) how the 
study compares to other study designs, and (ii) what the estimate of the power is. In this 
setting, we are interesting in (i) and, more specifically, how a CRT is affected by varying 
cluster size. The precision allows a direct comparison between study designs, without the 
prerequisite of a treatment effect estimate that is necessary to estimate power. Here, the 
precision can be used to compare a CRT with unequal cluster size to a CRT with equal cluster 
size when the total sample size is fixed. As such, the relative efficiency (RE) of the design is 
used here, given as the ratio of the precision for a design with unequal cluster size to the 







 Types of variation in cluster sizes in a SW-CRT 5.2.2.1
In a SW-CRT, time is split into a number of (equal) time-periods, and so the size of a cluster 
can be denoted by the total cluster size (size of a cluster over the whole study) (M) or by a 
cluster-period size (size of a cluster at one time-period) (𝑚𝑖𝑗). When referring to cluster size 
variation, there are two forms that this can take: (1) between-cluster variation in size; and 
(2) within-cluster variation over time.  
The main source of variation will likely stem from the variation between clusters. That is, the 
number of participants will differ cluster to cluster, often as a result of logistical limitations 
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(57) – such as each cluster containing a different number of beds which limits the maximum 
participants for that cluster, such as in the ERFIC trial (see section 1.6.3) (25). The differing in 
size between clusters is described as between-cluster variation in size. 
Since a SW-CRT is split into time-periods, it is possible that the number of participants in a 
cluster will vary over time. This could be due to fluctuations in work load or recruitment. This 
is referred to as the within-cluster variation in size over time. 
Therefore, cluster size variation can be in the form of between-cluster variation or within-
cluster variation (or both). To begin, we consider only the between-cluster variation in size, 
and assume that there is no within cluster-variation in size (i.e. within a cluster, there is no 
variation in size over time) – since it is likely that between-cluster variation will account for 
the majority of the variation. The methodology will then be extended to include within-
cluster variation in size over time. 
In the discussion of cluster sizes, we have previously referred to the cluster-period size. To 
establish the terminology and prevent confusion, a summary of the terms and notations 
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Table 5.1: Summary of key terminology used in reference to cluster size 
 
 
















Where ?̅?𝑖• is the average cluster-period size for cluster i, and ?̅?•• is the average cluster-
period size. Both are calculated from the simulated cluster-period sizes (𝑚𝑖𝑗).  
Throughout this work, 𝜇 refers to a value that is being used to simulate cluster-period sizes. 
The term 𝑚𝑖𝑗 will refer to the simulated cluster-period sizes. The terms ?̅?𝑖• and ?̅?•• refer to 
an average, which is estimated from a set of simulated values.  
Term Notation Description 
Design matrix (Matrix) Z The design of a SW-CRT, indicating whether 





(Matrix) V The variance-covariance of the cell means 
ordered by time within cluster 
 
True cluster-period size 𝜇 The (known) average cluster-period size – used 
to simulate all other cluster-period sizes 
 
Coefficient of variation 
 
cv The (known) coefficient of variation in cluster 
sizes – calculated as the ratio of the standard 
deviation of cluster sizes to the mean cluster size 
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Below, we discuss the steps taken to evaluate the impact of between-cluster variation in size 
on the precision of a SW-CRT and a P-CRT, and assess the effect of within-cluster variation on 
the precision of a SW-CRT. 
 
5.2.3 Impact of between-cluster variation in size in a SW-CRT 
In the design stage of a CRT, a measurement of the total cluster size (number of participants 
in a cluster over the whole study period) and the cluster-period size (number of participants 
in a cluster during one time-period) are likely to be known. If the clusters vary in size, then 
an average total cluster size or average cluster-period size may be known, alongside a 
measure of dispersion – such as the coefficient of variation of cluster sizes.  
The impact of varying cluster size in a SW-CRT can be shown by comparing the precision of a 
SW-CRT with unequal cluster sizes to the precision of a SW-CRT with equal cluster sizes, 
when both SW-CRTs have the same total sample size. If the sample size differs between the 
designs, any change in efficiency may due to a difference in sample size, opposed to the 
effect of clusters varying in size. This also ensures that each estimate of the RE is from a SW-
CRT with an identical sample size – and so the distribution of the RE and any loss in average 
RE will be due to varying cluster size. 
To this end, we simulate cluster-period sizes that vary for each of C clusters at each of T 
time-periods, and calculate the precision for the simulated cluster-period sizes. Alongside 
this, the precision is estimated for a SW-CRT with clusters of equal size, and of the same 
total sample size. The precision of the unequal design and equal design are then compared 
as a relative efficiency (RE). Below, in sections 5.2.3.2 to 5.2.3.6, we discuss the steps taken 
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to simulate cluster-period sizes and estimate the RE. Prior to that, an example is presented 
to illustrate the outline of the methods, and then each step is discussed in more detail.  
 Example of estimating the relative efficiency of a SW-CRT with 5.2.3.1
unequal cluster sizes 
We begin with a SW-CRT with equal cluster sizes, with 12 clusters, 6 time-periods, and a true 
cluster-period size 𝜇 = 50. Since 𝑚𝑖𝑗 = 𝑚𝑖`𝑗` ∀ 𝑖, 𝑖′ and 𝑗, 𝑗′, it follows that 𝑚𝑖𝑗 = 𝑚𝑖′𝑗′ =
50 ∀ 𝑖, 𝑖′ and 𝑗, 𝑗′, and so the sample size in the SW-CRT with equal cluster sizes (𝑆𝑒) will be: 
𝑆𝑒 = 𝜇 × 𝐶 × 𝑇 = 50 × 12 × 6 = 3600. 
Now, consider a SW-CRT with unequal cluster size, with 12 clusters, 6 time-periods, a true 
cluster-period size 𝜇 = 50 and a coefficient of variation of cluster sizes, 𝑐𝑣 = 0.5. Now, we 
assume that the average cluster-specific cluster-period sizes (?̅?𝑖•) follow a Gamma 
distribution, and so we use 𝜇 and 𝑐𝑣 to simulate the average cluster-specific cluster-period 
size (?̅?𝑖•) for each cluster 𝑖. A set of potential ?̅?𝑖• values are: 
𝑚1•  =  47.10 𝑚2•  =  68.90 𝑚3•  =  33.82 𝑚4•  =  56.24 
𝑚5•  =  47.44 𝑚6•  =  71.67 𝑚7•  =  26.81 𝑚8•  =  83.26 
𝑚9•  =  28.17 𝑚10•  =  12.09 𝑚11•  =  63.87 𝑚12•  =  60.64 
 
These values indicate the average cluster-period size for that cluster, so that 𝑚1•  =  47.10 
indicates that the average size for cluster 1 at one time-period is 47.10. The values of 𝑚𝑖• 
can then be used to obtain the size of a cluster at a particular time-period – the cluster-
period size (𝑚𝑖𝑗). Since there is no within-cluster variation, each cluster is the same size at 
each time period, so that 𝑚𝑖𝑗 = 𝑚𝑖𝑗′  ∀ 𝑗, 𝑗′. Now, to estimate the RE, the sample size should 
 
 
Page | 147 
 
be identical in the SW-CRT with unequal cluster size and the SW-CRT with equal cluster size. 
In a SW-CRT with unequal cluster sizes, the total sample size 𝑆𝑢 is the sum of all of the 
cluster-period sizes 𝑚𝑖𝑗, so that: 





Now, under the assumption of 𝑆𝑢 = 𝑆𝑒, we calculate the precision for the SW-CRT with 
unequal cluster sizes and the precision for the SW-CRT with equal cluster sizes using 
equation 5.2 by replacing the 𝑚𝑖𝑗 values in each 𝑉𝑖 matrix. Following this, the RE is 
calculated as the ratio of the two precisions.  
The steps taken to estimate the RE can be broken down into five sections: simulating cluster-
period sizes, scaling cluster-period sizes to maintain the total sample size, estimating the 
precision, estimating the relative efficiency, and compiling the relative efficiency estimates. 
Each step is discussed in more detail below. 
 The simulation of cluster sizes 5.2.3.2
Since the cluster-period sizes are unknown, we use the true cluster-period size (𝜇) and the 
coefficient of variation of cluster sizes (𝑐𝑣) to simulate potential cluster-period sizes (𝑚𝑖𝑗). 
We simulate the average cluster-specific cluster-period size, ?̅?𝑖•, for each cluster i, using a 
Gamma distribution with mean 𝜇 and coefficient of variation 𝑐𝑣, so that the following holds:  




Here 𝐸(?̅?𝑖•) indicates the expected value of the average cluster-specific cluster-period size 
for cluster i, and 𝑉(?̅?𝑖•) represents the variance of the average cluster-specific cluster-
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period sizes. Rather than assume cluster sizes follow a Normal distribution, which is highly 
unlikely, we would expect clusters sizes to exhibit a positive skew. Furthermore, we require 
that the distribution contains no negative values – since clusters cannot contribute a 
negative number of patients in a time-period. In this context, it is not essential that the 
cluster sizes are integer sizes. Since the role of this chapter is to consider how variation in 
cluster sizes affects a stepped-wedge design, it is vital that a fixed average cluster size (and 
fixed total sample size) can be used, whilst changing the degree of variation in the cluster 
sizes. As such, we have chosen a Gamma distribution to reflect the distribution of cluster 
sizes. 





𝛽 = 𝜇 × 𝑐𝑣2 
 
By specifying the values of 𝜇 and 𝑐𝑣, values of 𝛼 and 𝛽 can be calculated to simulate ?̅?𝑖• 
values. In this setting, there is no variation in size within a cluster, so that: 
𝑚𝑖𝑗 = 𝑚𝑖𝑗′  ∀ 𝑗, 𝑗′. 
To ensure an unbiased comparison of precision between the unequal cluster size design and 
the equal cluster size design, the total sample size in the SW-CRT with equal cluster size 
should be the same as the sample size in the SW-CRT with unequal cluster size. To ensure a 
fixed total sample size is maintained between the two designs, we describe a scaling factor 
that is used. 
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 Scaling cluster-period sizes to maintain the total sample size  5.2.3.3
In the unequal cluster size design, the total sample size (𝑆𝑢) is the sum of the cluster-period 
sizes 𝑚𝑖𝑗 from every cluster and from every time-period: 





?̅?•• × 𝐶 × 𝑇 
 In a design with equal cluster sizes, the total sample size (𝑆𝑒) is: 
𝑆𝑒 = 𝜇 × 𝐶 × 𝑇 
When simulating 𝑚𝑖𝑗, the total sample size in the unequal cluster size design will differ from 




𝑖=1  ≠ 𝜇 × 𝐶 × 𝑇. As such, 
a scaling factor is required to maintain the fixed sample size.  
An inherent ability of the Gamma distribution is that it can be scaled and still follow a 
Gamma distribution. That is, if X ~ Γ(𝑎, 𝑏), the distribution of 𝑌 = 𝜔𝑋 (where 𝜔 is a scalar) 
also follows a Gamma distribution (see Appendix J). 
Since the average cluster-specific cluster-period sizes (?̅?𝑖•) follow a Gamma distribution, it is 
possible to scale the ?̅?𝑖• values, and they will still follow a Gamma distribution. As such, we 
scale the ?̅?𝑖• values to ensure the total sample size is the same in the unequal cluster size 
design as the equal cluster size design.  
The scaling factor (𝜔) is calculated as the ratio of the total sample size in the equal cluster 





μ × 𝐶 × 𝑇
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Now, each of the cluster-period sizes, 𝑚𝑖𝑗, are multiplied by ω, so that each of cluster-period 




𝑖=1 = 𝜇 × 𝐶 × 𝑇. The 𝜔𝑚𝑖𝑗 values are then used to 
calculate the precision in a SW-CRT with varying cluster size. 
 Estimating the precision 5.2.3.4
To estimate the precision, the study design – the number of clusters, time-periods, DPM – is 
used to create the design matrix, Z. Then, the simulated 𝜔𝑚𝑖𝑗 values are inputted into each 
𝑉𝑖 matrix, to create the variance-covariance matrix, V. From this, the precision is estimated 
using equation 5.2. 
 Estimating the relative efficiency 5.2.3.5
To estimate the RE, the precision of the unequal cluster size design must be compared to the 
precision of an equal cluster size design. The design matrix Z will be identical in both the 
equal cluster size and unequal cluster size scenarios. For the equal cluster size design, all 
clusters are the same size, for each and every time-period, so that 𝑚𝑖𝑗 = 𝜇 = 𝑚𝑖′𝑗′  ∀ 𝑖, 𝑖′ 
and 𝑗, 𝑗′, and contain a total sample size of 𝑆𝑒 = 𝜇 × 𝐶 × 𝑇 which is identical to the unequal 
cluster size design. The values of 𝑚𝑖𝑗 can be inputted into each 𝑉𝑖 matrix, and the precision 
can be estimated using equation 5.2. 
The precision from a SW-CRT with unequal cluster size is then compared to the precision of a 
SW-CRT with equal cluster size as the RE (equation 5.3).  
 Compiling estimates of the relative efficiency 5.2.3.6
The methodology described above generates one estimate of the RE for a particular set of 
simulated 𝑚𝑖𝑗 values. After this estimate of the RE has been made, 𝛼 and 𝛽 are used to 
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simulate a new set of 𝑚𝑖𝑗 values, to obtain a new estimate of the precision. This estimate is 
compared to the precision of a SW-CRT with equal cluster size to obtain a new estimate of 
the RE.  
The simulation of 𝑚𝑖𝑗 to estimate the RE is repeated a large number of times, in order to 
form a distribution of possible efficiency values, from which the average RE can be obtained. 
 Simulation study 5.2.3.7
There are many design features that can impact the precision in a SW-CRT, such as: the 
number of clusters, the cluster size, the number of steps, the ICC, and the coefficient of 
variation of cluster sizes. However, we combine the ICC and the cluster size as the cluster 
mean correlation – which is described below – and investigate the impact of the cluster 
mean correlation on the precision of a SW-CRT.  
The cluster mean correlation, denoted as R, represents the correlation between the cluster 
means of two repeated sets of observations taken from the same cluster (61) and is defined 
as (9, 48, 61): 
𝑅 =
𝑀 × 𝜌
1 + (𝑀 − 1)𝜌
 
Generally, 0 ≤ 𝑅 ≤ 1, and it has been shown that R can approach 1, even for small values of 
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In the simulation study, four factors are considered: (1) the number of steps, (2) the number 
of clusters, (3) the cluster mean correlation, and (4) the coefficient of variation of cluster 
sizes (Table 5.2). For the number of steps, values of 2, 3, 4, 6, and 12 were chosen. In the 
methodological review (Chapter 3), it was identified that over 50% of studies used a design 
with 4 or less randomisation steps. To capture the full effect, the values of 6 and 12 were 
also chosen. For simplicity, we maintain an equal number of clusters randomised at each 
step, so it was necessary that the total number of clusters be a multiple of 12, and so values 
of 12, 24, 48, and 96 were chosen – which is appropriate since the majority of SW-CRTs 
include studies with more than ten clusters. For ease, we assumed a total cluster size of 72 
participants, which provides an integer cluster-period size for the equal cluster size design 
regardless of the number of steps. As such, the total number of participants (total sample 
size) in the 12-cluster, 24-cluster, 48-cluster, and 96-cluster designs are 864, 1728, 3456, and 
6912. This sample size is fixed for equal and unequal cluster designs, for all values of the 
cluster mean correlation, and irrespective of the number of steps. Since it has been 
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established that the cluster mean correlation impacts the precision of the SW-CRT, a wide 
spectrum of values were chosen (0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0). The degree 
of variation in cluster sizes ranged from small (𝑐𝑣 = 0.25) to large (𝑐𝑣 = 1.5), with incremental 
values chosen between this range.  
Table 5.2: Summary of parameter values used in simulation 
Variables Values chosen 
Number of steps 
 
2, 3, 4, 6, 12 
Number of clusters 
 
12, 24, 48, 96 
Cluster mean correlation 
 
0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0 
Coefficient of variation of cluster sizes 
 
0.25, 0.5, 0.75, 1.0, 1.25, 1.5 
  
 
In total, 4 x 4 x 11 x 6 = 1,056 combinations of variables were considered. 
The number of simulations used to estimate the distribution of the RE is determined by a 
Monte Carlo estimate of the error around the precision (44). Here, to maintain an error 
smaller than 1%, 4,000 simulations will be used to form a detailed understanding of the 
distribution of efficiency. 
 Summary of methods 5.2.3.8
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Box 5.1: Outline of the steps taken to estimate the relative efficiency of a stepped-wedge 
cluster randomised trial with varying cluster size compared to a stepped-wedge cluster 
randomised trial with equal cluster size. 
Background: Define the SW-CRT design 
Define the design of the SW-CRT such as number of time-periods, number 
of clusters, number of steps, and the cluster mean correlation (i.e. select 
one of the scenarios from Table 5.2). 
Step 1: Simulate cluster-period sizes 
Simulate for each cluster, its cluster-period size, 𝑚𝑖𝑗 such that 𝑚𝑖𝑗 =
𝑚𝑖𝑗′  ∀ 𝑗, 𝑗′ using a gamma distribution, with mean 𝜇 and coefficient of 
variation, 𝑐𝑣. 
Step 2: Scale cluster-period sizes 









 Calculate 𝜔 which is the ratio of the total sample size in an equal cluster 












 Scale the cluster-period sizes 𝑚𝑖𝑗, as 𝑚𝑖𝑗 × 𝜔. 
Step 3: Estimating the precision 
 Calculate matrices Vi (i=1, ... , C) using the 𝜔𝑚𝑖𝑗 from step (2). 
 Form matrix V using the block matrices Vi . 
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Box 5.1 continued… 
Step 4: Estimating the relative efficiency 
 Estimate the precision for a SW-CRT with equal cluster sizes with a total 
sample size 𝑆𝑒 = 𝜇 × 𝐶 × 𝑇, so that each cluster-period is size 𝜇.  
  Calculate the RE of the design as a ratio of the precision of the unequal 
cluster size design (from step 3) compared to the equal cluster size 
design (from step 4). 
Step 5: Compiling the efficiency estimates 
 Repeat steps (1) - (4) 4,000 times.  
 Collate the estimates of the RE to form the distribution (and average) of 
the RE. 
 
5.2.4 Between cluster variation in a P-CRT  
Conventional DEs for a P-CRT assume a singular RE value and the methods are approximate. 
Here, we want to establish whether the RE is a singular value, and use an exact method to 
obtain the RE. To this end, the methodology described in section 5.2.3 can be applied to a P-










By describing a P-CRT in this way, an estimate of the precision of the treatment effect 
estimate for a P-CRT can then be obtained using equation 5.2. Throughout this work, we 
consider estimates of the precision for a P-CRT calculated via this approach, and not via a 
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design effect. This approach allows us to relax the assumption of a balance of observations 
between the intervention and control arms, and provides a distribution of possible RE values 
– rather than a fixed value.  
A P-CRT is a study design with only one time-period, and so essentially, the cluster-period 
size 𝑚𝑖𝑗 refers to the size of cluster 𝑖 over the whole study duration. The methodology 
described in sections 5.2.3.2 and 5.2.3.3 can be used to simulate the 𝑚𝑖𝑗 values, and the 
precision can be estimated using equation 5.2. The precision is then calculated for a P-CRT 
with equal cluster size and the same total sample size (𝑆𝑒 = 𝜇 × 𝐶 × 𝑇). The precision in the 
P-CRT with unequal cluster size is then compared to the precision in a P-CRT with equal 
cluster size as a RE. This is repeated a large number of times, and the estimates of the RE are 
compiled to produce a distribution of possible RE estimates – similar to section 5.2.3.6.  
 Simulation study 5.2.4.1
In this simulation study, three factors are considered: (1) the number of clusters, (2) the 
cluster mean correlation, and (3) the coefficient of variation of cluster sizes. The parameter 
values used in this simulation study were based on the values used in the earlier simulation 
study for the SW-CRT and are summarised below (Table 5.3). 
Table 5.3: Summary of parameter values used in simulation 
Parameter Values chosen 
Number of clusters 12, 24, 48, 96 
Cluster mean correlation 0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0 
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The number of simulations used for each combination of variables was maintained from the 
SW-CRT, so that 4,000 simulations were used to maintain an error rate smaller than 1%.  
 Summary of methods 5.2.4.2
The steps taken to estimate the RE are summarised in Box 5.2. 
Box 5.2: Outline of the steps taken to estimate the relative efficiency of a parallel cluster 
randomised trial with varying cluster size compared to a parallel cluster randomised trial 
with equal cluster size. 
Background: Define the P-CRT design 
Define the design of the P-CRT such as the number of clusters and the cluster 
mean correlation (i.e. select one of the scenarios from Table 5.3). 
Step 1: Simulate cluster-period sizes 
Simulate for each cluster, its cluster-period size, 𝑚𝑖𝑗, using a gamma 
distribution, with mean 𝜇 and coefficient of variation, 𝑐𝑣. 
Step 2: Scale the cluster-period sizes 









 Calculate 𝜔 which is the ratio of the total sample size in an equal cluster 
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Box 5.2 continued… 
Step 3: Estimating the precision 
 Calculate matrices Vi (i=1, ... , C) using the 𝜔𝑚𝑖𝑗 from step (2). 
 Form matrix V using the block matrices Vi . 
 Calculate the precision using equation 5.2. 
Step 4: Estimating the relative efficiency 
 Estimate the precision for a P-CRT with equal cluster sizes with a total 
sample size 𝑆𝑒 = 𝜇 × 𝐶 × 𝑇, so that each cluster-period is size 𝜇.  
 Calculate the RE of the design as a ratio of the precision of the unequal 
cluster size design (from step 3) compared to the equal cluster size design 
(from step 4). 
Step 5: Compiling the efficiency estimates 
 Repeat steps (1) - (4) 4,000 times.  
 Collate the estimates of the RE to form the distribution (and average) of 
the RE. 
 
5.2.5 Impact of within-cluster variation in size over time 
In section 5.2.3, a method was described to estimate the RE of a SW-CRT with unequal 
cluster sizes compared to a SW-CRT with equal cluster sizes – with the assumption of each 
cluster being in fixed in size over time. In this section, we now extend the method to allow 
individual clusters to independently vary in size over time.  
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Here, we compare the precision in a SW-CRT with unequal cluster sizes to the precision in a 
SW-CRT with equal cluster sizes, when the sample size is the same in both designs. To do 
this, we use the true cluster-period size, the between-cluster coefficient of variation of 
cluster sizes, and the within-cluster variation in cluster sizes, to simulate potential cluster-
period sizes. The between-cluster coefficient of variation in cluster sizes describes the 
variation in the average cluster-specific cluster-period sizes. That is, it describes the 
variability in the average cluster size at one time-period. The within-cluster coefficient of 
variation describes the variability in size of one cluster over time.  
Below, sections 5.2.5.2 to 5.2.5.6 detail the steps taken to simulate cluster-period sizes with 
between-cluster and within-cluster variation in size, and how the RE is estimated. Initially, 
we illustrate the methods though an example, before elaborating on each step in more 
depth. 
 Example of estimating the relative efficiency in a SW-CRT with 5.2.5.1
between-cluster and within-cluster variation in size 
We start with a SW-CRT with 12 cluster, 3 time-periods, and a true cluster-period size 
𝜇 = 50. Since 𝑚𝑖𝑗 = 𝑚𝑖′𝑗′  ∀ 𝑖, 𝑖′ and 𝑗, 𝑗′, it follows that 𝑚𝑖𝑗 = 𝑚𝑖′𝑗′ = 50 ∀ 𝑖, 𝑖′ and 𝑗, 𝑗′, and 
so the sample size in the SW-CRT with equal cluster sizes (𝑆𝑒) will be: 
𝑆𝑒 = 𝜇 × 𝐶 × 𝑇 = 50 × 12 × 3 = 1800. 
Now consider a SW-CRT with 12 clusters and 3 time-periods, with 𝜇 = 50, 𝑐𝑣 = 0.5, 
and 𝑐𝑣𝑤 = 0.1. Assuming that ?̅?𝑖• follows a Gamma distribution, we can use 𝜇 and 𝑐𝑣 to 
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simulate the average cluster-specific cluster-period size (?̅?𝑖•) for each cluster i. A set of 
potential ?̅?𝑖• values are: 
𝑚1•  =  47.10 𝑚2•  =  68.90 𝑚3•  =  33.82 𝑚4•  =  56.24 
𝑚5•  =  47.44 𝑚6•  =  71.67 𝑚7•  =  26.81 𝑚8•  =  83.26 
𝑚9•  =  28.17 𝑚10•  =  12.09 𝑚11•  =  63.87 𝑚12•  =  60.64 
 
These values indicate the average cluster-period size for that cluster, so that 𝑚1•= 47.10 
indicates that the average cluster-period size over the study for cluster 1 is 47.10. The 
average cluster-specific cluster-period sizes (?̅?𝑖•) can then be used to obtain the cluster-
period sizes (𝑚𝑖𝑗). Here, each cluster is modelled using an independent Gamma distribution, 
with mean, ?̅?i•, and coefficient of variation 𝑐𝑣𝑤. Using the values of ?̅?i• above, and 
𝑐𝑣𝑤 = 0.1, the simulated cluster-period sizes (𝑚𝑖𝑗) for each cluster i may be: 
 Time-period 1 Time-period 2 Time-period 3 
Cluster 1 𝑚1 1  = 43.80 𝑚1 2  = 49.85 𝑚1 3  = 47.65 
Cluster 2 𝑚2 1  = 64.53 𝑚2 2  = 77.27 𝑚2 3  = 64.89 
Cluster 3 𝑚3 1  = 31.88 𝑚3 2  = 36.06 𝑚3 3  = 33.53 
Cluster 4 𝑚4 1  = 54.75 𝑚4 2  = 57.98 𝑚4 3  = 55.98 
Cluster 5 𝑚5 1  = 42.03 𝑚5 2  = 49.21 𝑚5 3  = 51.08 
Cluster 6 𝑚6 1  = 75.56 𝑚6 2  = 60.79 𝑚6 3  = 78.67 
Cluster 7 𝑚7 1  = 26.29 𝑚7 2  = 26.78 𝑚7 3  = 27.36 
Cluster 8 𝑚8 1  = 97.55 𝑚8 2  = 80.53 𝑚8 3  = 71.71 
Cluster 9 𝑚9 1  = 28.30 𝑚9 2  = 27.63 𝑚9 3  = 28.57 
Cluster 10 𝑚10 1  = 12.31 𝑚10 2  = 10.00 𝑚10 3  = 13.95 
Cluster 11 𝑚11 1  = 63.75 𝑚11 2  = 64.82 𝑚11 3  = 63.04 
Cluster 12 𝑚12 1  = 58.16 𝑚12 2  = 60.70 𝑚12 3  = 63.06 
 
 
These values correspond to cluster-period sizes for cluster i at time j, so that 𝑚4 2 = 57.98 
indicates that cluster 4 at time 2 has 57.98 observations.  
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In the SW-CRT with unequal cluster sizes, the total sample size 𝑆𝑢 is the sum of all of the 
cluster-period sizes 𝑚𝑖𝑗, so that: 





By assuming that 𝑆𝑢 = 𝑆𝑒, the precision is calculated for a SW-CRT with unequal cluster sizes 
and the precision for a SW-CRT with equal cluster sizes using equation 5.2 by inputting each 
𝑚𝑖𝑗 value into each 𝑉𝑖 matrix. The RE is calculated as the ratio of the two precisions.  
Similar to section 5.2.3, the steps used to estimate the RE can be split into five sections – 
which are discussed in depth, below. 
 The simulation of cluster sizes 5.2.5.2
Since the cluster-period sizes are unknown, we use the true cluster-period size (𝜇), the 
between-cluster coefficient of variation of cluster sizes (𝑐𝑣), and the within-cluster 
coefficient of variation (𝑐𝑣𝑤) to simulate potential cluster-period sizes (𝑚𝑖𝑗). Firstly, we 
simulate the average cluster-specific cluster-period size (?̅?𝑖•) for each cluster i, using a 
Gamma distribution with mean 𝜇 and coefficient of variation 𝑐𝑣. Following this, the cluster-
period sizes (𝑚𝑖𝑗) are simulated for each cluster independently using a Gamma distribution 
with mean ?̅?𝑖• and coefficient of variation 𝑐𝑣𝑤, so that the following holds: 
𝑚𝑖𝑗|?̅?𝑖•~Γ(𝛼𝑤𝑖 , 𝛽𝑤𝑖) 𝐸(𝑚𝑖𝑗|?̅?𝑖•) = 𝛼𝑤𝑖 × 𝛽𝑤𝑖 = ?̅?i• 𝑉(𝑚𝑖𝑗|?̅?𝑖•) = 𝛼𝑤𝑖 × 𝛽𝑤𝑖
2 = 𝜎𝑤𝑖
2 
𝑚𝑖~Γ(𝛼𝑚, 𝛽𝑚) 𝐸(𝑚𝑖) = 𝛼𝑚 × 𝛽𝑚 = 𝜇 𝑉(𝑚𝑖) = 𝛼𝑚 × 𝛽𝑚
2 = 𝜎𝑚
2 
Where the values of 𝛼𝑚, 𝛼𝑤𝑖, 𝛽𝑚, and 𝛽𝑤𝑖 can be calculated as follows: 
 
 









𝛽𝑚 = 𝜇 × 𝑐𝑣
2 𝛽𝑤𝑖 = ?̅?𝑖• × 𝑐𝑣𝑤
2 
 
By specifying the values of 𝜇, 𝑐𝑣, and 𝑐𝑣𝑤, values of 𝛼𝑚 and 𝛽𝑚, can be calculated to 
simulate ?̅?𝑖• and then 𝑚𝑖𝑗 values.  
An unbiased comparison of the precision in an unequal cluster size design and the precision 
in an equal cluster size design relies on the total sample size being equal in the two designs – 
to ensure loss in precision is due to the unequal cluster size structure and not a difference in 
sample size. A scaling factor is used to maintain a fixed total sample size, which is described 
below. Although some aspects of the scaling factor were reported in section 5.2.3.3, it is 
reiterated here for clarity. 
 Scaling factor to maintain a fixed total sample size 5.2.5.3
Because 𝑚𝑖𝑗 are simulated, the total sample size will differ between the unequal and equal 




𝑖=1  ≠ 𝜇 × 𝐶 × 𝑇. Since there is between-cluster and 
within-cluster variation, two scaling factors are required to maintain the fixed sample size – 
one to maintain the total sample size, and one to maintain the total cluster size. 
To this end, we firstly assume that there is no within-cluster variation in size (only between-
cluster variation in size), and use a scaling factor that was described in section 5.2.3.3. Then 
a second scaling factor is applied to each individual cluster, and compares a cluster with 
variation in size over time to a cluster with no variation in size over time. Essentially, this is 
the same scaling factor that is used in section 5.2.3.3 but it is applied cluster-periods within 
an individual cluster, rather than average cluster-specific cluster-period sizes across clusters.  
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Scaling factor for total sample size 
We begin by considering the total sample size (𝑆𝑒) in a SW-CRT with equal cluster sizes: 
𝑆𝑒 = 𝜇 × 𝐶 × 𝑇 
In a design with unequal clusters, the total sample size (𝑆𝑢) is the sum of the cluster-period 
sizes 𝑚𝑖𝑗 from every cluster and from every time-period: 





?̅?•• × 𝐶 × 𝑇 
Firstly, the scaling factor (𝜔) is calculated for the average cluster-specific cluster-period sizes 
(?̅?𝑖•) as the ratio of the total sample size in the equal cluster size design (𝑆𝑒) to the total 





μ × 𝐶 × 𝑇





Now, each of the cluster-period sizes, 𝑚𝑖𝑗, are multiplied by ω, so that each of cluster-period 




𝑖=1 = 𝜇 × 𝐶 × 𝑇. 
Scaling factor for total cluster size 
For each cluster, the average cluster-period size must be calculated - using the 𝜔𝑚𝑖𝑗 values. 
We refer to this as 𝜔𝑚̅̅ ̅̅ ̅i•, which is calculated as: 
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Following this, for cluster i, we simulate new values of 𝑚𝑖𝑗 from a Gamma distribution with 
mean 𝜔𝑚̅̅ ̅̅ ̅i• and coefficient of variation 𝑐𝑣𝑤. As such, the new values of 𝑚𝑖𝑗 now contain 
variation in size over time, and so differ from those simulated earlier. As a result, the 
average cluster-specific cluster-period size ?̅?𝑖• will differ from its earlier value.  
Now, for a SW-CRT with no within-cluster variation in size, the total cluster size for cluster i 
(𝑀𝑒𝑖) is: 
𝑀𝑒𝑖 = 𝜔𝑚̅̅ ̅̅ ̅𝑖• × 𝑇 
In a design with within-cluster variation in size over time, the total cluster size for cluster i 
(𝑀𝑢𝑖) is the sum of the cluster-period sizes for cluster I from each time period: 
𝑀𝑢𝑖 =  ∑ 𝑚𝑖𝑗 =
𝑇
𝑗=1
?̅?𝑖• × 𝑇 
Now, since 𝑚𝑖𝑗 are simulated, the total cluster size for cluster i with within-cluster variation 
will differ from the total cluster size with no within-cluster variation, so that 
∑ 𝑚𝑖𝑗 ≠
𝑇
𝑗=1 𝜔𝑚̅̅ ̅̅ ̅𝑖• × 𝑇, and a scaling factor is required to maintain a fixed total cluster size.  











Now, each of the cluster-period sizes (𝑚𝑖𝑗) in cluster i are multiplied by 𝜔𝑖, so the cluster-
period sizes 𝑚𝑖𝑗 become 𝜔𝑖𝑚𝑖𝑗. The 𝜔𝑖𝑚𝑖𝑗 values are then used to calculate the precision in 
a SW-CRT with varying cluster size. 
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 Estimating the precision 5.2.5.4
To estimate the precision, the study design – the number of clusters, time-periods, and DPM 
– is used to create the design matrix, Z. The simulated cluster-period sizes (𝑚𝑖𝑗) are 
inputted into each 𝑉𝑖 matrix, to create the variance-covariance matrix, V. The precision is 
then estimated using equation 5.2. 
 Estimating the relative efficiency 5.2.5.5
To estimate the RE, the precision of an unequal cluster size design is compared to the 
precision of an equal cluster size design. In both designs, the design matrix Z will be identical. 
In the equal cluster size design, all clusters are the same size, for each and every time-
period, so that 𝑚𝑖𝑗 = 𝑚𝑖′𝑗′  ∀ 𝑖, 𝑖′ and 𝑗, 𝑗′, and so the total sample size is 𝑆𝑒 = 𝜇 × 𝐶 × 𝑇 
which is identical to the unequal cluster size design. Each 𝑚𝑖𝑗 can be inputted into each 𝑉𝑖 
matrix, and the precision can be estimated using equation 5.2. 
The precision from a SW-CRT with unequal cluster size is then compared to the precision of a 
SW-CRT with equal cluster size as the RE (equation 5.3).  
 Compiling estimates of the relative efficiency 5.2.5.6
The above methodology generates one RE estimate for a particular set of 𝑚𝑖𝑗 values. After 
an estimate of the RE has been made, 𝛼 and 𝛽 are used to simulate a new set of 𝑚𝑖𝑗 values 
(which are corrected to ensure the same total sample size) and a new estimate of the 
precision is obtained. This estimate is compared to the precision of a SW-CRT with equal 
cluster size to obtain a new estimate of the RE. 
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The simulation of 𝑚𝑖𝑗 to calculate the RE is repeated a large number of times, to form a 
distribution of possible RE values, and an estimate of the average RE. 
 Simulation study 5.2.5.7
Table 5.4 highlights the scenarios used in this simulation study. Since SW-CRTs typically 
employ a small number of clusters, only the two smaller numbers of clusters were used (12 
and 24). To encapsulate the impact of the number of steps, only the two extreme values 
were used (2 and 12). All values of R and 𝑐𝑣 used in the primary analysis were included in 
this secondary analysis. For the within-cluster variation component, we used only small (𝑐𝑣𝑤 
= 0.25) and medium (𝑐𝑣𝑤 = 0.50) levels of within-cluster variation.  
 
Table 5.4: Summary of parameter values used in the variation over time extension to the 
simulation study 
Parameter Values chosen 
Number of steps 
 
2, 12 
Number of clusters 
 
12, 24 
Cluster mean correlation 
 
0, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1.0 
Coefficient of variation of cluster sizes 
 
0.25, 0.5, 0.75, 1.0, 1.25, 1.5 




For each combination of variables, the number of simulations was maintained from that 
used for the earlier SW-CRT simulation study and the P-CRT simulation study, so that 4,000 
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 Summary of methods 5.2.5.8
The steps taken to estimate the RE are summarised in Box 5.3. 
Box 5.3: Outline of the steps taken to estimate the relative efficiency of a stepped-wedge 
cluster randomised trial with varying cluster size (between-cluster and within-cluster) 
compared to a stepped-wedge cluster randomised trial with equal cluster size. 
Background: Define the SW-CRT design  
 Define the design of the SW-CRT such as number of time-periods, number 
of clusters, number of steps, and the cluster mean correlation (i.e. select 
one of the scenarios from Table 5.4). 
Step 1: Simulate cluster-period sizes with no within-cluster variation in size 
 Simulate for each cluster, its cluster-period size, 𝑚𝑖𝑗 such that 𝑚𝑖𝑗 =
𝑚𝑖𝑗′  ∀ 𝑗, 𝑗′ using a gamma distribution, with mean 𝜇 and coefficient of 
variation, 𝑐𝑣. 
Step 2: Scale the cluster-period sizes 









  Calculate 𝜔 which is the ratio of the total sample size in an equal cluster 
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Box 5.3 continued… 
  Calculate for each cluster, the average cluster-period size 𝜔𝑚̅̅ ̅̅ ̅𝑖• as: 







Step 3: Simulate cluster-period sizes with within-cluster variation in size 
Simulate, for each cluster independently, a new cluster-period size (𝑚𝑖𝑗) 
using a Gamma distribution with mean 𝜔𝑚̅̅ ̅̅ ̅𝑖• and coefficient of variation 𝑐𝑣𝑤.  
Step 4: Apply a scaling factor 









 For cluster 𝑖, calculate 𝜔𝑖 which is the ratio of the total cluster size in a 
design with no within-cluster variation in size over time (𝑀𝑒𝑖) to the total 












 Scale the cluster-period sizes 𝑚𝑖𝑗, as 𝜔𝑖𝑚𝑖𝑗. 
Step 5: Estimate the precision 
 Calculate matrices Vi (i=1, ... , C) using 𝜔𝑖𝑚𝑖𝑗 from step (4) 
 Form matrix V using the block matrices Vi . 
 Calculate the precision using equation 5.2. 
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Box 5.3 continued… 
Step 6: Estimating the relative efficiency 
 Estimate the precision for a SW-CRT with equal cluster sizes with a total 
sample size 𝑆𝑒 = 𝜇 × 𝐶 × 𝑇 so that each cluster-period is size 𝜇. 
 Calculate the RE of the design as a ratio of the precision of the unequal 
cluster size design (from step 4) compared to the equal cluster size design 
(from step 5). 
Step 7: Compiling the efficiency estimates 
 Repeat steps (1) - (6) 4,000 times.  
 Collate the estimates of the RE to form the distribution (and average) 
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5.3 Results 
5.3.1 Relative efficiency plots used to display the results 
For each scenario described earlier (sections 5.2.3, 5.2.4, and 5.2.5), estimates of the 
precision were simulated with unequal cluster size and compared to the precision for an 
equivalent design with equal cluster size. The total sample size is identical in both the equal 
and unequal settings, to ensure that any differences are to the unequal cluster size 
structure. All results are presented as the relative efficiency (RE) of the unequal cluster size 
scenario compared to the equal cluster size scenario. These results provide an approximate 
upper bound for the RE of a given design. All estimates are plotted as efficiency curves, with 
RE plotted against the cluster mean correlation (denoted as R). For all efficiency plots, each 
value of R contains 4,000 estimates of the RE, so that each graph contains 44,000 
simulations.  
There are two types of graphs presented here. We firstly consider estimates of the mean 
and median values of the RE, calculated using the 4,000 simulated values. This allows us to 
consider how the design is affected, on average. Secondly, we consider the full distribution 
of the RE estimates, and present the quintiles of these estimates. 
On all graphs, a RE of 1 would indicate that the unequal cluster size scenario is equally 
efficient as the equal cluster size setting. This is indicated by the bold horizontal line on 
Figure 5.6. An estimate of the RE greater than 1 would indicate that the unequal cluster 
setting is more efficient than an equal cluster size design, and a RE less than one would 
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favour the equal cluster size setting. Essentially RE>1 indicates more precision in the unequal 
cluster size design, and RE<1 indicates more precision in the equal cluster size design. 
The mean and median are plotted on all graphs, with the mean of the RE presented as a 
black dotted line with circles representing the data points, whilst the median is presented as 
a red dashed line with a cross indicating the data points. In all scenarios, the data is skewed 
towards zero, and so the mean is always less than the median. Because of this skewness, we 
present both the mean and median in all plots. 
Figure 5.6: Explanation of mean and median efficiency curves  
 
 
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes compared 
to the precision in a SW-CRT with equal cluster sizes. R represents the cluster mean correlation. 
 
 
To highlight the full distribution of the precision, we present the full range of simulated 
estimates of the RE, in which different shadings are used to represent the quintiles of the 
data – see, for example Figure 5.7. The lightest shaded region represents the outside 40% of 
the RE estimates, signifying the 0 – 20% region (1st quintile) and the 80 – 100% region (5th 
quintile) of the RE values. The slightly darker region indicates the next 40% of the data, 
referring to the 20 – 40% region (2nd quintile) and the 60 – 80% region (4th quintile). The 
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darkest shaded area reflects the middle 20% of the RE values (3rd quintile). An example is 
given below in Figure 5.7. The mean and median values are presented alongside the shaded 
quintile regions. Again, a value of the RE greater than one would favour the unequal cluster 
size design, and a value of RE less than one would favour the equal cluster size design. In the 
design below, when R = 0, the RE varies from 0.4 to 1.3, highlighted by the edges of the 0% 
and 100% percentiles. This would indicate that at best, a SW-CRT with unequal cluster size 
may offer 30% more precision than a SW-CRT with equal cluster sizes. However, at worst, a 
SW-CRT with unequal cluster sizes may offer 60% less precision than a SW-CRT with equal 
cluster sizes. The middle 20% of the RE values are between 0.89 and 0.96.  
 
Figure 5.7: Explanation of quintiles on efficiency curves 
 
 
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes compared 




In this section, the key results are highlighted, and we present a selection of graphical 
illustrations to support these. Full results of the simulation study are provided via efficiency 
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curves showing the full range of the RE estimates, and can found in Appendix K, Appendix L, 
and Appendix M. 
 
5.3.2 Impact of varying cluster size on stepped-wedge cluster 
randomised trials 
In this section, we present the results highlighting the impact of within-cluster variability on 
the precision of a SW-CRT by comparing the precision in a SW-CRT with varying cluster size 
to the precision of a SW-CRT with equal cluster size as a RE. We present results of the 
average efficiency change and the distribution of efficiency. It is highlighted how changes to 
the number of steps, the number of clusters, and R may affect the efficiency of a SW-CRT 
with varying cluster size. 
 Average values of the relative efficiency 5.3.2.1
Firstly, only the mean and median values of the RE are presented. In all scenarios, both the 
mean and median RE estimates are never greater than 1 (Appendix K). This leads us to our 
first key finding, which is given in Box 5.4. 
 
Box 5.4: Key finding for SW-CRT in relation to the average efficiency loss when clusters 
vary in size 
 
The unequal cluster setting is, on average, less efficient than a setting with equal cluster size. 
This holds true for all designs, and so is irrespective of the number of steps, the number of 
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Figure 5.8 shows that for small 𝑐𝑣, the RE of the design is not heavily impacted by the cluster 
mean correlation – the average RE remains close to the reference line. For larger 𝑐𝑣 values, 
there is visibly more influence of R on the efficiency (Figure 5.9). Between R = 0 and R = 0.4, 
the average efficiency is decreasing. However, between R = 0.4 and R = 1, the average RE is 
increasing. The RE is at its lowest when R = 0.4, and at its highest when R = 1.  
 
Figure 5.8: Average efficiency vs R for a SW-
CRT with 12 clusters, 2 randomisation steps, 
and cv = 0.25 
Figure 5.9: Average efficiency vs R for a SW-
CRT with 12 clusters, 2 randomisation steps, 





Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes compared 
to the precision in a SW-CRT with equal cluster sizes. R represents the cluster mean correlation. 
 
This leads us to our next key point, which is given in Box 5.5.  
Box 5.5: Key finding of the cluster mean correlation on the average precision 
 
When the variability between cluster sizes is small, there is little loss in precision, for any 
value of the cluster mean correlation. When the variability between cluster sizes is large, the 
amount of precision lost is related to the cluster mean correlation. 
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For many scenarios, there is a large difference between the mean and median RE – which is 
highlighted further by the distribution plots which show a large negative skew. As such, 
when describing the average efficiency, we refer to the median RE.  
Our third key result is given in Box 5.6 and highlighted in Figure 5.10, which shows that as 𝑐𝑣 
increases, the average efficiency deviates further from the reference value of 1. Noticeably, 
whilst the general shape is similar for each R value, the rate of decay in the efficiency varies 
depending on the value of R. When considering the average efficiency, the design with R at 
its extreme values (R = 1 and R = 0) seems to lose the least amount of efficiency as the 𝑐𝑣 
increases, whilst R = 0.4 loses the most (Figure 5.10). This result is consistent regardless of 
the number of clusters or the number of randomisation steps. 
Box 5.6: Key finding of increasing between-cluster variability on the average precision 
 
The greater the cluster size variability, the smaller the average precision will be. 
 
Figure 5.10: Median efficiency vs coefficient of variation (cv) for a SW-CRT with 12 clusters 
and 12 randomisation steps 
 
 
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes compared 
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 Distribution of efficiency estimates 5.3.2.2
A full depiction of the efficiency of the SW-CRT comes when we consider the complete 
efficiency curves, which highlight the full distribution of the efficiency. That is, they display 
every estimate of the RE that is calculated for that particular scenario. The complete 
efficiency curves lead us to our next key finding – given in Box 5.7. The efficiency curves 
show that it is possible for the RE to be greater than 1. This would indicate the unequal 
cluster size setting being more efficient than a design with equal cluster size conditional on a 
particular randomisation order. That is, a SW-CRT with unequal cluster sizes can have a 
precision that is greater than in a SW-CRT with equal cluster sizes. 
 
Box 5.7: Key finding of the distribution of precision in a SW-CRT with unequal cluster size 
 
In a SW-CRT with varying cluster size, it is possible for the precision to be greater than in a 




Figure 5.11 shows that as 𝑐𝑣 increases, the amount of variability in RE increases, as well as 
the magnitude of the possible change in RE. In this scenario, even for small values of 𝑐𝑣, 
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Figure 5.11: Efficiency vs coefficient of variation (cv) for a SW-CRT with 12 clusters and 12 
randomisation steps and R = 0 
 
 
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes compared 
to the precision in a SW-CRT with equal cluster sizes. R represents the cluster mean correlation. 
 
When 𝑐𝑣 is small, there is little loss in the average efficiency, and little variation in the 
potential efficiency. That is, unequal cluster sizes has little impact on the precision when 𝑐𝑣 
is small. However, for large 𝑐𝑣, there is a loss in the average precision and a large variation in 
the potential efficiency. As such, we now present distribution curves separately for scenarios 
with small and large values of 𝑐𝑣. 
Small values of the coefficient of variation 
Figure 5.12 shows that for small 𝑐𝑣, the potential change in RE is quite small. The largest 
potential change in RE is at R = 0 (RE range: 0.9 - 1.1), and so the precision in an unequal 
cluster size may be between 10% lower or 10% higher than the precision of an equal cluster 
size scenario. The likelihood of an unequal cluster size scenario offering greater precision 
than the equal cluster size scenario is almost half.  
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As R increases, the potential change in RE decreases further, so that at R = 1, there is little 
deviation in RE from the reference value. That is to say the precision in the unequal cluster 
size scenario will be almost identical to the precision in an equal cluster size scenario. This 
leads to our next key finding (Box 5.8). 
 




Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
compared to the precision in a SW-CRT with equal cluster sizes. R represents the cluster mean 
correlation. 
 
Box 5.8: Impact of small cluster size variability on the precision 
 
If the variability in cluster sizes is small, then the potential loss or gain in precision in a SW-
CRT with varying cluster size compared to a SW-CRT with equal cluster size is very small. As 
such, varying cluster size is likely to have minimal impact on the power when the coefficient 
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Large values of the coefficient of variation 
Figure 5.13 shows that for large 𝑐𝑣, the RE is very variable. At R = 0, the RE varies between 
0.2 and 1.3 – indicating that the unequal cluster size scenario may increase the precision by 
30% compared to an equal cluster size scenario, or decrease the precision by 80%. This 
magnitude is much greater than for small 𝑐𝑣 (Figure 5.12). However, the likelihood of RE>1 is 
only 20%, which is much less than for small 𝑐𝑣 (Figure 5.12). 
As R increases, the upper RE value decreases, so that at R = 1, the upper RE value is just 
above 1 – which would indicate that at best, the unequal cluster size scenario will have 
slightly more precision than an equal cluster size scenario – though this increase would be 
tiny in magnitude. The lower RE value does not change much as R increases.  
For large 𝑐𝑣, the plots are less symmetrical – since the upper RE value decreases as R 
increases. However, the inner 60% of the RE values are relatively unaffected by changes to R.  
 
 
Figure 5.13: Efficiency vs R for a SW-CRT with 12 clusters, 12 randomisation steps, and cv 
= 1.5 
 
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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 Impact of increasing number of steps 5.3.2.3
The average RE is influenced by the number of randomisation steps. As the number of steps 
increases, the average RE decreases. That is, for a fixed total sample size, a SW-CRT with 2-
steps loses less precision when the clusters vary in size than a SW-CRT with any other 
amount of steps (Figure 5.14). Conversely, as the number of steps increases, the greater the 
potential increase in RE – which would indicate a greater increase in precision in the unequal 
cluster size scenario from the equal cluster size scenario.  
 
 
Figure 5.14: Median efficiency vs R for a SW-CRT with 12 clusters, and cv = 0.75 
 
 
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes compared 
to the precision in a SW-CRT with equal cluster sizes. R represents the cluster mean correlation. 
 
 
Figure 5.15 shows that for large 𝑐𝑣 when R = 0, increasing the number of steps can lead to 
greater RE values. With 2 steps, the maximum RE is approximately one, which would indicate 
the unequal cluster size scenario would have at best the same precision as an equal cluster 
size scenario. However, an unequal scenario with 12 steps could have 30% more precision 
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than an equal cluster size scenario with 12 steps. The potential loss in efficiency is relatively 
constant regardless of the number of steps – the unequal cluster size scenario may have only 
20% of the precision of an equal cluster size scenario. When the 𝑐𝑣 = 1.5, the likelihood of 
RE>1 is approximately 20%, regardless of the number of randomisation steps.  
 
Figure 5.15: Efficiency vs steps for a SW-CRT with 12 clusters, R = 0, and cv = 1.50 
 
 
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes compared 
to the precision in a SW-CRT with equal cluster sizes. R represents the cluster mean correlation. 
 
 
Comparing RE across R shows similar results. Figure 5.16 and Figure 5.13 show that an 
increase in the number of steps does not greatly change the lower 80% of the RE values, 
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Figure 5.16: Efficiency vs R for a SW-CRT 
with 12 clusters, 2 randomisation steps, and 
cv = 1.50 
 
Figure 5.13: Efficiency vs R for a SW-CRT 
with 12 clusters, 12 randomisation steps, 
and cv = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes compared 
to the precision in a SW-CRT with equal cluster sizes. R represents the cluster mean correlation. 
 
 
The most variability in RE is found in scenarios with a greater number of steps. However, the 
additional variability is due to the potential for the RE >1 – so whilst it is more variable, the 
unequal cluster size scenario may offer more precision than an equal cluster size scenario, 
with scenarios with a greater number of steps offering the largest increases in precision. 
This leads us to our next key result, given in Box 5.9. 
Box 5.9: Impact of the number of randomised steps on the precision 
 
The average relative efficiency is affected less in designs with fewer randomisation steps, i.e. 
designs with a greater number of steps will have a smaller average relative efficiency. 
Furthermore, increasing the number of randomisation steps increases the variability in the 
relative efficiency. Consequently, designs with a greater number of randomisation steps can 
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 Impact of increasing number of clusters 5.3.2.4
The impact of increasing the number of clusters is quite unambiguous – an increase in the 
number of clusters leads to a decrease in the variability of the RE estimates. That is, the 
distribution becomes narrower as more clusters are included – so that the potential gains or 
losses in precision are minimised (Figure 5.17). This is to be expected, as an increase in the 
number of clusters will lead to more clusters being randomised at each step, and so there is 
a lower likelihood of an imbalance between the number of participants contributing to the 
intervention and control conditions.  
Figure 5.17: Efficiency vs number of clusters for a SW-CRT with 12 randomisation steps, R = 
0 and cv = 1.5 
 
 
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes compared 
to the precision in a SW-CRT with equal cluster sizes. R represents the cluster mean correlation. 
 
 
Figure 5.13 and Figure 5.18 show the decrease in variability in the RE as the number of 
clusters increases – and the shift towards 1 for the average RE. This mostly comes from a 
shift towards 1 from the bottom 0-20% percentile. Generally, increasing the number of 
clusters has minimal impact on the top 80-100% quintile. When the 𝑐𝑣 is large, both the 12-
cluster and 96-cluster scenarios could offer a 20% increase in precision in the unequal cluster 
size scenario compared to an equal cluster size scenario. However, the 12-cluster unequal 
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cluster size scenario may lose 80% of the precision of the equal cluster size scenario, 
whereas the 96-cluster scenario only loses up to 25% of its precision.  
Figure 5.13: Efficiency vs R for a SW-CRT 
with 12 clusters, 12 randomisation steps, 
and cv = 1.5 
 
Figure 5.18: Efficiency vs R for a SW-CRT 
with 96 clusters, 12 randomisation steps, 
and cv = 1.50 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes compared 
to the precision in a SW-CRT with equal cluster sizes. R represents the cluster mean correlation. 
 
 
5.3.3 Impact of varying cluster size on parallel cluster randomised 
trials 
As a comparator, plots of the RE against R are also presented for the parallel design. Since 
there are no randomisation steps in a P-CRT, there are only 4 main scenarios – representing 
the RE of a study with 12, 24, 48, and 96 clusters.  
The average efficiency is less than 1 for all scenarios (Appendix L), indicating that a P-CRT 
with unequal cluster size is, on average, less efficient than a P-CRT with equal cluster size. As 
expected, if the variability in cluster sizes is small, there is little efficiency loss. As the 
variability in cluster sizes increases, there is a much greater degree of efficiency loss. 
Noticeably, the results show that the common assumption of the RE for a P-CRT being a 
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single value may not be appropriate – and the RE can vary in a P-CRT and is dependent on 
the randomisation of the clusters. This leads us to our next key finding (Box 5.10). For all 
scenarios, the efficiency curves show that the RE is bounded by 1 (Appendix L). 
Box 5.10: Key finding for the relative efficiency in a P-CRT 
 
The precision (and hence the relative efficiency) is not a single value in a P-CRT with unequal 
cluster sizes. Instead the precision can be viewed as a distribution, which is influenced by the 
randomisation order of the clusters. 
 
 
The efficiency curves also corroborate that there is little efficiency loss in a P-CRT when 𝑐𝑣 is 
small. For example, Figure 5.19 shows that 𝑐𝑣 = 0.25, there is little variation in the 
distribution of the RE. The most variability is at R = 0, with RE between 0.9 and 1.0. This 
corresponds to a 10% decrease in precision in the unequal cluster size scenario compared to 
the equal cluster size scenario. As R increases, we see a slight decrease in the variability of 
the RE. At R = 1, there is almost no variation in RE, so the unequal cluster size scenario will 
almost always have the same precision as an equal cluster size scenario. 
Figure 5.19: Efficiency vs R for a P- CRT with 12 clusters, and cv = 0.25 
 
 
Efficiency is calculated as the ratio of the precision in a P-CRT with unequal cluster sizes compared 
to the precision in a P-CRT with equal cluster sizes. R represents the cluster mean correlation. 
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An increase to the 𝑐𝑣 can create a large variability in the potential RE in a P-CRT. Figure 5.20 
shows that for 𝑐𝑣 = 1.5 there is huge variability in the possible RE values. At R = 0, the RE 
varies between 0.1 and 1.0, which would indicate that a P-CRT with unequal cluster size may 
only have 10% of the precision of a P-CRT with equal cluster size.  
As R increases, the middle 60% of the RE values generally follow the same parabolic 
trajectory as the median RE – and are most variable at R = 0 and least variable at R = 1. 
However, the upper and lower values remain generally unaffected by R, and remain hugely 
variable.   
Figure 5.20: Efficiency vs R for a P-CRT with 12 clusters, and cv = 1.5 
 
 
Efficiency is calculated as the ratio of the precision in a P-CRT with unequal cluster sizes compared 
to the precision in a P-CRT with equal cluster sizes. R represents the cluster mean correlation. 
 
 Impact of increasing the number of clusters 5.3.3.1
Figure 5.21 shows that increasing the number of clusters in the P-CRT does not influence the 
median RE. The RE generally follows the same parabolic trajectory regardless of the number 
of clusters, apart from at R = 0 – in which the RE increases in scenarios with more clusters.  
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Figure 5.21: Median efficiency vs R for a P-CRT with cv = 1.5 
 
 
Efficiency is calculated as the ratio of the precision in a P-CRT with unequal cluster sizes compared to 
the precision in a P-CRT with equal cluster sizes. R represents the cluster mean correlation. 
 
 
Figure 5.20 and Figure 5.22 show that increasing the number of clusters leads to a decrease 
in the variability of RE. At R = 0, scenarios with 12 clusters and 𝑐𝑣 = 1.50 may have lose 90% 
of the precision of an equal cluster size scenario – this is in contrast to the 96 cluster 
scenario in which the precision may decrease by approximately 20%. The middle 60% of RE 
values becomes much narrower as the number of clusters increases. 
Figure 5.20: Efficiency vs R for a P-CRT with 
12 clusters, and cv = 1.5 
 
Figure 5.22: Efficiency vs R for a P-CRT with 
96 clusters, and cv = 1.5 
  
Efficiency is calculated as the ratio of the precision in a P-CRT with unequal cluster sizes compared to 
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5.3.4 Comparison of P-CRTs and SW-CRTs 
In this section we compare the RE of a SW-CRT to the RE of a P-CRT. In this section, the RE of 
a SW-CRT will refer to a SW-CRT with unequal cluster size compared to a SW-CRT with equal 
cluster size, and the RE of a P-CRT will refer to a P-CRT with unequal cluster size compared to 
a P-CRT with equal cluster size. 
 Comparison of the average relative efficiency  5.3.4.1
The median RE estimates are greater in the SW-CRT than in the P-CRT for most values of R. 
However, when R is close to its extreme values (R = 0 and R = 1), the P-CRT has greater RE. 
This is particularly evident in cases with large values of the 𝑐𝑣. These results are consistent 
for designs with a small number of steps (Figure 5.23) and designs with a greater number of 
steps (Figure 5.24). Essentially, this indicates that, on average, the SW-CRT is more efficient 
than the P-CRT. 
Figure 5.23: Comparison of average 
efficiency of a 24 cluster CRT under a 
stepped-wedge design (2 steps) and a 
parallel design with cv = 1.5 
 
Figure 5.24: Comparison of average 
efficiency of a 24 cluster CRT under a 
stepped-wedge design (12 steps) and a 
parallel design with cv = 1.5 
  
Efficiency is calculated as the ratio of the precision in a CRT with unequal cluster sizes compared to 
the precision in a CRT with equal cluster sizes. R represents the cluster mean correlation. 
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 Comparison of the distribution of relative efficiency 5.3.4.2
When considering the full distribution of RE estimates, there is a noticeable difference 
between the P-CRT and the SW-CRT. There were many instances in the SW-CRT when 
unequal cluster size presented a design more precision than one with equal cluster size (i.e. 
RE>1) (Appendix K). However, in the P-CRT, there is no circumstances in which the RE > 1 
(Appendix L), and so an unequal cluster size scenario can never offer more precision than an 
equal cluster size scenario. Figure 5.13 and Figure 5.20 show that at R = 0, the SW-CRT RE 
can lie between 0.2 and 1.3, whereas the P-CRT lies between 0.1 and 1.0 – indicating that 
the SW-CRT can lose 80% of the precision of an equal cluster size scenario but the P-CRT 
could lose 90%. However, the SW-CRT could have 30% more precision than an equal cluster 
size scenario, whereas the P-CRT cannot increase in precision. As R increases, the variability 
in the SW-CRT RE decreases, whereas the variability in the P-CRT RE only decreases at R = 1. 
The middle 60% of RE values is narrower in the P-CRT than the SW-CRT, which emphasises 
that the P-CRT RE is less variable than the SW-CRT RE. 
Figure 5.13: Efficiency vs R for a SW-CRT 
with 12 clusters, 12 randomisation steps, 
and cv = 1.5 
 
Figure 5.20: Efficiency vs R for a P-CRT with 
12 clusters, and cv = 1.5 
  
Efficiency is calculated as the ratio of the precision in a CRT with unequal cluster sizes compared to 
the precision in a CRT with equal cluster sizes. R represents the cluster mean correlation. 
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The RE estimates are more widely distributed for a SW-CRT than a P-CRT, principally when 
the number of steps is greater than 2. This includes the range of RE estimates and the 
quintiles. This leads to the key result for the impact of varying cluster size in the SW-CRT 
compared to the P-CRT, which is given in Box 5.11. 
Box 5.11: Key finding of the impact of varying cluster size in a stepped-wedge cluster 
randomised trial compared to a parallel cluster randomised trial. 
On average, a SW-CRT is affected less by varying cluster size than a P-CRT. Potentially, a SW-
CRT can offer a more efficient design with unequal cluster sizes than equal cluster sizes, 
which is impossible in a P-CRT. However, there is a greater degree of variability in the 
possible RE of the SW-CRT.  
  
 Comparison when increasing the number of clusters 5.3.4.3
When increasing the number of clusters in the P-CRT the median RE is not influenced. This is 
in stark contrast to the SW-CRT in which the RE increases as more clusters are included. The 
full distribution of RE values becomes much narrower in both the SW-CRT and P-CRT when 
more clusters are included in the study. 
 
5.3.5 Impact of within-cluster variation in size over time 
In this section, we compare the precision of a design with between-cluster variation and 
within-cluster variation to a design with equal cluster size – with a fixed total sample size in 
both designs – as a RE. The added 𝑐𝑣𝑤 component reflects additional variation in this section 
than in section 5.3.2, and remarks will be made to compare to the 𝑐𝑣𝑤 = 0 scenario (i.e. no 
within-cluster variation). Results presented consider both small (𝑐𝑣𝑤= 0.25) and medium 
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(𝑐𝑣𝑤 = 0.50) values of 𝑐𝑣𝑤. Estimates of the RE were also calculated, assuming that 𝑐𝑣𝑤 =
𝑐𝑣, but the results were hugely variable, and showed levels of variance in cluster sizes 
unlikely to be seen in practice. Efficiency curve plots of 𝑐𝑣𝑤 = 𝑐𝑣 can be found in Appendix 
M. 
The results still consider how the efficiency is affected by increases to the between-cluster 
variation, which is still referred to as 𝑐𝑣 and should not be confused with the within-cluster 
variation, denoted as 𝑐𝑣𝑤. 
In all scenarios, the median RE is never greater than 1 (Appendix M), and so the unequal 
design is, on average, less efficient than a design with equal sized clusters. When considering 
the full distribution of the RE, it can be noted that the RE can be greater than 1 for all 
designs that were considered, indicating that unequal cluster size can offer more precision 
than an equal cluster size design (Appendix M).  
The inclusion of within-cluster variability leads to a greater variability in the potential RE. The 
degree of impact is influenced by the number of randomisation steps, and so the results are 
presented separately for designs with few steps and designs with a large number of steps.  
 Small number of steps 5.3.5.1
For design with few randomisation steps, when the between-cluster variation (𝑐𝑣) is small, 
there is little loss in the average efficiency as the within-cluster (𝑐𝑣𝑤) increases. That is, 
when comparing to a scenario with equal cluster size, the median precision lost in the 𝑐𝑣𝑤 = 
0 scenario and the median precision lost in the 𝑐𝑣𝑤 = 0.50 scenario is relatively negligible. As 
the between-cluster variation increases, there is a large disparity between the median RE for 
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the 𝑐𝑣𝑤 = 0, 0.25, and 0.50 scenarios. The loss in RE between the 𝑐𝑣𝑤 = 0 and 𝑐𝑣𝑤 = 0.25 
scenarios remains relatively constant across R.  
The full distribution of RE estimates is influenced by the within-cluster variation. In a design 
with small between-cluster variation in size and no within-cluster variation in size (Figure 
5.25), there is little variability in the RE. However, in a design with small between-cluster 
variation in size and a large within-cluster variation in size (Figure 5.26), there is large 
variability in RE. This result is consistent for all R values.  
Figure 5.25: Efficiency vs R for a SW-CRT 
with 12 clusters, 2 randomisation steps, and 
cv = 0.25 (no within-cluster variation) 
 
Figure 5.26: Efficiency vs R for a SW-CRT 
with 12 clusters, 2 randomisation steps, cv = 
0.25, and cvw = 0.50 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes compared 
to the precision in a SW-CRT with equal cluster sizes. R represents the cluster mean correlation. 
 
As the between-cluster variability increases, the within-cluster variability can still add a large 
degree of variability to the RE. Noticeably, Figure 5.16 and Figure 5.27 show that for 
scenarios with large 𝑐𝑣, the inclusion of within-cluster variability allows the RE>1, which 
does not occur when 𝑐𝑣𝑤  = 0. That is to say, it is possible to have more efficient designs 
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when 𝑐𝑣𝑤 > 0 than scenarios with 𝑐𝑣𝑤 = 0. However, the lower RE values remain the same 
regardless of the 𝑐𝑣𝑤 value.  
Figure 5.16: Efficiency vs R for a SW-CRT 
with 12 clusters, 2 randomisation steps, and 
cv = 1.50 (no within-cluster variation) 
 
Figure 5.27: Efficiency vs R for a SW-CRT 
with 12 clusters, 2 randomisation steps, cv = 
1.50 and cvw = 0.50 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes compared 
to the precision in a SW-CRT with equal cluster sizes. R represents the cluster mean correlation. 
 
 Large number of steps 5.3.5.2
In designs with a large number of randomisation steps, an increase to the within-cluster 
variation (𝑐𝑣𝑤) has minimal effect on the average RE regardless of the degree of between-
cluster variability (𝑐𝑣). That is, when comparing to a scenario with equal cluster size, the 
average precision lost in the 𝑐𝑣𝑤 = 0 scenario and the median precision lost in the 𝑐𝑣𝑤 = 0.5 
scenario is relatively negligible. 
The full distribution of RE is also not greatly impacted by changes to the RE as 𝑐𝑣𝑤 increases, 
irrespective of the amount of between-cluster variation in size. Figure 5.12 and Figure 5.28 
shows that the within-cluster variation has little impact when 𝑐𝑣 is small, with the RE for 
scenarios with 𝑐𝑣𝑤 = 0 ranging between 0.9 and 1.1, whilst scenarios with 𝑐𝑣𝑤 = 0.5 ranging 
between 0.8 and 1.2. Noticeably, as R increases, the RE quintiles remains relatively constant 
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for 𝑐𝑣𝑤 = 0.5, whereas the RE tends to 1 for all quintiles when 𝑐𝑣𝑤 = 0. As such, when R is 
close to 1, the precision in an unequal cluster size scenario, with 𝑐𝑣𝑤  = 0, will be very similar 
to the precision in an equal cluster size scenario, whereas if 𝑐𝑣𝑤  = 0.5, the precision may be 
20% higher or lower than the precision in an equal cluster size scenario. 
Figure 5.12: Efficiency vs R for a SW-CRT 
with 12 clusters, 12 randomisation steps, 
and cv = 0.25 (no within-cluster variation) 
 
Figure 5.28: Efficiency vs R for a SW-CRT 
with 12 clusters, 12 randomisation steps, cv 
= 0.25, and cvw = 0.50 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes compared 
to the precision in a SW-CRT with equal cluster sizes. R represents the cluster mean correlation. 
 
Figure 5.13 and Figure 5.29 show that for large 𝑐𝑣, the inclusion of within-cluster variation 
does not greatly influence the distribution of RE. At R = 0, the variability in RE is almost 
identical for 𝑐𝑣𝑤 = 0 and 𝑐𝑣𝑤  = 0.5 – varying between 0.2 and 1.3. The only noticeable 
differences in the RE distribution is at R = 1, in which scenarios with within-cluster variation 
can obtain RE>1 – that is to say, at R=1, it is possible for an unequal cluster size scenario 
(with within-cluster variation) to have more precision than an SW-CRT with equal cluster 
size, whereas it is not possible for an unequal cluster size scenario with 𝑐𝑣𝑤 = 0 to obtain 
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Figure 5.13: Efficiency vs R for a SW-CRT 
with 12 clusters, 12 randomisation steps, 
and cv = 1.5 (no within-cluster variation) 
 
Figure 5.29: Efficiency vs R for a SW-CRT 
with 12 clusters, 12 randomisation steps, cv 
= 1.50 and cvw = 0.50 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes compared 
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5.4 Discussion 
In this chapter, we have examined the impact of cluster size variability on SW-CRTs by 
comparing a SW-CRT with unequal cluster size to a SW-CRT with equal cluster size. The 
methodology used centres upon the fitting of a mixed-effect model to a continuous 
outcome, and so the results may only be applicable in this setting. A simulation study was 
used to establish the influence of the cluster mean correlation, the number of clusters, and 
the number of randomisation steps. The results show that it is possible for a SW-CRT with 
varying cluster size to have only 20% of the efficiency of a SW-CRT with equal cluster size. 
That is to say, on average, a trial that is powered using methodology that assumes equal 
cluster size when the cluster sizes are not equal may have an underpowered trial.  
We have shown that the average efficiency loss in a SW-CRT with varying cluster size 
compared to a SW-CRT with equal cluster size may not be large on average, but the variation 
in the RE is large, and so the actual efficiency loss is conditional on the randomisation order 
of the clusters. Noticeably, we found that it is possible for a SW-CRT with unequal cluster 
size to offer greater precision than a SW-CRT with equal cluster size. Since it is typically 
assumed that the RE of a P-CRT with varying cluster size compared to a P-CRT with equal 
cluster size is a single value (62) – based on the assumption of an equal number of 
observations in the control and intervention period – we utilised the same methodology as 
for a SW-CRT to highlight the effect of varying cluster size in a P-CRT. It was shown here that 
the RE may actually be a distribution of values. A P-CRT with unequal cluster size can never 
offer more precision than a P-CRT with equal cluster size. When comparing the results from 
the SW-CRT to the P-CRT, the median RE is greater in the SW-CRT than in the P-CRT for most 
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values of the cluster mean correlation. This indicates that on average, the SW-CRT loses less 
efficiency than the P-CRT when the clusters vary in size. However, the variability of the RE is 
greater in the SW-CRT than the P-CRT, with the SW-CRT able to offer extremely efficient and 
extremely inefficient designs. Even if a equal cluster size design would be sufficiently 
powered, the volatility of the RE of a SW-CRT with large 𝑐𝑣 makes it difficult to give a high 
degree of certainty that a study will be sufficiently powered for all possible randomisation 
permutations.     
Within CRTs, there are often settings in which there is variation in the size of the clusters 
(57). This may be to variation in actual size of the centre (such as hospital or school), or due 
to drop-out and non-response. In P-CRTs, equal cluster size optimises the estimation of 
variables and variance components. Previous research has considered the loss in efficiency 
when considering varying cluster size in P-CRTs compared to the equal sized cluster case 
(62). This has led to some simple approximations for the RE to consider the impact of cluster 
size variation (60).  
SW-CRTs are an increasingly used type of CRT, but one in which there is much less research 
than the traditional parallel design. As such, there is little or no research that considers the 
impact of varying cluster size in SW-CRTs, with previous methodological paper highlighting 
this flaw (45). In this chapter, existing methodology that allows the estimation of the 
precision of a treatment effect estimate for a SW-CRT is considered. It is shown how 
simulations can allow this methodology to be extended to examine the effects of varying 
cluster size. We introduce the idea of a between-cluster variation in cluster size and a within-
cluster variation in cluster size. In a trial, the between-cluster variation is likely to be larger, 
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and so will have most impact on the RE of a design. A simulation study allowed varying 
degrees of cluster size variation to be considered on a variety of designs. 
In pre-trial sample size calculations and post-trial analysis, it is recommended that trialists 
report whether the clusters are expected to vary in size (70). Often, trials may be sufficiently 
powered for a design with no cluster size variability, whereas the actual cluster sizes may 
vary, and the study may be underpowered. The large amount of variability in RE also means 
that adjusting for the average loss in efficiency still may not create a study with sufficient 
power, as the randomisation of clusters may leave the study with a lower power. The post-
trial reporting of cluster sizes in published SW-CRTs – which is underreported (see Chapter 3) 
– would allow the conduction of a post-trial power calculation to assess a study’s true power 
(150). 
Although the methods and results described here have been for continuous outcomes, the 
methods can be used as an approximation for binary outcomes. As such, similar results are 
likely for binary outcomes. However, the approach is conditional on the number of 
observations being sufficiently large so that a Normal approximation can be used. 
Furthermore, the approximation is likely to be appropriate only when the time and 
intervention effects are small – since large effects would lead to greater differences in the 
prevalence and would violate the assumption of constant variance. 
This chapter has assumed the fitting of a generalised linear mixed model (GLMM). An 
alternative method would have been to use generalised estimating equations (GEE) (31). 
GEE models are more robust for any misspecification in the variance structure (90) – which 
may be important given the continuing research into the most appropriate variance 
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structure in a SW-CRT. However, GEEs require a large number of clusters to fit correctly. 
Recent systematic reviews have shown that many SW-CRTs have few clusters (31). 
Therefore, GEE models may not always be appropriate to fit. 
5.4.1 Loss of precision in SW-CRTs when clusters vary in size 
Little research has previously been presented on the inclusion of varying cluster size in a SW-
CRT, and so there is little evidence of potential variations in the precision based upon the 
randomisation of clusters. We have shown here that the RE is much more variable in a SW-
CRT than a P-CRT – and so a SW-CRT can be greater affected by varying cluster size than a P-
CRT. Notably, there were many scenarios in which a SW-CRT with unequal cluster size could 
offer more precision than a SW-CRT with equal cluster size. Conversely, P-CRTs can never 
obtain a greater precision in an unequal cluster size setting than the equal cluster size 
setting, and so the RE can never exceed 1 in a P-CRT. 
When the between-cluster variation in cluster sizes is small, there is little efficiency lost in a 
SW-CRT with unequal cluster size compared to a SW-CRT with equal cluster size, and there is 
little variation in the potential efficiency change. As the amount of variability in cluster sizes 
increases, there in more efficiency lost on average, and so the unequal design is, on average, 
more inefficient. However, an increase to the between-cluster variability can also lead to 
designs that offer much greater precision when the cluster sizes vary than designs with equal 
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 Impact of the SW-CRT design features on the efficiency loss 5.4.1.1
There has been much research on the impact of the SW-CRT design features (number of 
steps, clusters, etc.) on the power of a SW-CRT – but no evidence on how they may impact a 
SW-CRT when clusters vary in size. It was shown here that the efficiency lost in a SW-CRT 
with unequal cluster size compared to a SW-CRT with equal cluster size is affected by the 
number of steps. On average, a greater the number of steps leads to a greater decrease in 
the RE. However, a greater number of steps can offer greater potential increases in RE, and 
so offer greater increases in precision than a SW-CRT with equal sized clusters. As expected, 
an increase in the number of clusters led to a decrease in the variability of the potential 
efficiency change. That is, the range of potential values of the precision is narrower as more 
clusters are included in the study.  
The cluster mean correlation (R) – a function of the cluster size, and the ICC – has previously 
been shown to be pivotal in deciding which of the SW-CRT and the P-CRT has greater 
precision, and power, for any given design (61). Whilst here, we were not showing which 
design was most favourable, in terms of precision, R has been shown to also influence the 
median RE of both designs when the clusters vary in size. For values of R close to its extreme 
(0 and 1), the P-CRT may be the most efficient design. However, for the majority values of R, 
the SW-CRT is, on average, more efficient. As such the SW-CRT is, on average, less affected 
by varying cluster size. The value of R also heavily impacts the distribution of the RE. For all 
scenarios, the most variation in RE was at R = 0, regardless of the degree of variability 
between-clusters and within-clusters. Furthermore, the least variability tended to be at R = 
1. For SW-CRTs, the likelihood of a design producing a RE > 1 was influenced by R, with R = 0 
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offering the greatest probability and prospective RE value. That is, the precision in an 
unequal cluster size scenario could be much more than the precision in an equal cluster size 
scenario when R = 0.  
5.4.2 Within-cluster variation in size over time 
P-CRTs only have between-cluster variation in cluster sizes. In this chapter, we have shown 
that in SW-CRTs, there are two types of cluster size variation – between-cluster and within-
cluster. The inclusion of time is crucial in the design and analysis of SW-CRTs, but the impact 
of time on the size of each cluster has not previously been considered. The design of SW-
CRTs is usually conducted under the assumptions of all clusters being equal in size, and each 
cluster remaining a fixed size over time. This is the first instance in which two types of cluster 
size variation have been considered, and the additional variation component leads to an 
increased range of potential RE values, even for small amounts of within-cluster, and 
between-cluster variations. The inclusion of within-cluster variation leads to possible 
increases in RE for all scenarios – regardless of the number of steps. That is, it is possible for 
studies with unequal cluster size to offer more precision than an equal cluster size scenario.  
Previously, only between-cluster variation in size had been considered important when 
conducted power calculations. As such, there are many examples of expected values of 𝑐𝑣 to 
describe the between-cluster variation – such as 𝑐𝑣 = 0.65 for UK general practices (57). 
Since within-cluster variation has not previously been considered, it is unknown what the 
likely values of 𝑐𝑣𝑤 would be. However, it is likely that the within-cluster variation in size will 
be much smaller than the between-cluster variation. Whilst in this research, values of 0.25 
and 0.50 were chosen for 𝑐𝑣𝑤, it may be that in practice, smaller values are necessary. 
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5.4.3 Unequal sized clusters in P-CRTs 
In P-CRTs, typically a singular RE value is used (60) – under the assumptions that the 
intervention and control arms are balanced in terms of number of observations – and small 
𝑐𝑣 values only minimally impact the power (57, 150), with no adjustment needed if 𝑐𝑣 < 0.23 
(57). If 𝑐𝑣 ≤ 1, then the median RE in a P-CRT may be between 0.8 and 0.9 (62) – which is 
also shown in this chapter. However, when considering the distribution of RE values, it is 
possible to have RE close to 0.1 in extreme scenarios. That is to say, it is possible for a P-CRT 
with varying cluster size to have only 10% of the precision of a P-CRT with equal cluster size. 
This may be due to the imbalance of observations in the intervention and control arms, and 
so may be motivation for an advancement on simple randomisation (i.e. cluster sizes should 
be used in a balancing algorithm). However, there is no evidence of earlier work considering 
the variability of RE in P-CRTs and the necessity to use cluster sizes as part of a balancing 
algorithm. For P-CRTs, ignoring varying cluster sizes could leave a trial seriously 
underpowered, depending on the randomisation of clusters.  
P-CRTs with few clusters and with small values of the cluster mean correlation were most 
affected by varying cluster size. This result has previously been reported for P-CRTs for 
designs with few clusters and small values of the ICC (150).  
5.4.4 Future research 
Previous research in P-CRTs has shown that it is always most efficient to have a design with 
equal cluster size. In SW-CRTs, there is the possibility of increases in the precision for designs 
with unequal cluster size. This therefore offers a potential route for further research, with 
the aim of investigating designs that offer the greatest RE under specific constraints. This can 
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be extended to consider which designs would minimise losses in RE. This could potentially 
lead to suggestions in how the randomisation process should be done in SW-CRTs with 
varying cluster size. For example, it may be necessary to match clusters based on estimated 
cluster size in order to prevent the possibility of a large efficiency loss. As part of this, the 
use of optimal designs could be considered. Whilst there has been research into optimal 
designs for cluster trials with equal cluster size (61), there is potential for optimal designs of 
stepped cluster studies with unequal cluster size. If a study has a small number of large sized 
clusters, then it may be necessary to randomise large sized clusters separately to smaller 
sized clusters to ensure a balance of participants in the intervention/control arms and 
prevent a loss in efficiency.   
Although the approach described is for continuous outcomes, it may be used as an 
approximation for binary outcomes. However, the approach is conditional on the number of 
observations being sufficiently large so that a Normal approximation can be used. 
Furthermore, the approximation is likely to be appropriate only when the time and 
intervention effects are small – since large effects would lead to greater differences in the 
prevalence and would violate the assumption of constant variance. Further research is 
necessary to consider the applicability of this work in studies with dichotomous outcomes. 
A key limitation of this work is that model chosen includes only a random effect for cluster. 
The previous chapter has illustrated that a more complex correlation structure may be 
necessary. However, even the model discussed in Chapter 4 may not be an adequate 
representation of the correlation structure in a SW-CRT and could be improved. In this 
model, the correlation between observations in the same cluster but at different time-
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periods is a fixed value (the inter-period correlation), and is independent of the duration of 
the time between the observations. Recent research has suggested using a more complex 
correlation structure that allows for the correlation between observations to become 
smaller as the length of time between the observations increases (151). In this framework, 
the correlation within a cluster exhibits an exponential decay. An alternative option would 
be to consider time as continuous (151). Under this approach, patients that have 
observations one week apart would have higher correlation than patients whose 
observations are one month apart which would be greater than those one year apart. 
However, a correct specification of the time component may be difficult in the design stage 
of a trial. Nevertheless, the Hussey and Hughes model is the most complex tractable model 
that we know, and so it is important to establish the impact of varying cluster size within this 
framework, before considering an extended framework. Further work may be necessary to 
establish the most appropriate correlation structure for SW-CRTs before being combined 
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5.5 Conclusion 
There is an abundance of research into the effects of varying cluster size in P-CRTs, and it is 
has been established that small degrees of variation in cluster sizes leads to little impact on 
the design (57). However, there is a dearth of literature surrounding the impact of varying 
cluster size in a SW-CRT – which this research aimed to address. Three simulation studies 
were presented to investigate the impact of between-cluster variability in a SW-CRT, and in a 
P-CRT, and to assess the impact of within-cluster variability over time in a SW-CRT. For this 
cluster-period sizes were simulated for to form a CRT with unequal cluster sizes, and this was 
comparted to a CRT with equal cluster sizes. 
The key result of this chapter is that the precision of a CRT with varying cluster size is actually 
a distribution of possible values, which are influenced by the randomisation of clusters. This 
allows the precision of a CRT with unequal cluster sizes to be much greater or much less than 
a CRT with equal sized clusters. Whilst the key findings have been reported in the results 
section, a summary of them is presented in Box 5.12. The next chapter aims to implement 
the methods presented in this chapter in a practical setting, by creating a Stata function to 
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Box 5.12: Key findings from simulation study on the impact of varying cluster size in a SW-
CRT and a P-CRT 
 
 The precision (and hence the power) is not a single value in a CRT with unequal cluster 
sizes. Instead the precision can be viewed as a distribution, which is influenced by the 
randomisation order of the clusters. 
 A CRT with unequal cluster sizes will, on average, have less precision than a CRT with 
equal sized clusters, regardless of the study design. 
 On average, a SW-CRT is affected less by varying cluster size than a P-CRT.  
 Potentially, a SW-CRT can offer a more efficient design with unequal cluster sizes than 
equal cluster sizes, which is impossible in a P-CRT.  
 There is a greater degree of variability in the possible precision of a SW-CRT with 
unequal cluster sizes than in a P-CRT. 
 The greater the cluster size variability, the smaller the average precision will be. 
 The greater the cluster size variability, the larger the variation in the possible 
precision  
 With little between-cluster variability in size, the potential loss or gain in precision in a 
SW-CRT with varying cluster size compared to a SW-CRT with equal cluster size is very 
small, and so only minimally impacts the precision. 
 The variability in the efficiency shows that the precision and power in a CRT is 
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CHAPTER 6:      A STATA FUNCTION TO 
ESTIMATE POWER IN STEPPED-WEDGE 
CLUSTER RANDOMISED TRIALS WITH 
VARYING CLUSTER SIZE 
6.1 Introduction 
6.1.1 Background 
The central focus of most research into cluster randomised trials (CRTs) is the assessment of 
power (52, 57, 74, 145-147) – which is defined as the probability of detecting a treatment 
effect, when a difference between the arms exists. The power in a CRT is influenced by the 
correlation between observations within a cluster (55) and by the cluster sizes and their 
variability (58). In the previous chapter, we showed that a stepped-wedge CRT (SW-CRT) 
with unequal cluster size will have less precision (and therefore power), on average, than a 
SW-CRT with equal cluster sizes. When using current statistical packages, the power 
calculation for a SW-CRT with varying cluster size would require the assumption of equal 
cluster sizes (63) or acknowledging varying cluster size through a design effect only 
appropriate for parallel CRTs (P-CRTs) (152). Current DEs to estimate sample size for a fixed 
power in a SW-CRT (21, 26) are only appropriate if the clusters are of equal size. Since 
unequal cluster sizes may decrease the power in a SW-CRT, power calculations should 
account for varying cluster size. 
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6.1.2 Chapter aim 
This chapter aims to implement the methods described in Chapter 5 in a Stata function – 
that will allow the power to be estimated in a SW-CRT with varying cluster size. To this end, 
we seek to:  
1. Show how the power can be estimated in a SW-CRT with known cluster size, for a 
given randomisation order and for all possible randomisation orders. 
2. Illustrate a Stata function that can estimate the power for a SW-CRT with equal or 
varying cluster size. 
3. Demonstrate how the Stata function works through a selection of examples. 
 
In this chapter, we reiterate the methods used to estimate the power in a SW-CRT with 
varying cluster size using the framework proposed in Chapter 5, which is appropriate for 
continuous outcomes. We then illustrate how this methodology can be implemented in 
practice, through a Stata function. The Stata function can estimate the power in a SW-CRT 
with unequal clusters sizes – including both known and unknown cluster sizes – which we 
highlight through a number of examples. The reporting of power includes both the average 
power and a measure of dispersion (inter-quartile range and range) where appropriate. For 
SW-CRTs with known cluster size, the power can be estimated for all randomisation orders, 
or one particular order.   
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6.2 Statistical Methods 
In the previous chapter, we presented a method to estimate the precision in a SW-CRT with 
varying cluster by simulating potential cluster-period sizes. As such, we do not repeat all of 
the methods here, but some will be reiterated for clarity. We begin with the analytical model 
used for a SW-CRT. 
 
6.2.1 Analytical model used to analyse SW-CRTs 
As highlighted in the previous chapter (section 5.2.1), the analysis of a SW-CRT typically 
involves the fitting of a generalised linear mixed model, as proposed by Hussey and Hughes 
(32), of the form:  
𝑌𝑖𝑗𝑘 = 𝜇 + 𝛽𝑗 + 𝑋𝑖𝑗𝛿 + 𝛼𝑖 +  𝑖𝑗𝑘 6.1 
 
Where, 𝑌𝑖𝑗𝑘 is the outcome for patient k in cluster i at time j, µ is the mean outcome in the 
unexposed period in the first time-period, 𝛽𝑗 is a fixed time effect for each time-period j = 
2,…, T (𝛽1 = 0 for identifiability), δ is the treatment effect, 𝛼𝑖 is a random effect for cluster i, 




      
if cluster i is exposed to the intervention at time j
if cluster i is not exposed to the intervention at time j
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When following the above model (6.1), the power of a SW-CRT to detect a specified 
difference (δ) can be estimated using the design matrix (Z) and the variance-covariance 




) − 𝑍1−𝛼 2⁄ ) 
6.2 
Where 𝜙 is the cumulative standard Normal distribution, [1,1] refers to the entry in the first 
column and first row, and 𝑍1−𝛼 2⁄  is the (1 − 𝛼 2⁄ )
𝑡ℎ quantile of the standard Normal 
distribution function.  
 
6.2.2 Estimating power in a SW-CRT with varying cluster sizes 
In the design stage of a SW-CRT, the cluster sizes are either known or unknown – with 
existing methods for estimating the power able to handle either. Below, we use an example 
to illustrate the steps taken to estimate the power in a SW-CRT, which is conditional on 
whether the cluster sizes are known or unknown. 
 Varying cluster size with known cluster sizes 6.2.2.1
In this section, we show how the power can be estimated in a SW-CRT with known cluster 
sizes. Firstly, consider a cross-sectional SW-CRT in which there are 4 clusters, randomised 
over 4 steps, with one period for baseline measurements – resulting in 5 time-periods in 
which measurements are made. The primary outcome is BMI z-score, for which the mean in 
the unexposed period is 1.5 (SD = 1). A clinically important difference is determined as a 
lowering of BMI z-score of 0.25, and the ICC is 0.05.  
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We wish to estimate the power given that the cluster-period size (size of cluster at one time-
period) for the four clusters A, B, C, and D are: 
 










We are assuming that the clusters remain the same size at each time-period, and so there is 
no within-cluster variation in size. Since this is the cluster-period size, the total cluster size 
for a cluster (size of a cluster over whole study duration) will be 5 times its corresponding 
cluster-period size.  
To estimate the power, the design matrix (Z), and the variance-covariance matrix of cluster 
means (V) are required (see section 5.2.2). Since this design consists of 4 clusters, 
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Figure 6.1: Design pattern matrix (DPM) for 
four cluster example 
 



































































































































The variance-covariance matrix of the cell means over time, matrix V, is composed of C 
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The term 𝑚𝑖𝑗 refers to the size of cluster i at time j, so that, for example, 𝑚3 4 refers to the 
size of cluster 3 at time-period 4. The variance components 𝜎𝑏
2 and 𝜎𝑤
2 are derived from 
the ICC and the variance of the outcome (𝜎2) as: 
𝜎𝑏
2 = 𝐼𝐶𝐶 × 𝜎2 
𝜎𝑤
2 = 𝜎2 − 𝜎𝑏
2 = 𝜎2(1 − 𝐼𝐶𝐶) 
The power is then calculated using equation 6.2.  
Typically, SW-CRTs assume equal sized clusters, and so all values of 𝑚𝑖𝑗 are identical. 
Therefore, the variance-covariance matrix V will be the same for each randomisation order, 
and so this order will not impact the power. When the cluster sizes vary, the matrices 𝑉𝑖 will 
differ depending on the randomisation order (since the cluster-period sizes, 𝑚𝑖𝑗, differ), and 
so will matrix V. Consequently, the power will also depend on the randomisation order. This 
is established in the previous chapter in terms of precision – whereby the precision can vary 
depending on the randomisation of clusters in a SW-CRT with varying cluster size. In a SW-
CRT with 4 clusters, there are 24 (= 4 x 3 x 2 x 1) possible randomisation orders (Table 6.1). 
Table 6.1: Possible randomisation orders for four clusters 
 
A B C D B A C D C A B D D A B C 
A B D C B A D C C A D B D A C B 
A C B D B C A D C B A D D B A C 
A C D B B C D A C B D A D B C A 
A D B C B D A C C D A B D C A B 
A D C B B D C A C D B A D C B A 
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Below, we show how the power can be determined for a given randomisation order, e.g. 
BACD, which indicates that: 
𝑚1𝑗 = 50, 𝑚2𝑗 = 10, 𝑚3𝑗 = 100, 𝑚4𝑗 = 500 
Assuming that there is no within-cluster variation – that is, a particular cluster is the same 











































































































































































































































































































































































The matrix V can then be used with the design matrix, Z, to estimate the power using 
equation 6.2. This randomisation order (BACD) would provide 83.16% to detect a 0.25 
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difference in BMI z-scores. Below, we have repeated this for each of the 24 possible 
randomisation orders (Table 6.2). 
Table 6.2: Estimates of the power for each randomisation order 
 
A B C D 
82.37% 
 
B A C D 
83.16% 
 
C A B D 
87.02% 
 
D A B C 
89.04% 
 
A B D C 
78.45% 
 
B A D C 
82.45% 
 
C A D B 
86.37% 
 
D A C B 
88.98% 
 
A C B D 
86.30% 
 
B C A D 
88.98% 
 
C B A D 
89.04% 
 
D B A C 
87.02% 
 
A C D B 
78.33% 
 
B C D A 
81.52% 
 
C B D A 
85.71% 
 
D B C A 
86.30% 
 
A D B C 
85.71% 
 
B D A C 
86.37% 
 
C D A B 
82.45% 
 
D C A B 
83.16% 
 
A D C B 
81.52% 
 
B D C A 
78.33% 
 
C D B A 
78.45% 
 




The order of randomisation can impact the value of the power when clusters vary in size 
(Table 6.2), with over 10% difference in power between the lowest (ACDB = 78.33%) and the 
highest value (CBAD = 89.04%). Each permutation order contains clusters randomised in a 
different order. Since the clusters vary in size, many of these designs will contain a different 
number of observations contributing to the exposed and unexposed periods, resulting in the 
power varying between the orders. As such, it is necessary to distinguish between two types 
of power – the conditional power, and the marginal power, which we define below.  
The conditional power refers to an estimate of the power that is conditional on the 
randomisation order – and so is most useful post-randomisation. The conditional power is 
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simple to estimate. Once the clusters are randomised to a particular implementation order, 
the clusters-period sizes (𝑚𝑖𝑗) are inputted into each matrix 𝑉𝑖 in this order. The power can 
then be estimated using equation 6.2. Since the randomisation order is fixed, the conditional 
precision is a single value. Each estimate of the power given on Table 6.2 is an estimate of 
the conditional power for its corresponding randomisation order. 
In a pre-trial power calculation for a SW-CRT with varying cluster size, one value of the 
power – obtained from one particular randomisation order – may not be sufficient. Instead, 
the power should consider the full set of randomisation orders, since each order will have a 
unique estimate of the power. The marginal power is defined as the median of the 
conditional powers. The methodology used to estimate the conditional power is repeated 
for each randomisation order, and the values of the conditional power are then collated and 
averaged. Since each conditional power is unique, it is possible to consider the conditional 
powers as a distribution of the possible values of the power that considers every 
randomisation order of the clusters. As such, when reporting a marginal power – which is 
estimated from the distribution of conditional powers – an IQR is also reported to highlight 
the distribution. In our hypothetical example, the marginal power is 84.44% [IQR: 81.95% to 
86.70%]. 
 Varying cluster size with unknown cluster sizes 6.2.2.2
In Chapter 5, we described a method to estimate the precision and power, in a SW-CRT with 
unknown cluster sizes. For this an estimate of the true cluster-period size (𝜇) and the 
coefficient of variation of cluster sizes (𝑐𝑣) were required. The full methodology is not 
repeated here, but an overview of the methods used to simulate cluster sizes, and estimate 
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the power is highlighted below. The methodology is split into SW-CRTs with between-cluster 
variation in cluster sizes only, and SW-CRTs with within-cluster and between-cluster 
variation in cluster sizes. The steps taken to estimate the power in a SW-CRT are summarised 
in Box 6.1 and Box 6.2. 
Box 6.1: Outline of the steps taken to estimate the power of a stepped-wedge cluster 
randomised trial with varying cluster size 
Background: Define the SW-CRT design 
Define the design of the SW-CRT such as number of time-periods, number 
of clusters, number of steps, the cluster-period size, the ICC, the difference 
to be detected, the significance level, and the variance of the outcome. 
Step 1: Simulate cluster-period sizes 
Simulate for each cluster, its cluster-period size, 𝑚𝑖𝑗 such that 𝑚𝑖𝑗 =
𝑚𝑖𝑗` ∀ 𝑖, 𝑖` using a gamma distribution, with mean 𝜇 and coefficient of 
variation, 𝑐𝑣. 
Step 2: Apply a scaling factor 









 Calculate 𝜔 which is the ratio of the total sample size in the unequal 
cluster size design (S1) to the total sample size in an equal cluster size 
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Box 6.1 continued… 
Step 3: Estimate the power 
 Calculate matrices Vi (i=1, ... , C) using the 𝜔𝑚𝑖𝑗 from step (2). 
 Form matrix V using the block matrices Vi . 
 Calculate the power using equation 6.2. 
Step 4: Compile the power estimates 
 Repeat steps (1) - (3) for a specified number of repetitions.  
 Collate the estimates of the power to form the distribution (and 
average) of the power. The conditional power is then reported. 
 
 
Box 6.2: Outline of the steps taken to estimate the power of a stepped-wedge cluster 
randomised trial with varying cluster size. 
Background: Define the SW-CRT design  
Define the design of the SW-CRT such as number of time-periods, number of 
clusters, number of steps, the cluster-period size, the ICC, the difference to 
be detected, the significance level, and the variance of the outcome. 
Step 1: Simulate cluster-period sizes with no within-cluster variation in size 
Simulate for each cluster, its cluster-period size, 𝑚𝑖𝑗 such that 𝑚𝑖𝑗 =
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Box 6.2 continued… 
Step 2: Apply a scaling factor 









 Calculate 𝜔 which is the ratio of the total sample size in the unequal 
cluster size design (S1) to the total sample size in an equal cluster size 











 Scale the cluster-period sizes 𝑚𝑖𝑗, as 𝑚𝑖𝑗 × 𝜔. 
 Calculate for each cluster, the average cluster-period size 𝜔𝑚̅̅ ̅̅ ̅i• as: 







Step 3: Simulate cluster-period sizes with within-cluster variation in size 
Simulate, for each cluster independently, a new cluster-period size (𝑚𝑖𝑗) 
using a Gamma distribution with mean 𝜔𝑚̅̅ ̅̅ ̅i• and coefficient of variation 𝑐𝑣𝑤.  
Step 4: Apply a scaling factor 
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Box 6.2 continued… 
  For cluster 𝑖, calculate 𝜔𝑖 which is the ratio of the total cluster size in a 
design with within-cluster variation in size over time (𝑀2𝑖) to the total 












 Scale the cluster-period sizes 𝑚𝑖𝑗, as 𝜔𝑖𝑚𝑖𝑗. 
Step 5: Estimate the power 
 Calculate matrices 𝑉𝑖 (𝑖=1, ... , 𝐶) using 𝜔𝑖𝑚𝑖𝑗 from step (4). 
 Form matrix V using the block matrices Vi . 
 Calculate the power using equation 6.2. 
Step 6: Compiling the power estimates 
 Repeat steps (1) - (5) for a specified number of repetitions.  
 Collate the estimates of the power to form the distribution (and average) 
of the power. The conditional power is then reported. 
 
Regardless of whether the variation in cluster sizes includes within-cluster variation or not, 
the methodology described above requires a large number of simulations to form a 
distribution of the potential values of the power. From this distribution, the median power 
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6.3 A function for estimating power in a SW-CRT 
In this section, we describe the swpower Stata function that can be used to estimate the 
power in a SW-CRT with varying cluster size for a continuous outcome – using the methods 
described in section 6.2. The command has been developed in two parts – a command and a 
dialog box – and either can be used. Below, we discuss the dialog box that can be used, and 
highlight the output that is reported from the swpower function.  
6.3.1 Dialog Box 
The dialog box is made up of three tabs: Design, Clusters, and Outcomes (Figure 6.3). 




 The Design tab 6.3.1.1
The Design tab (given in Figure 6.4) allows the specification of the trial design, such as 
whether the design is complete or incomplete (see section 1.3.1). The DPM is required in the 
data editor for an incomplete design, and can, if selected, be printed alongside the results 
for confirmation. The Design tab requires a description of the cluster-period sizes. That is, 
whether the cluster-period sizes are equal or unequal and whether the sizes are known or 
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Figure 6.5: Pathway to describing cluster sizes 
 
Green boxes are questions to be asked, orange boxes are partial answers, and blue boxes are the final 
description of cluster sizes. 
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Once it is known which description of the cluster sizes is appropriate, the necessary options 
can be selected on the swpower function. A summary of the cluster sizes, a description of 
them and how they are selected on the swpower dialog box is given in Table 6.3. 
Table 6.3: Description of the cluster sizes are how they are selected on the swpower dialog 
box 
Cluster sizes Description Selected on swpower 
function 
Equal The cluster are all of equal size, and are 
the same size during each time-period. 
 
Select “equal cluster sizes” 
in the cluster size section. 
Unequal clusters 
sizes with known 
cluster sizes 
 
The cluster are unequal in size, but the 
size of each cluster is already known. 
 
Select “unequal cluster 
size” in cluster size section 





variation in cluster 
sizes only 
The clusters are unequal in size, but 
the size of each cluster is not known – 
but an average cluster-period size is 
known and a measure of the variation 
between cluster sizes. Each cluster 
remains the same size during each 
time-period. 
 
Select “unequal cluster 
size” in cluster size section, 








variation in cluster 
sizes 
The clusters are unequal in size, but 
the size of each cluster is not known. 
Clusters vary in size between clusters 
but individual clusters also vary across 
time. An average cluster-period size, 
the between-cluster and within-cluster 
coefficient of variation of cluster sizes 
are required. 
Select “unequal cluster 
size” in cluster size section, 
then “Unknown sizes”, and 




The selections chosen on the Design tab influences the required input on the other tabs. The 
user can specify the significance level (default is 0.05) and, when appropriate, the number of 
simulations to be performed (default is 1000). The number of simulations is only required for 
an unequal cluster size scenario (either known or unknown). If the cluster-period sizes are 
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known, then the number of simulations (N) specified will lead to either the conditional 
power being calculated (if N = 1) or the marginal power (if N>1). 
 The Cluster tab 6.3.1.2
The Cluster tab (Figure 6.6) is used to enter information regarding the clusters and is split 
into three sections: cluster information, cluster correlation, and the description of varying 
clusters (i.e. the specification of the between-cluster coefficient of variation and within-
cluster coefficient of variation). The options available here are influenced by the selection on 
the Design tab, and a summary of them is given on Table 6.4. The ICC is required for all 
designs. For unequal cluster designs with unknown cluster sizes, the within-cluster 
coefficient of variation is only required if the user has specified between-cluster and within-
cluster variation on the Design tab. A design with unequal cluster sizes and known sizes 
requires the user to specify: the number of time-periods (including baseline) (T), the number 
of clusters randomised per step (S), and the ICC. The number of clusters specified in the data 
editor must be equal to (𝑇 − 1) × 𝑆. 
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Table 6.4: Variables required for each design based on whether the cluster sizes are equal 











Equal N/A Complete Time-periods, 
Cluster size, 
Number of clusters randomised per step, 
ICC. 
 
Equal N/A Incomplete Cluster size, 
Number of clusters randomised per step, 
ICC. 
 
Unequal Known Complete Time-periods, 
Number of clusters randomised per step, 
ICC. 
 
Unequal Known Incomplete ICC. 
 
Unequal Unknown Complete Time-periods, 
Cluster size, 
Number of clusters randomised per step, 
ICC, 
Between-cluster cv, 
Within-cluster cv (if appropriate). 
 
Unequal Unknown Incomplete Cluster size, 
Number of clusters randomised per step, 
ICC, 
Between-cluster cv, 
Within-cluster cv (if appropriate). 
Note: an incomplete design is a design in which observations for one or more time-periods do not 
contribute towards the analysis 
 
 The Outcomes tab 6.3.1.3
The Outcomes tab (Figure 6.7) allows the user to specify the mean and standard deviation 
for the intervention and control conditions in the study. It is also possible to indicate 
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whether the standard deviation corresponds to the total variance of the outcome, or the 
within cluster variance only. The default option is for the total variance to be selected. 




If the cluster sizes are known, then the (conditional or marginal) power is estimated 
following the methods described in section 6.2.2.1. If the cluster sizes are unknown, then the 
power is estimated using the methods described in section 6.2.2.2. Following this, a 
description of the study design and the power is presented in the window – which we 
discuss below. 
 
6.3.2 Results output 
Upon submitting the command, the results are shown in the Stata window (Figure 6.8). It is 
highlighted that the power calculation is for a two sample comparison of means using 
normal approximations and whether equal or unequal cluster sizes have been used. If 
selected, the DPM is then printed, though the printing of this matrix may not be appropriate 
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for studies with a large number of clusters or time-periods. The main output is separated 
into five sections – study parameters, cluster size variation, outcome parameters, number of 
simulations, and the estimated power. The study parameters are printed for confirmation, 
and include: the number of time-periods, the number of clusters, the (average) cluster size 
per period, the (average) total cluster size, the (expected) total number of observations, the 
significance level, and the ICC. The cluster size variation reports, when applicable, the 
between-cluster, and within-cluster, coefficients of variation. If equal cluster sizes are 
assumed, then a message will be displayed at the top of results to report this, and the cluster 
size variation section will not be outputted. The outcome parameters are grouped together, 
and include: the mean in arms 1 and 2, the standard deviation in arms 1 and 2, the 
difference to be detected, and the standardised effect size. The number of simulations 
section reports the number of simulations used in the estimation of power and is only 
reported for designs with unequal cluster size. The final grouping reflects the estimated 
power, which is highlighted in red text. For designs with unequal cluster size, the median 
power is presented, alongside the inter-quartile range and the range. For designs with equal 
cluster size, or if the number of simulations is one, then the conditional power is presented 
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6.4 Practical Examples of estimating power 
In this section, we describe how the swpower function can be used to estimate the power 
for a SW-CRT by illustrating three examples: a SW-CRT with equal cluster size; a SW-CRT with 
unequal cluster sizes with unknown cluster sizes; and a SW-CRT with unequal cluster sizes 
with known cluster sizes. An example of the dialog box will be shown for the first example. 
All further examples will only show any necessary input into the data editor. The Stata 
output displaying the results will be shown for all examples. 
6.4.1 Equal sized clusters 
The WOSLAD trial (see section 1.6.1) is an example of a SW-CRT in which the clusters are all 
equal in size (5). The study aimed to determine whether a hospital training programme 
increases women’s satisfaction with doctor-patient relationship in labour and delivery 
rooms. The study recruited four hospitals (clusters), and expected the total cluster size to be 
500 observations per cluster over the study duration, with observations made during 5 time-
periods (100 observations per cluster per time-period).  
The primary outcome is mean satisfaction score, with the mean (SD) in the control period 
expected to be 3.15 (0.75). A clinically important difference is a mean difference of 0.2. The 
power calculation was conducted using a 5% significance level. We present results with an 
ICC of 0.01.  
For a SW-CRT design with equal cluster sizes, the Design (Figure 6.9), Cluster (Figure 6.10), 
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The Stata output is given below (Figure 6.12). For the parameter values described, the SW-
CRT would have 93% power to detect a 0.2 difference in means (standardised effect size = 
0.27). Since the power is calculated using equal cluster size, the “Cluster size variation” and 
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6.4.2 Unequal sized clusters and unknown sizes 
Our second example highlights how the swpower function can be used to estimate the 
power in a SW-CRT with clusters of unequal size, in which only the mean cluster size and a 
measure of the variation of cluster sizes are known.  
Consider a cross-sectional SW-CRT that plans to recruit 8 general practices (clusters) which 
will be randomised over 8 time-periods – so that the study contains 9 time-periods. Each 
practice contributes an average of 180 participants over the study duration, so that there are 
20 participants per cluster per time-period on average. The study wants to lower the BMI Z-
score from 1.25 (SD 1) in the control condition by 0.25. This corresponds to a standardised 
effect size of 0.25. The ICC used is 0.01, and the between-cluster coefficient of variation of 
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cluster sizes is 1.25. The options selected on each tab to estimate the power is given by 
Table 6.5.  
Table 6.5: Options selected on each tab to estimate the power for a SW-CRT with unequal 
cluster sizes that are unknown and fixed over time (no within-cluster variation in size) 
Tab Options Selected Value inputted 
Design Complete design  
 Unequal cluster size  
 Unknown cluster sizes  
 Between-cluster variation only  
 Significance level 0.05 
 Number of simulations 1000 
   
Clusters Time-periods 9 
 Cluster size per time-period 20 
 Clusters randomised per step 1 
 ICC 0.01 
 Between-cluster coefficient of variation 1.25 
   
   
Outcomes Mean 1  1.25 
 Mean 2 1.00 
 SD in arm 1 1.00 
 SD in arm 2 1.00 
 Within cluster variance  
 
In this example, the median power for the SW-CRT is 80.4% [IQR: 76.2% to 82.9%] (Figure 
6.13). However, the full range of power is 45.4% to 86.8%. So whilst the average may be 
sufficient power for a study, the full range show how low the power may be, conditional on 
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Figure 6.13: Results output for stepped-wedge design with unequal cluster sizes (unknown 





Suppose now that we wish to re-run the power calculation, but with the inclusion of a 
within-cluster coefficient of variation of 0.2. Now, “Between cluster and within cluster 
variation” is selected on the Design tab, and the within-cluster coefficient of variation in 
inputted on the Cluster tab. The average power is this SW-CRT with between-cluster and 
within-cluster variation in size is now 80.0% [IQR: 75.3% to 83.1%], and the range of power 
values is 41.5% to 87.3% (Figure 6.14). The inclusion of within-cluster variation has led to a 
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Figure 6.14: Results output for stepped-wedge design with unequal cluster sizes (unknown 





6.4.3 Unequal sized clusters and known sizes  
In this section, we show how the marginal and conditional power can be calculated for a SW-
CRT when the cluster sizes are known. This includes estimating the conditional power when 
the cluster sizes are known for every time-period and individual clusters vary in size over 
time. 
 Estimating the marginal power 6.4.3.1
Consider a SW-CRT that contains 8 hospitals (clusters) that will be randomised over 4 time-
periods. The cluster sizes vary and are known – but each cluster remains fixed in size over 
time (no within-cluster variation). The study aims to decrease the waist Z-score in patients in 
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a particular clinic from the current mean of 2 (SD 3.5) to 1.44 (SD 3.5). This corresponds to 
an effect size of 0.16. The power will be estimated, assuming an ICC of 0.002. The sizes of 
the hospitals in ascending order are: 42, 51, 60, 72, 90, 108, and 270, and these can be 
inputted into the Stata data editor, as shown by Figure 6.15.  




We plan to estimate the marginal power – to give an indication of the expected power for 
our study and the expected variation in this value. To estimate the marginal power, the 
options selected on the swpower tabs are given on Table 6.6. Although there are 8! (40,320) 
possible randomisation orders for the clusters, we consider a subset of them, and leave the 
number of simulations as its default value of 1000. The median power for this design would 
be 84.74% [IQR: 83.35% to 86.01%] (Figure 6.16), and the range of possible power values 
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Table 6.6: Options selected on each tab to estimate the marginal power for a SW-CRT with 
unequal cluster sizes that are known and fixed over time 
Tab Options Selected Value inputted 
Design Complete design  
 Unequal cluster size  
 Known cluster sizes  
 Significance level 0.05 
 Number of simulations 1000 
   
Clusters Time-periods 5 
 Clusters randomised per step 2 
 ICC 0.002 
   
Outcomes Mean 1  2.00 
 Mean 2 1.44 
 SD in arm 1 3.50 
 SD in arm 2 3.50 
 Within cluster variance  
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 Estimating the conditional power  6.4.3.2
To estimate the power conditional on a randomisation order, there are two options within 
the swpower function – based on whether the cluster sizes vary in size over time or not. If 
there is no within-cluster variation in size over time, then the cluster sizes can be inputted 
into the first column of the data editor in the order they are randomised. See Figure 6.15 for 
example. Alternatively, if the cluster sizes vary over time – and these sizes are known – then 
the cluster sizes over every time-period can be inputted into the data editor. This can also be 
used post-trial to evaluate the power of a study.  
If estimating the power conditional on the randomisation order given in Figure 6.15, 
assuming there is no within-cluster variation in size, then the options selected can be given 
by Table 6.7. This SW-CRT would have 85.31% power to detect the 0.16 effect size (Figure 
6.17). Since this is a conditional power, there is no measure of variation around this value. 
 
Table 6.7: Options selected on each tab to estimate the conditional power for a SW-CRT 
with unequal cluster sizes that are known and fixed over time 
Tab Options Selected Value inputted 
Design Complete design  
 Unequal cluster size  
 Known cluster sizes  
 Significance level 0.05 
 Number of simulations 1 
   
Clusters Time-periods 5 
 Clusters randomised per step 2 
 ICC 0.002 
   
Outcomes Mean 1  2.00 
 Mean 2 1.44 
 SD in arm 1 3.50 
 SD in arm 2 3.50 
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Figure 6.17: Results output for complete design with unequal cluster sizes (conditional 




If the known cluster-period sizes vary in size over time, then the swpower function can be 
used to estimate the conditional power. In the above study with known cluster sizes, there 
are 8 clusters and 4 randomisation steps. We firstly consider the DPM for this study, given in 
Figure 6.18. We can also think of the size of each cluster over time as a matrix. Figure 6.19, 
for example, may describe the cluster-period size of each of cluster over time, in the order 
they are randomised in. That is, cluster 𝐶1 and 𝐶2 are randomised to receive the intervention 
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Figure 6.18: Design pattern matrix for an 
SW-CRT with 8 clusters and 4 steps 
 
Figure 6.19: A matrix of cluster-period sizes 
































































In Figure 6.19, the individual clusters vary in size over time – though some clusters may not 
vary. To estimate the conditional power, the DPM, and the cluster-period sizes are combined 
to create a new matrix, which can be inputted into the data editor as shown in Figure 6.20. 
In this matrix, the “-“ (negative integer) indicates that the cluster is contribution to the 
control period at that time-period, whilst a “+” (positive integer) indicates that the cluster is 
contributing to the intervention period at that time-period. For example, a “-41” would 
indicate that the cluster is contribution 41 participants to the control, whilst a value of 
“(+)40” would indicate that the cluster is contributing 40 participants to the intervention. 
The positive and negative values are then used to generate the DPM, and in turn, the design 
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Figure 6.20: Data editor for input of known cluster sizes and incomplete design with 




To estimate the conditional power for the known cluster-period sizes with within-cluster 
variation in size given in Figure 6.19, the options selected in the swpower function are given 
on Table 6.8. The incomplete design option is selected to inform the function that the 
cluster-period sizes for every time-period should be obtained from the data editor. This SW-
CRT would have 77.83% power to detect the 0.16 effect size (Figure 6.21). 
Table 6.8: Options selected on each tab to estimate the conditional power for a SW-CRT 
with unequal cluster sizes that are known and vary over time 
Tab Options Selected Value inputted 
Design Incomplete design  
 Unequal cluster size  
 Known cluster sizes  
 Significance level 0.05 
 Number of simulations 1 
   
Clusters Time-periods 5 
 Clusters randomised per step 2 
 ICC 0.002 
   
Outcomes Mean 1  2.00 
 Mean 2 1.44 
 SD in arm 1 3.50 
 SD in arm 2 3.50 
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Figure 6.21: Results output for incomplete design with unequal cluster sizes (known cluster 
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6.5 Discussion 
In this chapter, we reiterated the method to estimate the power in a SW-CRT with varying 
cluster size – based on whether the cluster sizes were known or unknown. To this end, we 
presented the swpower Stata command, which has been developed to estimate the power 
in SW-CRTs with varying cluster size. Several examples were presented to show the practical 
use of the command for SW-CRT and P-CRTs with equal and unequal cluster sizes.  
There is extensive research into the effect of varying cluster size in P-CRTs, which has led to 
numerous design effects that can be used to estimate the power (57, 58). However, the 
methodological research into SW-CRTs is still in its infancy, and so a much smaller pool of 
research has been published. Nevertheless, the number of SW-CRTs being conducted is 
steadily increasing (23, 28, 29). To aid power calculations, there is both a design effect (21) 
and Stata function (63) for SW-CRTs, though both assume that all clusters will be equal in 
size. Chapter 3 highlighted that varying cluster size is often not acknowledged in a SW-CRT, 
and there has been no evidence of a trial correctly acknowledging varying cluster size in a 
power calculation. In P-CRTs, it is known that a study with varying cluster sizes has less 
power than an identical study with equal sized clusters (57, 145).  
In Chapter 5 it was shown that in relation to precision, the SW-CRT with varying cluster size 
may be less efficient, on average, than a SW-CRT with equal sized clusters. That is, the 
average power in a SW-CRT with varying cluster size will be lower than the power in a SW-
CRT with equal cluster size. However, the variation in the potential power is also important. 
Here, we presented some examples to show how the swpower function can be used to 
estimate the power in a SW-CRT with varying cluster size. These examples showed that for 
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SW-CRTs with known and unknown cluster sizes that vary, the power can be extremely 
variable. When considering simply the average power and the inter-quartile range, a SW-CRT 
may be sufficiently powered. However, the full range of potential values of the power 
highlights its large variability, and emphasises the need to account for varying cluster size. 
The methodological rigor of reported power calculations from SW-CRTs is sub-optimal, and 
many are conducted using inappropriate methods (Chapter 3) which could lead to an 
underpowered study. The Stata command swpower has been developed to ensure future 
power calculation use appropriate methodology and correctly acknowledge any variation in 
cluster sizes. The command is a useful tool that will allow the estimation of power in a SW-
CRT with equal sized clusters, varying cluster sizes with unknown cluster sizes, and varying 
cluster sizes with known cluster sizes. To provide for greater usability, an accompanying 
dialog box has been produced to co-exist with the command. For greater flexibility, the 
function allows the input of the DPM, allowing trialists to indicate a design identical to their 
own study. The function also enables the power to be estimated for a P-CRT.   
6.5.1 Limitations 
This function only allows the estimation of power for studies, and does not allow for the 
computation of a sample size or detectable difference. As such, this command can aid 
researchers in estimating the power of a trial for a set of parameters, or allow the testing of 
the impact of cluster size variation on their trial, but will not provide an estimate of the 
necessary sample size.  
Since the model used here is that presented by Hussey and Hughes (32), there is no random 
effect for the individual participants. As such, the model assumes that there is no correlation 
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between the individuals at different time-periods and so is applicable only to a cross-
sectional SW-CRT.  
In Chapter 4, we introduced the concept of the within-period correlation and the inter-
period correlation. They fundamentally rely on a model with a random cluster by time effect. 
Since the only random effect included in the model in the swpower function is for cluster, 
the within-period and inter-period correlations cannot be specified in this work. As such, it is 
assumed that the correlation between outcomes in a cluster is independent of the timing of 
the observations, so that the correlation does not decay over time.  
6.5.2 Possible future adaptations 
Currently, for designs in which the number of simulations exceeds one, the function reports 
the median power, alongside the inter-quartile range (IQR), and the range. The median is 
reported since it is known that the distribution of power is skewed (Chapter 5). However, it 
is possible that the distribution of power could be represented in a graphical format, in 
which the distributions are plotted on a graph, in addition to the reporting of the median, 
IQR and range. This would then include all estimates of the power from the number of 
specified simulations and highlight the likelihood of obtaining a specific power value. 
When estimating the power for an incomplete design with varying cluster size and known 
cluster sizes, the current function is limited to estimating the conditional power. However, 
some studies may know the size of the clusters prior to the study, and be using an 
incomplete design, and so require the marginal power instead. As such, any future versions 
of the function will allow for the marginal power to be estimated for an incomplete design 
with known clusters of varying size. 
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6.6  Conclusions 
This chapter establishes a Stata function for estimating power when clusters vary in size – for 
scenarios with known and unknown cluster size. This should lead to an improvement in the 
methodological quality of sample size in calculations reported in SW-CRTs, and allow for the 
inclusion of varying cluster size (if appropriate). This chapter has built on work presented in 
previous chapters, and adds an important tool to the SW-CRT literature. The next chapter 
pools together the key results from each of the preceding chapters, and highlights the 
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CHAPTER 7:      DISCUSSION 
7.1 Thesis summary 
Stepped-wedge cluster randomised (SW-CRTs) are an increasingly used alternative to 
parallel cluster randomised trials (P-CRTs). However, there is a sparsity of research into the 
SW-CRT in comparison to the P-CRT and other design types. As such, the methodological 
literature is at a less advanced stage for a SW-CRT than a P-CRT. The work in this thesis aims 
to address some of the current methodological gaps by expanding the knowledge base of 
SW-CRTs and provide a platform for future work. 
The overall aim of this thesis was to develop the understanding of several key design 
features found in a SW-CRT. Chapter 3 reviews the reporting quality and methodological 
quality of published SW-CRTs, which led to two key issues in the design stage being apparent 
– few studies allowed for the decay in correlation between observations within a cluster 
over time, and few allowed for varying cluster size. Chapter 4 presents a correlation 
structure for SW-CRTs that allows for the correlation between observations to be dependent 
on the timing of the observations and provides a resource of estimates of the inter-period 
correlation and the within-period correlation. The last two chapters (5 and 6) focus on 
varying cluster size in SW-CRTs, developing methods to estimate the power in a SW-CRT with 
varying cluster size and investigating how a SW-CRT with varying cluster size compares to a 
SW-CRT with equal cluster size. A short summary of the chapters is given below. 
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7.2 Chapter overview 
Chapter 2 presented a review of the methodological literature for SW-CRTs – highlighting 
the sparsity compared to the literature for P-CRTs. There are a number of methodological 
issues that were yet to be addressed, with little research on varying cluster size in SW-CRTs , 
and only recent research on alternative correlation structures in SW-CRTs.  
A methodological review of the reporting quality of published SW-CRTs was given in Chapter 
3. The adherence to the CONSORT statement for randomised trials and the extension for 
cluster trials were identified for each study. Additionally, the methodological rigor of the 
sample size calculation was assessed and the analytical method used in full trial reports was 
evaluated. 
In Chapter 4, we present a method to allow for the correlation between observations within 
a cluster to be dependent on the timing of the observations. We introduce the notion of the 
intra-cluster correlation (ICC) for studies in which the correlation is time-independent, and 
the inter-period correlation (IPC), and the within-period correlation (WPC) for studies in 
which the correlation is time-dependent. In addition, and as an illustration, we provide 
estimates of the ICC, IPC, and WPC for outcomes associated with type-2 diabetes using 
anonymised patient data from The Health Improvement Network. For dichotomous 
outcomes, we make a careful distinction between the latent ICC and the natural ICC, and 
clarify why the natural ICC should be used for sample size calculations.  
The impact of varying cluster size in a SW-CRT was explored in Chapter 5, by comparing the 
precision of a SW-CRT with unequal cluster size to the precision of a SW-CRT with equal 
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cluster size using a measure of a relative efficiency (RE). A simulation study was presented to 
show how the cluster mean correlation, the number of clusters, the number of steps, and 
the degree of variation in cluster sizes affect the RE. The RE of a P-CRT with varying cluster 
size compared to a P-CRT with equal cluster size was also reported – as a comparison. We 
explored both between-cluster variation in size and within-cluster variation in size.  
Chapter 6 implemented the methodology developed in Chapter 5 to allow researchers and 
trialists to estimate power in a SW-CRT with varying cluster size. To this end, we presented a 
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7.3 Areas of contribution to the field of SW-CRTs 
This thesis has contributed to the methodological literature for SW-CRTs by addressing each 
of the following research aims: 
1. Review the sample size calculations for SW-CRTs to assess whether they are 
sufficiently reported, and whether appropriate methodology has been used.  
2. Evaluate the validity of the assumption that the correlation between observations 
within a cluster is independent of time.  
3. Demonstrate the impact of varying cluster size in a SW-CRT, and make comparisons 
to the impact of varying cluster size in a P-CRT. 
4. Propose a method for estimating power in a SW-CRT when clusters vary in size. 
The key results emanating from this work in relation to these research aims are highlighted 
in the discussion section within each chapter. A summary of the main results are given 
below. 
7.3.1 Methodological review of sample size calculations  
Early systematic reviews had suggested that the justification of a sample size is often under 
reported for published SW-CRTs (28, 29). However, in those that justify a sample size, it was 
not known whether the details of the sample size calculation are well reported, or whether 
appropriate methodology is used. To address this research question, a methodological 
review of protocols and full trial reports was conducted to assess the quality of reporting by 
checking the adherence to the CONSORT recommendations for randomised trials and the 
extension for cluster randomised trials. A list of SW-CRT specific items was also extracted, 
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alongside the methodology of the sample size calculations. For full trial reports, an 
evaluation of the analytical methods used was conducted.  
It was identified that the quality of reporting in SW-CRTs is sub-optimal, and the 
methodology being used is often inadequate and inappropriate. Of the 9 items 
recommended by the CONSORT cluster extension, the median number of items reported 
was 5 [IQR: 2 to 6], with no trials reporting all 9 items – though there was some evidence of 
an improvement in reporting post 2012. Generally, the number of steps and the number of 
clusters randomised per step were well reported. However, the design type (cross-sectional 
or cohort) was often not explicitly reported, and there was often ambiguity about whether 
the cluster size referred to the total cluster size or the cluster-period size. In a SW-CRT, the 
lack of clarity of the design type is especially important – since the methods used to estimate 
the sample size and for post-trial analysis hinge on whether a cross-sectional or cohort 
design was used. Cohort designed SW-CRTs require additional random effects to indicate 
repeated measurements from participants over time – not including this random effect may 
lead to an over-precise confidence interval for a treatment effect. 
Often, sample size calculations we identified not to be using appropriate the methodology, 
with over a quarter not reporting any adjustment for clustering in the sample size 
calculation. This is notable since there are published guidelines for CRTs that explicitly state 
that an adjustment for clustering in the sample size calculation should be reported. 
Additionally, almost two-thirds of the included studies did not report an adjustment for time 
effects in the sample size calculation. Since the treatment effect can be confounded with 
time, ignoring time in the sample size calculation may lead to an underpowered study. The 
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lack of reporting of clustering and time in the sample size calculation may be a result of 
incorrect methods being used. Typically, a design effect appropriate for a P-CRT was 
reported, even though it ignores the effect of time. Nevertheless, almost a third of studies 
reported using the recommended Hussey and Hughes framework. However, this framework 
is appropriate for cross-sectional designs, and many of the studies were cohort designs. As 
such, without adaptations, the methods may still not be appropriate for the sample size 
calculation. There was some evidence of studies including a transition period in the design 
between the control and intervention conditions. Though, there was little reporting of this 
being addressed in the sample size calculation – which may have led to underpowered 
studies. 
A systematic review of P-CRTs found two-thirds of full trials contains unequal sized clusters 
(146). This review found that only a small number of SW-CRTs had reported varying cluster 
size in the context of the sample size calculation or in their trial description. However, of the 
few SW-CRTs that acknowledged that the clusters may vary in size, they often did not report 
an adjustment for this in the sample size calculation, or simply did not report how or 
whether varying cluster size was accounted for. 
The reporting of an extended correlation structure was extremely poor – though this may be 
expected since the research into extended correlation structures in a SW-CRT has only 
recently being in the forefront of the methodological literature. Indeed, only two studies 
reported extended correlation measures, and these related to a correlation coefficient of 
repeated measures and a within-patient correlation over time. Neither of these used an 
appropriate sample size method.  
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The post-trial analysis of studies was generally mixed. Whilst the majority of studies 
reported an inclusion for clustering in the analysis, only half reported an acknowledgment of 
the effect of time. A failure to include time in the analysis is likely to produce an over-precise 
treatment effect estimate. Additionally, although most of the studies were cohort or open 
cohort designs, repeated measures were often not reported or included in the analysis. This 
would also lead to an over-precise treatment effect estimate as the analysis would treat 
each observation as a new participant and ignore the within-participant correlation over 
time. 
This work echoes the call for reporting guidelines for SW-CRTs. Currently, a CONSORT 
extension is being developed for SW-CRTs which may help to address some of these 
concerns (71). 
 
7.3.2 Appropriate correlation structure in a SW-CRT 
An estimate of the correlation between observations within a cluster (ρ) is necessary for pre-
trial sample size calculations. In the absence of period effects, the ICC denotes the 
correlation between observations within a cluster (i.e. 𝐼𝐶𝐶 = 𝜌). However, in longitudinal 
CRTs, there is a need to acknowledge the possibility of a decay in correlation over time 
within a cluster. This led to the concept of the WCC, IPC, and WPC. The WPC is defined as the 
correlation between any two observations from within the same cluster and the same time-
period. The IPC is defined as the correlation between any two observations from within the 
same cluster during but from different time periods. The WCC is the correlation between any 
two random observations within a cluster, and is a function of the IPC and WPC. The WCC 
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and the ICC are both equal to 𝜌, but are only defined in time-dependent models and time-
independent models, respectively. If the IPC=WPC – which is often assumed (32) – then 
there are no period effects present, and the ICC can be used to replace 𝜌 in a design effect 
for a P-CRT. However, if the IPC ≠ WPC, then a period effect is present, and the WCC should 
be used to replace 𝜌 in a design effect for a P-CRT. Recently, research has suggested that the 
WPC and IPC should be included in the sample size calculation for a SW-CRT (27, 48). 
Recently, a DE was published for SW-CRTs that acknowledged the IPC and WPC (26) 
(equation 2.10). However, there is a dearth of likely values of the IPC and WPC to inform 
methodological research and sample size calculations. As such, there have been calls for 
estimates of the IPC and WPC to be published (26, 27). Previously, the same value had been 
used to represent the ratio of the IPC to the WPC (27, 48), but with little evidence to justify 
the value. 
In Chapter 4, as an illustration, estimates of the ICC, IPC, and WPC were presented for typical 
outcomes associated with type-2 diabetes using anonymised patient data from The Health 
Improvement Network. In all of the results presented, the WPC and IPC differ – leading to 
the conclusion that period effects were present. Within this, it was shown how increasing 
the study length (with a fixed time-period length) or increasing the time-period length (with 
a fixed study length) may impact the IPC and WPC. When presenting the impact of study 
length and time-period length on the IPC and WPC, increasing the period length (with a fixed 
study length) tended to decrease both the IPC and WPC. This is perhaps expected as 
increasing the potential length of time between two observations is likely to lead to a 
decrease in the correlation between them. Increasing the study length (with a fixed time-
period length), tended to increase the WPC but decrease the IPC. Whilst it is not surprising 
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that the IPC decreases (since there is a longer duration between possible observations), it 
was unexpected that the WPC increased, since the time-periods length remained fixed. 
It is recommended that in similar settings, the ICC should not be used as an estimate for 𝜌 in 
the design effect for a P-CRT. Instead the WCC should be calculated – as a function of the IPC 
and WPC in a setting with an equal number of observations in each time-period – and used 
to replace 𝜌 in the design effect. The presence of a period effect emphasises that a recent 
DE for SW-CRT that includes the IPC and WPC should be used for cross-sectional SW-CRTs. 
Recently, the IPC and WPC have been recognised as important to SW-CRTs and other 
longitudinal designs. However, there has been little evidence of likely values of the IPC and 
WPC, which has led to ad-hoc values being used in the methodological literature. Chapter 4 
is the first resource of possible IPC and WPC values, which may be useful for pre-trial sample 
size calculations and for methodological research.  
In scenarios in which the WPC and IPC differ, the current assumption of correlation between 
observations being independent of the time in which the observations are made is invalid. 
Instead, a time-dependent model – that is, a model with a cluster-by-time random effect – 
should be fitted to the data in the analysis stage, and in the estimation of the correlation 
structure. This allows the WPC and the IPC to depict the correlation between participants 
over multiple time-periods. Furthermore, the WCC – estimated as a function of the IPC and 
WPC (equation 4.5) when the number of observations is equal in each time-period – should 
be used in the sample size calculation for longitudinal CRTs.  
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7.3.3 Explored the impact of varying cluster size in a SW-CRT 
Typically, it is assumed that a CRT will contain clusters of equal size. However, in practice this 
is unlikely to be true (57, 146). In the context of P-CRTs, there has been a variety of research 
into the effect of varying cluster size on the precision and power – and it is known that 
cluster size variation decreases the power compared to a P-CRT with equal cluster size. In 
published SW-CRTs, there is little evidence of the reporting of an allowance for varying 
cluster size in the power calculation. 
In Chapter 5, a set of simulation studies were presented to examine how the precision in a 
CRT with unequal cluster sizes compares to the precision of a CRT with equal cluster size – 
presented as a relative efficiency. Results were shown for: a SW-CRT with between-cluster 
variation in size; a P-CRT with between-cluster variation in size; and a SW-CRT with between-
cluster and within-cluster variation in size.  
For a SW-CRT with between-cluster variability in cluster sizes, the average amount of 
precision lost compared to a SW-CRT with equal cluster sizes may not be large in magnitude. 
However, when considering all possible values of the precision, there is a large degree of 
variability. That is, on average, a SW-CRT with varying cluster size may only have slightly less 
precision (and hence power) than a SW-CRT with equal cluster size; nevertheless, the large 
amount of variability in the potential precision could lead to a potential 20% increase or 80% 
decrease in precision, compared to a SW-CRT with equal cluster sizes. As such, the precision 
for a SW-CRT with varying cluster size is conditional on the randomisation order of the 
clusters. In a SW-CRT with varying cluster size, it is possible for the precision (and power) to 
be greater than a SW-CRT with equal cluster size. As the number of clusters in a SW-CRT 
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increase, the design is less influenced by cluster size variation – and there is a decrease in 
the variability in the distribution of the RE. 
In the context of P-CRTs, it is often assumed that there will be a balance in the number of 
observations in the intervention and control arms (60, 62). When this is true, the precision is 
a fixed value, and so the ratio of the precision in an unequal cluster size design to the 
precision in an equal cluster size design will always be a single fixed value. However, in 
practice, CRTs often contain a small number of clusters, and so there is inevitably an 
imbalance in terms of the number of observations in the intervention and control arms. In 
Chapter 4, we allow the number of observations to vary between arms, and show that the 
RE for a P-CRT is a distribution of RE values, and may contain a large degree of variation. In a 
P-CRT with varying cluster size, the precision (and power) can never be greater than a P-CRT 
with equal cluster size – and so an unequal cluster size design is always less efficient than an 
equal cluster size design. The average RE and the distribution of RE of a P-CRT with unequal 
cluster size is greatly affected by changes to the cluster mean correlation – which is 
particularly evidenced when the variation in cluster sizes is not small. That is, for a given 
trial, the power may be a lot less than the average power.  
Since the SW-CRT is a longitudinal CRT and is split into time-periods, individual clusters can 
differ in size over time. Chapter 5 also presented results of a simulation study that 
considered both between-cluster and within-cluster variation in size. The inclusion of within-
cluster variability leads to a greater variability in the RE. That is, for a given trial, the power 
may be a lot different to the average or expected power. Again, regardless of the number of 
 
 
Page | 258 
 
steps, it is possible for a SW-CRT with unequal cluster size (with between-cluster and within-
cluster variation) to offer more precision, and power, than a SW-CRT with equal cluster size.  
The key result emanating from this work in relation to the research question is: 
On average, a SW-CRT with varying cluster size will have less power than a SW-CRT with 
equal cluster size. However, the potential power is hugely variable, and so a given trial could 
potentially have a lot less power or more power than the expected power. Although not 
appreciated, a P-CRT suffers from the same phenomenon – though to a lesser degree. A SW-
CRT is, on average, affected less by varying cluster size than a P-CRT. However, the variability 
in power in a SW-CRT with varying cluster size is much greater than in a P-CRT.   
7.3.4 Estimating power in a SW-CRT with varying cluster size 
The assessment of power is important when designing a study. For SW-CRTs, there exists a 
framework for estimation of power under the assumption of equal cluster sizes (45) which 
has been presented as a Stata function (63) to encourage future trialists to use the correct 
methodology. However, Chapter 5 established that the SW-CRT is highly affected by varying 
cluster size. As such, a method is necessary to estimate the power in a SW-CRT with varying 
cluster size.  
In Chapter 5, we proposed a method to estimate the precision in a SW-CRT with varying 
cluster size, if the cluster sizes are not known. We then implement this method in Chapter 6. 
Additionally, in Chapter 6, we extend this method to consider the power of a SW-CRT with 
unequal cluster sizes, if the cluster sizes are not known, but estimates of the average cluster 
size and the between-cluster coefficient of variation (and within-cluster coefficient of 
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variation – if applicable) are known. This is applicable for SW-CRTs with between-cluster 
variation in cluster sizes or between-cluster and within-cluster variation in cluster sizes. It is 
then shown how the power can be estimated in a SW-CRT with unequal cluster sizes, if the 
cluster sizes are known. When the cluster sizes are known, the power is affected by the 
randomisation order of the clusters. As such, we introduce the concept of the marginal 
power and the conditional power. The conditional power is the power for a SW-CRT 
conditional on the randomisation order – and is useful post-randomisation. The marginal 
power is the average power calculated as the median of all possible conditional powers.  
In Chapter 6, we implement a method to estimate the power in a SW-CRT with unequal 
cluster sizes as a Stata function, with examples presented to show its use. The examples 
highlight that variability in power that can be expected when cluster sizes vary. The swpower 
function will ensure that the design of future SW-CRTs uses appropriate methods and, if 
appropriate, acknowledges varying cluster size in their sample size calculation. 
We found that it is possible for some randomisation orders to have a relative efficiency 
greater than one, indicating that unequal cluster sizes could offer more precision, and power 
than a design with equal cluster sizes. Nevertheless, it is unlikely that an investigator could 
capitalise on unequal cluster sizes to improve power without undermining the 
randomisation process. Prior to randomising, all clusters should have an equal opportunity 
to be randomised to a given sequence – i.e. they have an equal chance to be initiated to the 
intervention condition at each time-period. Since a relative efficiency greater than one 
applies to only specific realisations, trying to pick one of these realisations would invalidate 
the randomisation process. 
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7.4 Limitations of this work 
The limitations of each research question are reported in the discussion section of the 
appropriate chapter. Here, we report only an overall limitation of this thesis. All of the 
methodological work in this thesis stems from the Hussey and Hughes framework which is 
appropriate for continuous outcomes in a cross-sectional framework (32). However, Chapter 
3 showed that many SW-CRTs are cohort designs and many have dichotomous outcomes. 
The use of a cohort design would require an additional random effect for participant to allow 
for a within-participant correlation over time – to allow for repeated measurement from the 
same participant over time. Whilst we extended the Hussey and Hughes framework to allow 
for a cluster-by-period interaction in Chapter 4, we did not consider the additional 
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7.5 Implications of research 
Previous systematic reviews had identified that published SW-CRTs did often not justify the 
sample size included in the study. However, of those studies who had reported a sample size 
calculation, it was not known how well reported these calculations were with respect to 
published guidelines. Whilst CONSORT statements for RCTS and CRTs exist, it was unknown 
how much, or how little, previous SW-CRTs had adhered to the recommendations. Part of 
this thesis has shown that there is a severe under reporting of many sample size items in 
SW-CRT protocols and trial reports, and there is an urgent need for a published CONSORT 
extension for SW-CRTs – though it is known that one is currently in development. 
Noticeably, there seemed to be a slight improvement in reporting since the CONSORT 
extension for CRTs, so a CONSORT extension for SW-CRTs will hopefully lead to a vast 
improvement in reporting quality. 
In P-CRTs and SW-CRTs, the ICC is used almost exclusively in pre-trial sample size calculations 
and to describe the correlation between observations within a cluster. However, the 
longitudinal nature of the SW-CRT means that this may not be sufficient to describe the 
correlation structure. Recent papers have introduced the concept of the correlation 
between observations being time-dependent in a SW-CRT through the IPC and WPC – 
though there is little evidence of likely values of these. If the IPC and WPC are equal, then 
there are no period effects present, and the ICC is sufficient to describe the correlation 
between observations within a cluster. However, if the IPC and WPC differ, then they, along 
with the WCC, should be used to describe the correlation between observations within a 
cluster. This thesis is the first known reporting of estimates of the IPC and WPC. This will 
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allow future SW-CRTs to use these estimates in their power calculation, and acknowledge 
the decay of correlation over time, by using the DE published by Hooper et al. (equation 
2.10) (26). As well as being used in future sample size calculations; the results establish that 
a time-dependent model is necessary for SW-CRTs to depict the correlation structure. The 
publication of possible values also enables other methodological researchers to consider the 
impact of the decay of correlation on the sample size of future SW-CRTs. 
This thesis has established that the SW-CRT is affected less, on average, than the P-CRT 
when clusters vary in size. It is known that a large proportion of P-CRTs had varying cluster 
size (146), and that the P-CRT is heavily influenced by the degree of variation in cluster sizes 
(57). However, no current systematic review has indicated the proportion of published full-
trial SW-CRTs that displayed varying cluster size. Currently, there may be a lack of 
acknowledgement that the clusters in a trial are likely to vary in size in pre-trial sample size 
calculations, since there has been no established methodology for estimating power in a SW-
CRT with varying cluster size. However, the Stata function presented in this thesis may allow 
future sample size calculations to acknowledge unequal cluster sizes. Nevertheless, it is 
important that any sample size calculation for a SW-CRT or P-CRT that includes varying 
cluster size should report the expected power and a measure of the likely variation in the 
power. The results of this thesis have already seen a change in approach for some CRTs. The 
acute coronary syndrome quality improvement in Kerala (ACS QUIK) study is a SW-CRT that 
contains clusters of varying size. The results of this chapter showed that the ACS QUIK study 
would not be sufficiently powered if a P-CRT was used, but that since the SW-CRT was 
affected less than the P-CRT, it would still be sufficiently powered, despite a large variation 
in cluster sizes.  
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By developing a Stata function, a practical element to the work has been shown, so that we 
do not present merely theoretical work. The Stata function can allow the power to be 
estimated in a SW-CRT with varying cluster size, and will encourage trialists to use the 
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7.6 Future research 
There are several areas of future research that has been identified from each of the 
chapters, which are discussed below. 
The methodological review in Chapter 3 could be extended to assess whether there has 
been any improvement to the reporting standards of published SW-CRTs since the review 
was conducted (October 2014). In addition to the publication of the findings of the current 
review, the future publication of a CONSORT extension for SW-CRTs is likely to impact the 
quality of reporting, and so a future methodological review should be conducted to assess 
what impact is made on reporting standards.  
The methodical review emphasised the need for guidelines on why a sample size calculation 
is important in a SW-CRT. This should include a lay term guide to how a sample size 
calculation should be conducted and reported. This could include details of the appropriate 
methodology, and how this methodology can be implemented in different statistical 
software packages. By highlighting how a sample size calculation is conducted and reported, 
it may increase the reporting quality and methodological rigor of future SW-CRT sample size 
calculations.  
Chapter 4 highlighted that if period effects are present, the ICC may not be appropriate as an 
estimate of ρ for use in a design effect to estimate the sample size – since the ICC assumes 
that the correlation between observations is time-independent. Instead, the WCC should be 
used in a sample size calculation, since it is a time-dependent measure of correlation. 
However, the varying number of observations in each time-period meant that we could not 
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provide an accurate estimate of the WCC from THIN data to compare to the ICC. Further 
research is required to provide estimates of the WCC for use in sample size calculations. IPCs 
and WPCs for outcomes associated with type-2 diabetes were presented in Chapter 4. Whilst 
useful as a platform for showing that correlation decays over time, IPCs and WPCs are 
necessary for other potential study populations, so that future trials can use correct values in 
a sample size calculation. Additionally, whilst a P-CRT is often treated as a single study-
period, it may be that recruitment and observations can also be split into time-periods. As 
such, it may be that the ICC is not sufficient to describe the correlation in a P-CRT, and the 
IPC and WPC should also be used in a P-CRT. 
Chapter 4 showed potential values of the IPC and WPC. Previously, there have been no 
published IPC or WPC estimates, and so it has often been assumed that they are equal. Since 
the results of Chapter 4 showed that the IPC and WPC differ – i.e. there are period effects 
present – recent literature surrounding the decay of correlation over time has become 
increasingly important. Previously, a single value had been used to represent the ratio of the 
IPC and WPC, which was much greater than found here. Future research is needed to 
increase the resource of IPC and WPC values.   
Chapters 5 and 6 showed that it is possible for SW-CRTs with varying cluster size to have 
more precision (i.e. more power) than a SW-CRT with equal cluster sizes. Conversely, it is 
also possible to have SW-CRTs with varying cluster size have less power than an equal cluster 
size design, and less power than expected with unequal cluster sizes. That is, there may be a 
large variation in the possible power of a SW-CRT if the clusters are of unequal size. To 
minimise the probability of a SW-CRT having less power than expected, it may be that 
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stratification is necessary in the randomisation process. Future research should investigate 
whether stratification by cluster sizes can guard against large losses in power in a SW-CRT. A 
second strand of future research should include the investigation of optimal SW-CRTs when 
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7.7 Conclusions 
The literature for SW-CRTs is constantly evolving, and is a challenging research area that still 
requires more methodological research to improve the existing knowledge base. The aim of 
this thesis was to develop the understanding of some of the design issues that are faced 
when carrying out a SW-CRT. Though some of the issues remain, and many further questions 
have arose during this research, this thesis has contributed towards improving the 
methodological literature for SW-CRTs and improving the quality and reporting of sample 
size calculations for SW-CRTs. Without a rigorous sample size calculation, a SW-CRT is flawed 
from the outset, so improving the quality of a sample size calculation, through theoretical 
development and practical application, will hopefully see a development in the 
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CHAPTER 9:      Appendices 
 
Appendix A 
1. step$ wedge.ti,ab. 
2. experimentally staged introduction.ti,ab. 
3. delayed intervention.ti,ab. 
4. (one directional cross over design or one directional crossover design).ti,ab. 
5. ((incremental or phased or staggered or stepwise or step wise or delayed) adj1 
(recruitment or introduction or implementation)).ti,ab. 
6. or/1-5 
7. limit 6 to english language 
8. Remove duplicates from 7 
9. limit 8 to randomized controlled trial 










































Page | 287 
 
Appendix C 
Sample size reporting – full trials vs protocols 
Table 9.1 compares the reporting of the CONSORT statement and the extension for the 
CONSORT statement for cluster trial for full trials reports and published protocols. For many 
items, there is a great disparity between protocols and full trials. A large proportion of 
protocols (93%) reported a sample size calculation, compared to 59% of full trials (p=0.003). 
The reporting of the power (p=0.003) and significance level (p=0.039) were significantly 
higher in protocols than full trials. The treatment effect was sufficiently reported in 22 (79%) 
of protocols compared to only 11 (34%) of full trials. The reporting of attrition and of the 
number of clusters was similar in both groups. A measure of the variation of outcomes 
within a cluster was poorly reported in full trials (34%), but much higher in protocols (79%). 
No full trial reports considered an uncertainty in this estimate. The median number of items 
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: a sufficient reporting of the treatment effect consists of either a standardised effect size; a mean difference and standard deviation; means in both arms and standard deviation; 
proportions in both arms; proportion in one arm and a difference. IQR: Inter-quartile range. ICC: Intra Cluster Correlation. P-value is for the comparison of full trial publications and 
protocols using a chi-squared test for proportions (categorical outcomes) or Mann-Whitney U test (where medians are reported), or (*) using Fisher’s exact test. 
 
 Protocols 
N = 28 
Full reports 
N = 32 
Absolute difference (95% 
confidence interval) 
P value 
Sample size justification     
    Reported  26 (93) 19 (59) 33.5 (14.0 to 53.0) 0.003 
ITEM 1:     
   Level of significance 22 (79) 17 (53) 25.4 (2.4 to 48.5) 0.039 
ITEM 2:      
   Power  26 (93) 19 (59) 33.5 (14.0 to 53.0) 0.003 
ITEM 3:      
   Treatment effect 1 22 (79) 11 (34) 44.2 (21.8 to 66.6) 0.001 
ITEM 4:      
   Consistency with primary outcome 22 (79) 16 (50) 28.6 (5.5 to 51.6) 0.022 
ITEM 5:      
   Allowance for attrition  11 (39) 7 (22) 17.4 (-5.7 to 40.5) 0.142 
ITEM 6:     
   Number of clusters   27 (96) 31 (97) -0.4 (-9.6 to 8.7) 0.923 
   Median cluster size   24 (86) 15 (47) 38.8 (17.2 to 60.4) 0.002 
ITEM 7:      
   Variation in cluster size*    2 (7) 4 (13) -5.4 (-20.3 to 9.6) 0.675 
ITEM 8     
   Variation in outcomes across clusters (i.e. ICC) 22 (79) 11 (34) 44.2 (21.8 to 66.6) 0.001 
ITEM 9:      
   Uncertainty of ICC (or equivalent)*  8 (29) 0 (0) 28.6 (11.8 to 45.3) 0.001 
All ITEMS     
   Number items reported Median [IQR] 6 [5 to 7] 4 [1 to 6] 2.20 ( 1.16 to 3.24) <0.001 
   Reporting all 9 items  0 (0) 0 (0)   
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A comparison of the reporting of items relating to a SW-CRT between full trials 
and protocols is given in Table 9.2. The number of randomisation points (steps) 
was reported explicitly in all protocols, with 81% of full trials explicitly stating the 
number, with it deducible in 97% of full trial reports. The reporting of the 
number of clusters randomised per step was high for both report types (89% vs 
97%). A schematic illustration was included in 25 (89%) of the protocols, 
compared to 66% of full trial reports (p = 0.031). The reporting of the study 
design type was poor for both report types. A high number of full trials reports 
did not report (or did not report clearly) the cluster size (59%). There was a larger 
degree of clarity of cluster size in protocols, with only 32% failing to clearly 
report the cluster size. 
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Table 9.2: Sample size reporting – stepped-wedge Items - Full trials vs Protocols 
  Protocols 
 
N = 28 
Full 
reports 
N = 32 
Absolute difference  
(95% confidence interval) 
P value 
Number of steps     
     Explicitly reported 28 (100) 26 (81) 18.8 (5.2 to 32.3) 0.016 
     Reported or deducible 28 (100) 31 (97) 3.1 (-2.9 to 9.2) 0.346 
Number clusters randomised per step     
    Reported  25 (89) 31 (97) -7.6 (-20.5 to 5.4) 0.240 
Schematic representation      
     Reported 25 (89) 21 (66) 23.7 (3.6 to 43.7) 0.031 
Design type (i.e. cross-sectional/cohort)     
     Explicitly reported 8 (29) 8 (25) 3.6 (-18.9 to  26.0) 0.755 
     Reported or deducible 22 (79) 21 (66) 12.9 (-9.5 to  35.3) 0.267 
Clarity of cluster size1     
     Total cluster size reported 10 (36) 7 (22) 13.8 (-9.0 to 36.6) 0.235 
     Cluster size per measurement period  14 (50) 11(34) 15.6 (-9.2 to  40.4) 0.221 
     Unclear/not reported 9 (32) 19 (59) -30.4 (-54.5 to -6.3) 0.035 
1
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Appendix D 
Derivation of the intra-cluster correlation coefficient 
The intra-cluster correlation coefficient (ICC), is the correlation between two participants in 
the same cluster independent of time. For two participant’s k and k’ in cluster i, the 
correlation between them can be given as: 
𝐼𝐶𝐶 = 𝐶𝑜𝑟𝑟(𝑌𝑖𝑘 , 𝑌𝑖𝑘′) 
Now, the correlation of two outcomes can be estimated using a function of the covariance of 
the two outcomes and their corresponding variances. As such, the ICC can be written as: 




Now, the covariance between 𝑌𝑖𝑘 and 𝑌𝑖𝑘′  can be calculated using the model framework as: 
𝐶𝑜𝑣(𝑌𝑖𝑘, 𝑌𝑖𝑘′) = 𝐶𝑜𝑣(𝛼𝑖 + 𝑖𝑘, 𝛼𝑖 + 𝑖𝑘′) 
= 𝐶𝑜𝑣(𝛼𝑖, 𝛼𝑖) +  𝐶𝑜𝑣( 𝑖𝑘, 𝑖𝑘′) + 𝐶𝑜𝑣(𝛼𝑖, 𝑖𝑘′) + 𝐶𝑜𝑣( 𝑖𝑘, ) 
= 𝑉𝑎𝑟(𝛼𝑖)  = 𝜎𝑏
2 
The variance of 𝑌𝑖𝑘 and 𝑌𝑖𝑘′  can also be calculated as:  
√𝑉𝑎𝑟(𝑌𝑖𝑘) × 𝑉𝑎𝑟(𝑌𝑖𝑘′) = √(𝜎𝑏
2 + 𝜎𝑤2) × (𝜎𝑏2 + 𝜎𝑤2) = 𝜎𝑏
2 + 𝜎𝑤
2 
Now, the ICC can be written as:  
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Appendix E 
Derivation of the within-cluster correlation 
Consider a stepped-wedge cluster randomised trial with T time-periods. 
Let X and Y be randomly chosen observations from within the same cluster. 
We now define J = 1, 0 which indicates whether observations are, or are not, made at the 




      
if X and Y are made at the same time-period
if X and Y are not made at the same time-period
 
Now, let us assume that Var(X) = 2 = 1 
When considering the conditional covariance formula: 
𝑊𝐶𝐶 = 𝑐𝑜𝑣(𝑋, 𝑌) = 𝐸𝑗𝑐𝑜𝑣(𝑋, 𝑌|𝐽) + 𝑐𝑜𝑣𝐽{𝐸(𝑋|𝐽), 𝐸(𝑌|𝐽)} 
Since 𝐸(𝑋|𝐽) is a constant, 𝑐𝑜𝑣𝐽{𝐸(𝑋|𝐽), 𝐸(𝑌|𝐽)} = 0, and so  
𝑊𝐶𝐶 = 𝑐𝑜𝑣(𝑋, 𝑌) = 𝐸𝑗𝑐𝑜𝑣(𝑋, 𝑌|𝐽) 
Now, the term 𝑐𝑜𝑣(𝑋, 𝑌|𝐽) can be broken down into the J = 0 and J = 1 components, so that: 
𝑐𝑜𝑣(𝑋, 𝑌|𝐽 = 0) = 𝐼𝑃𝐶 𝑐𝑜𝑣(𝑋, 𝑌|𝐽 = 1) = 𝑊𝑃𝐶 
 
Now, 𝑃𝑟{𝐽 = 1} =
1
𝑇
= 1 − 𝑃𝑟{𝐽 = 0} 
As such,  






𝑊𝑃𝐶 =  𝐼𝑃𝐶 +
1
𝑇
(𝑊𝑃𝐶 − 𝐼𝑃𝐶)  
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Appendix F 
Derivation of the within-period correlation 
The within-period correlation (WPC), is the correlation between participants in the same 
cluster during the same time-period. For two participant’s k and k’ in cluster i at time j, the 
correlation between them can be given as: 
𝑊𝑃𝐶 = 𝐶𝑜𝑟𝑟(𝑌𝑖𝑗𝑘 , 𝑌𝑖𝑗𝑘′) 
Now, the correlation of two outcomes can be estimated using a function of the covariance of 
the two outcomes and their corresponding variances. As such, the WPC can be written as: 




Now, the covariance between 𝑌𝑖𝑗𝑘 and 𝑌𝑖𝑗𝑘′  can be calculated using the model framework 
as: 
𝐶𝑜𝑣(𝑌𝑖𝑗𝑘, 𝑌𝑖𝑗𝑘′) = 𝐶𝑜𝑣(𝛼𝑖 + 𝜔𝑖𝑗 + 𝑖𝑗𝑘, 𝛼𝑖 + 𝜔𝑖𝑗 + 𝑖𝑗𝑘′) 
= 𝐶𝑜𝑣(𝛼𝑖, 𝛼𝑖) +  𝐶𝑜𝑣(𝛼𝑖, 𝜔𝑖𝑗) +  𝐶𝑜𝑣(𝛼𝑖, 𝑖𝑗𝑘′) + 𝐶𝑜𝑣(𝜔𝑖𝑗, 𝛼𝑖) +  𝐶𝑜𝑣(𝜔𝑖𝑗, 𝜔𝑖𝑗)
+  𝐶𝑜𝑣(𝛼𝑖, 𝑖𝑗𝑘′) + 𝐶𝑜𝑣( 𝑖𝑗𝑘, 𝛼𝑖) +  𝐶𝑜𝑣( 𝑖𝑗𝑘, 𝜔𝑖𝑗) +  𝐶𝑜𝑣( 𝑖𝑗𝑘, 𝑖𝑗𝑘′) 
= 𝑉𝑎𝑟(𝛼𝑖) + 𝑉𝑎𝑟(𝜔𝑖𝑗) = 𝜏
2 + 𝜎𝑡
2  
The variance of 𝑌𝑖𝑗𝑘 and 𝑌𝑖𝑗𝑘′  can also be calculated as: 
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Now, the WPC can be written as:  
𝑊𝑃𝐶 = 𝐶𝑜𝑟𝑟(𝑌𝑖𝑗𝑘, 𝑌𝑖𝑗𝑘′) =
𝜏2 + 𝜎𝑡
2












Derivation of the inter-period correlation 
The inter-period correlation (IPC), indicates the correlation between participants in the same 
cluster at different time-periods. As such, it provides the correlation between participant’s k 
and k’ from cluster i at times j and j’, and can be given as: 
𝐼𝑃𝐶 = 𝐶𝑜𝑟𝑟(𝑌𝑖𝑗𝑘 , 𝑌𝑖𝑗′𝑘′) 
The correlation between two participants k and k’ from cluster i at different time-periods j 
and j’ can be described using their covariance and variance as follows: 





𝐶𝑜𝑣(𝑌𝑖𝑗𝑘 , 𝑌𝑖𝑗′𝑘′) = 𝐶𝑜𝑣(𝛼𝑖 + 𝜔𝑖𝑗 + 𝑖𝑗𝑘, 𝛼𝑖 + 𝜔𝑖𝑗 + 𝑖𝑗′𝑘′) 
= 𝐶𝑜𝑣(𝛼𝑖, 𝛼𝑖) +  𝐶𝑜𝑣(𝛼𝑖, 𝜔𝑖𝑗′) +  𝐶𝑜𝑣(𝛼𝑖, 𝑖𝑗′𝑘′) + 𝐶𝑜𝑣(𝜔𝑖𝑗 , 𝛼𝑖) +  𝐶𝑜𝑣(𝜔𝑖𝑗 , 𝜔𝑖𝑗′)
+  𝐶𝑜𝑣(𝛼𝑖 , 𝑖𝑗′𝑘′) + 𝐶𝑜𝑣( 𝑖𝑗𝑘, 𝛼𝑖) +  𝐶𝑜𝑣( 𝑖𝑗𝑘, 𝜔𝑖𝑗′) +  𝐶𝑜𝑣( 𝑖𝑗𝑘, 𝑖𝑗′𝑘′) 
= 𝑉𝑎𝑟(𝛼𝑖) = 𝜏
2  
And 
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Now, the IPC can be written as: 
𝐼𝑃𝐶 = 𝐶𝑜𝑟𝑟(𝑌𝑖𝑗𝑘, 𝑌𝑖𝑗′𝑘′) =
𝜏2











Table 9.3: Dates used to define periods to estimate the impact of study length on the IPC 
and WPC 
Number of periods Dates for each period 
2 P1: 1st January 2007 to 31st December 2007 
P2: 1st January 2008 to 31st December 2008 
 
3 P1: 1st January 2006 to 31st December 2006 
P2: 1st January 2007 to 31st December 2007 
P3: 1st January 2008 to 31st December 2008 
 
4 P1: 1st January 2005 to 31st December 2005 
P2: 1st January 2006 to 31st December 2006 
P3: 1st January 2007 to 31st December 2007 
P4: 1st January 2008 to 31st December 2008 
 
5 P1: 1st January 2004 to 31st December 2004 
P2: 1st January 2005 to 31st December 2005 
P3: 1st January 2006 to 31st December 2006 
P4: 1st January 2007 to 31st December 2007 
P5: 1st January 2008 to 31st December 2008 
 
6 P1: 1st January 2003 to 31st December 2003 
P2: 1st January 2004 to 31st December 2004 
P3: 1st January 2005 to 31st December 2005 
P4: 1st January 2006 to 31st December 2006 
P5: 1st January 2007 to 31st December 2007 
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Table 9.4: Dates used to define periods to estimate the impact of period length on the IPC 
and WPC 
Number of periods Dates for each period 
2 P1: 1st February 2009 to 15th September 2009 
P2: 16th September 2009 to 30th April 2010 
 
3 P1: 1st February 2009 to 30th June 2009 
P2: 1st July 2009 to 30th November 2009 
P3: 1st December 2009 to 30th April 2010 
 
4 P1: 1st February 2009 to 24th May 2009 
P2: 25th May 2009 to 15th September 2009 
P3: 16th September 2009 to 6th January 2010 
P4: 7th January 2010 to 30th April 2010 
 
5 P1: 1st February 2009 to 30th April 2009 
P2: 1st May 2009 to 31st July 2009 
P3: 1st August 2009 to 31st October 2009 
P4: 1st November 2009 to 31st January 2009 
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Appendix I 
Table 9.5: Intra-cluster correlation coefficients (ICCs) for binary outcomes (dichotomised 
clinical measures) associated with type-2 diabetes from THIN database for study period 







Clinical Measures    
     HbA1c (>7.5) 0.34240 0.037 0.027 
    (0.031 to 0.043) (0.023 to 0.031) 
     Systolic blood pressure (>140) 0.27024 0.0595 0.035 
    (0.051 to 0.069) (0.030 to 0.041) 
     Systolic blood pressure (>130) 0.58416 0.043 0.035 
    (0.037 to 0.050) (0.030 to 0.040) 
     Diastolic blood pressure (>80) 0.24068 0.084 0.045 
    (0.073 to 0.097) (0.039 to 0.051) 
     BMI (>30) 0.49166 0.021 0.015 
    (0.017 to 0.025) (0.013 to 0.019) 
     BMI (>25) 0.83543 0.021 0.010 
    (0.017 to 0.027) (0.008 to 0.012) 
     Total cholesterol (>4) 0.50256 0.026 0.020 
    (0.022 to 0.030) (0.017 to 0.024) 
     HDL cholesterol (<1.2) 0.50389 0.036 0.027 
    (0.031 to 0.043) (0.023 to 0.032) 
Medication    
     Taking of Insulin 0.59059 0.108 0.076 
 Clinical Outcomes   (0.095 to 0.123) (0.067 to 0.087)  
    
     Atrial fibrillation 0.01034 0.010 0.000 
    (0.002 to 0.052) (0.000 to 0.002) 
     Chronic kidney disease 0.00332 0.132 0.002 
    (0.088 to 0.193) (0.002 to 0.003) 
     Chronic obstructive pulmonary 
disease 
0.00804  0.053 0.002 
    (0.032 to 0.087) (0.001 to 0.003) 
     Ischaemic heart disease 0.01061 0.026 0.001 
    (0.011 to 0.060) (0.000 to 0.002) 
     Peripheral vascular disease 0.00537 0.117 0.004 
    (0.084 to 0.162) (0.003 to 0.005) 
     Stroke 0.00410 0.258 0.010 
    (0.200 to 0.325) (0.008 to 0.012) 
1
: Adjusted for age, sex, location, and deprivation quintiles 
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Table 9.6: Estimates of the within-period correlation and inter-period correlation for 
continuous outcomes associated with type-2 diabetes from THIN database for study period 






Clinical measures    
     HbA1c (%) 2 0.0348 0.0186 0.5334 
(0.0298 to 0.0405) 
 
(0.0135 to 0.0255)   
     Systolic blood pressure (mmHg) 3 0.0286 0.0174 0.6107 
(0.0245 to 0.0332) 
 
(0.0127 to 0.0239)   
     Diastolic blood pressure (mmHg) 3  0.0392 0.0287 0.7341 
(0.0339 to 0.0452) 
 
(0.0227 to 0.0364)   
     BMI (kg/m2) 3  0.0219 0.017 0.775 
(0.0186 to 0.0258) 
 
(0.0134 to 0.0216)   
     Total cholesterol (mmol/L) 3  0.021 0.0068 0.3245 
(0.0179 to 0.0247) 
 
(0.0035 to 0.0133)   
     HDL cholesterol (mmol/L) 3  0.0206 0.0175 0.8482 
(0.0175 to 0.0243) (0.0139 to 0.0220)   
WPC: Within-period correlation. IPC: Inter-period correlation. CA: Cluster autocorrelation. CI: Confidence 
interval. BMI: Body mass index. 
1
: Adjusted for age, sex, location, and deprivation quintiles. 
2
: Two consecutive 
12-month periods were used (01/01/2007 – 31/12/2007 & 01/01/2008 – 31/12/2008). 
3
: Two consecutive 15-




Page | 301 
 
Table 9.7: Impact of increasing the study length on the within-period correlation and inter-
period correlation for HbA1c from included participants from THIN database when 











2 2 0.0348 0.0186 0.5334 
(0.0298 to 0.0405) 
 
(0.0135 to 0.0255)   
3 3 0.0382 0.0173 0.4532 
(0.0325 to 0.0448) 
 
(0.0124 to 0.0240)   
4 4 0.0396 0.0176 0.4436 
(0.0337 to 0.0466) 
 
(0.0128 to 0.0241)   
5 5 0.0402 0.0166 0.4136 
(0.0341 to 0.0473) 
 
(0.0119 to 0.0232)   
6 6 0.0412 0.0166 0.4023 
(0.0349 to 0.0486) (0.0119 to 0.0231)   
WPC: Within-period correlation. IPC: Inter-period correlation. CA: Cluster autocorrelation. CI: Confidence 
interval. 
1
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Table 9.8: Impact of period length on the within-period correlation and inter-period 
correlation for continuous outcomes associated with type-2 diabetes from THIN database 
for study period 01/02/2009 to 30/04/2010 from an adjusted model 
Period Length WPC1 (95% CI) IPC1 (95% CI) CA1 
    
7.5 month period length    
Systolic blood pressure (mmHg)  0.040 (0.032 to 0.042) 0.014 (0.010 to 0.020) 0.387 
Diastolic blood pressure (mmHg)  0.040 (0.034 to 0.045) 0.034 (0.028 to 0.040) 0.867 
BMI (kg/m2) 0.022 (0.020 to 0.027) 0.020 (0.017 to 0.024) 0.872 
Total cholesterol (mmol/L) 0.021 (0.017 to 0.024) 0.017 (0.014 to 0.021) 0.869 
HDL cholesterol (mmol/L) 0.023 (0.019 to 0.026) 0.019 (0.015 to 0.023) 0.839 
Median    
    
5 month period length    
Systolic blood pressure (mmHg)  0.042 (0.035 to 0.044) 0.019 (0.015 to 0.024) 0.492 
Diastolic blood pressure (mmHg)  0.041 (0.034 to 0.046) 0.036 (0.030 to 0.042) 0.894 
BMI (kg/m2) 0.024 (0.021 to 0.029) 0.020 (0.017 to 0.024) 0.809 
Total cholesterol (mmol/L) 0.021 (0.017 to 0.024) 0.018 (0.015 to 0.022) 0.875 
HDL cholesterol (mmol/L) 0.024 (0.020 to 0.027) 0.019 (0.016 to 0.023) 0.825 
Median    
    
3.75 month period length    
Systolic blood pressure (mmHg)  0.043 (0.035 to 0.045) 0.021 (0.017 to 0.026) 0.529 
Diastolic blood pressure (mmHg)  0.040 (0.034 to 0.046) 0.036 (0.031 to 0.042) 0.912 
BMI (kg/m2) 0.023 (0.021 to 0.029) 0.021 (0.017 to 0.025) 0.840 
Total cholesterol (mmol/L) 0.022 (0.017 to 0.024) 0.018 (0.015 to 0.022) 0.873 
HDL cholesterol (mmol/L) 0.025 (0.020 to 0.028) 0.019 (0.016 to 0.023) 0.811 
Median    
    
3 month period length    
Systolic blood pressure (mmHg)  0.044 (0.037 to 0.047) 0.022 (0.018 to 0.027) 0.529 
Diastolic blood pressure (mmHg)  0.041 (0.035 to 0.046) 0.037 (0.031 to 0.043) 0.915 
BMI (kg/m2) 0.025 (0.022 to 0.030) 0.021 (0.017 to 0.025) 0.807 
Total cholesterol (mmol/L) 0.022 (0.018 to 0.025) 0.018 (0.015 to 0.022) 0.875 
HDL cholesterol (mmol/L) 0.026 (0.021 to 0.029) 0.020 (0.016 to 0.023) 0.789 
Median    
    
1 month period length    
Systolic blood pressure (mmHg)  0.046 (0.039 to 0.049) 0.025 (0.021 to 0.030) 0.578 
Diastolic blood pressure (mmHg)  0.043 (0.037 to 0.048) 0.037 (0.032 to 0.043) 0.883 
BMI (kg/m2) 0.027 (0.023 to 0.032) 0.021 (0.018 to 0.025) 0.784 
Total cholesterol (mmol/L) 0.022 (0.018 to 0.025) 0.019 (0.016 to 0.022) 0.884 
HDL cholesterol (mmol/L) 0.026 (0.021 to 0.029) 0.020 (0.017 to 0.024) 0.835 
Median    
WPC: Within-period correlation. IPC: Inter-period correlation. CA: Cluster autocorrelation. CI: Confidence 
interval. 
1
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Appendix J 
The Gamma distribution has a scaling property, so that, if ),(~ X ,  the distribution of 
cXY   (where c is some scalar) also follows the Gamma distribution. 
 
Firstly, let X follow a Gamma distribution so that ),(~ X . As such, the moment 
generating function of X can be given as: 
      XXMx 1  
 
Now, let c be a positive, real constant. Now, we consider the transformation cXXgY  )( . 
From this , the moment generating function of Y can be given as: 
          XccXMXMYM XcXY 1  
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Appendix K 
Below, we present the efficiency curves for the simulation study to assess the impact of 
between-cluster variation in a SW-CRT. Results are presented grouped by the number of 
clusters in the SW-CRT.   
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Efficiency of a SW-CRT with 12 clusters 
Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 12 clusters and 2 randomisation steps. Cluster size 
= 72. 
CV = 0.25 
 
CV = 0.5 
  
 
CV = 0.75 
 
 
CV = 1.0 
  
 
CV = 1.25 
 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 12 clusters and 3 randomisation steps. Cluster size 
= 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 12 clusters and 4 randomisation steps. Cluster size 
= 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
  
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 12 clusters and 6 randomisation steps. Cluster size 
= 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 12 clusters and 12 randomisation steps. Cluster 
size = 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency of a SW-CRT with 24 clusters 
Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 24 clusters and 2 randomisation steps. Cluster size 
= 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 24 clusters and 3 randomisation steps. Cluster size 
= 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 24 clusters and 4 randomisation steps. Cluster size 
= 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 24 clusters and 6 randomisation steps. Cluster size 
= 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 24 clusters and 12 randomisation steps. Cluster 
size = 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency of a SW-CRT with 48 clusters 
Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 48 clusters and 2 randomisation steps. Cluster size 
= 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 48 clusters and 3 randomisation steps. Cluster size 
= 72. 
CV = 0.25 
 




CV = 0.75 
  




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 48 clusters and 4 randomisation steps. Cluster size 
= 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 48 clusters and 6 randomisation steps. Cluster size 
= 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 48 clusters and 12 randomisation steps. Cluster 
size = 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency of a SW-CRT with 96 clusters 
Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 96 clusters and 2 randomisation steps. Cluster size 
= 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 96 clusters and 3 randomisation steps. Cluster size 
= 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 96 clusters and 4 randomisation steps. Cluster size 
= 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 96 clusters and 6 randomisation steps. Cluster size 
= 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 96 clusters and 12 randomisation steps. Cluster 
size = 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Appendix L 
Below, we present the efficiency curves for the simulation study to assess the impact of 
between-cluster variation in a P-CRT. Results are presented grouped by the number of 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a P-CRT with 12 clusters. Cluster size = 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a P-CRT with 24 clusters. Cluster size = 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a P-CRT with 48 clusters. Cluster size = 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a P-CRT with 96 clusters. Cluster size = 72. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Appendix M 
Below, we present the efficiency curves for the simulation study to assess the impact of 
within-cluster variation in a SW-CRT. Results are presented grouped by the within-cluster 
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Within-cluster coefficient of variation = 0.25 
Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 12 clusters and 2 randomisation steps. Cluster size 
= 72. The within-cluster coefficient of variation = 0.25. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
   
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 12 clusters and 12 randomisation steps. Cluster 
size = 72. The within-cluster coefficient of variation = 0.25. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 24 clusters and 2 randomisation steps. Cluster size 
= 72. The within-cluster coefficient of variation = 0.25. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 24 clusters and 12 randomisation steps. Cluster 
size = 72. The within-cluster coefficient of variation = 0.25. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Within-cluster coefficient of variation = 0.5 
Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 12 clusters and 2 randomisation steps. Cluster size 
= 72. The within-cluster coefficient of variation = 0.5. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 12 clusters and 12 randomisation steps. Cluster 
size = 72. The within-cluster coefficient of variation = 0.5. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 




Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 24 clusters and 2 randomisation steps. Cluster size 
= 72. The within-cluster coefficient of variation = 0.5. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 24 clusters and 12 randomisation steps. Cluster 
size = 72. The within-cluster coefficient of variation = 0.5. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Within-cluster coefficient of variation = between-cluster coefficient of variation 
Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 12 clusters and 2 randomisation steps. Cluster size 
= 72. The within-cluster coefficient of variation = between-cluster coefficient of variation. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 12 clusters and 12 randomisation steps. Cluster 
size = 72. The within-cluster coefficient of variation = between-cluster coefficient of 
variation. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 24 clusters and 2 randomisation steps. Cluster size 
= 72. The within-cluster coefficient of variation = between-cluster coefficient of variation. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
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Efficiency vs cluster mean correlation (R) for a selection of between-cluster coefficient of 
variation (CV) values for a SW-CRT with 24 clusters and 12 randomisation steps. Cluster 
size = 72. The within-cluster coefficient of variation = between-cluster coefficient of 
variation. 
CV = 0.25 
 




CV = 0.75 
 




CV = 1.25 
 
CV = 1.5 
  
Efficiency is calculated as the ratio of the precision in a SW-CRT with unequal cluster sizes 
compared to the precision in a SW-CRT with equal cluster sizes. R represents the cluster mean 
correlation. 
 
